Home
  >  
Section 55

EurekaMag Full Text Articles Chapter 54,955



References:

Ozierański, P.; McKee, M.; King, L. 2012: Pharmaceutical lobbying under postcommunism: universal or country-specific methods of securing state drug reimbursement in Poland?. Health Economics Policy and Law 7(2): 175-195
Dzhalilova, K.I. 2009: Pharmaceutical logistic in turnover of pharmaceutical products of Azerbaijan. Georgian Medical News 176: 61-65
Gazit, A.Z.; Oren, P.P. 2009: Pharmaceutical management of decompensated heart failure syndrome in children: current state of the art and a new approach. Current Treatment Options in Cardiovascular Medicine 11(5): 403-409
Markman, M. 2008: Pharmaceutical management of ovarian cancer : current status. Drugs 68(6): 771-789
Chen, J.T.; Summers, K.H. 2007: Pharmaceutical manufacturer prescription assistance programs: are they worth it?. Journal of Managed Care Pharmacy: Jmcp 13(7): 611-613
Greig, D.M. 1933: Clinical Studies in the Pathology of Bone. No. III.-A Cicatricial Heterotopic Bone. Edinburgh Medical Journal 40(10): 482-484
Abdollahias, A.; Nikfar, S.; Abdollahi, M. 2011: Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions. Archives of Medical Science: Ams 7(3): 365-367
Greene, J.A.; Kesselheim, A.S. 2010: Pharmaceutical marketing and the new social media. New England Journal of Medicine 363(22): 2087-2089
Greene, J.A. 2007: Pharmaceutical marketing research and the prescribing physician. Annals of Internal Medicine 146(10): 742-748
Anonymous 2010: Pharmaceutical marketing: nurses are also targeted. Prescrire International 19(108): 190
Dor, A. 2010: Pharmaceutical markets and insurance worldwide. Overview. Advances in Health Economics and Health Services Research 22: Xiii-Xxxi
Pollock, A. 2008: Pharmaceutical meaning-making beyond marketing: racialized subjects of generic thiazide. Journal of Law Medicine and Ethics: a Journal of the American Society of Law Medicine and Ethics 36(3): 530-536
Chan, E.C.Y.; New, L.S.; Yap, C.W.; Goh, L.T. 2009: Pharmaceutical metabolite profiling using quadrupole/ion mobility spectrometry/time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry: Rcm 23(3): 384-394
Hellrup, J.; Mahlin, D. 2011: Pharmaceutical micro-particles give amorphous sucrose higher physical stability. International Journal of Pharmaceutics 409(1-2): 96-103
Krause, U.; Harris, S.; Green, A.; Ylostalo, J.; Zeitouni, S.; Lee, N.; Gregory, C.A. 2010: Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proceedings of the National Academy of Sciences of the United States of America 107(9): 4147-4152
Collins, C.J.; Strutwolf, J.ör.; Arrigan, D.W.M. 2011: Pharmaceutical modulation of diffusion potentials at aqueous-aqueous boundaries under laminar flow conditions. Electrophoresis 32(8): 844-849
Hernon, C.; Paoloni, D.; Ganetsky, M. 2007: Pharmaceutical modulation of illicit drug effects. American Journal on Addictions 16(3): 245-246
Moutzouri, E.; Daios, G.; Elisaf, M.; Milionis, H.J. 2010: Pharmaceutical modulation of the Renin Angiotensin aldosterone system for stroke prevention: a review of experimental and clinical evidence. Cns Spectrums 15(11): 619-629
Sander, J.R.G.; Bucar, D-Kresimir.; Henry, R.F.; Zhang, G.G.Z.; MacGillivray, L.R. 2010: Pharmaceutical nano-cocrystals: sonochemical synthesis by solvent selection and use of a surfactant. Angewandte Chemie 49(40): 7284-7288
Peltonen, L.; Hirvonen, J. 2010: Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. Journal of Pharmacy and Pharmacology 62(11): 1569-1579
Aljayyoussi, G.; Abdulkarim, M.; Griffiths, P.; Gumbleton, M. 2012: Pharmaceutical nanoparticles and the mucin biopolymer barrier. Bioimpacts: Bi 2(4): 173-174
Müller, R.H.; Keck, C.M. 2010: Pharmaceutical nanoparticles--from their innovative origin to their future. International Journal of Pharmaceutics 390(1): 1-2
Mei, L.; Zhang, Z.; Zhao, L.; Huang, L.; Yang, X-Liang.; Tang, J.; Feng, S-Shen. 2013: Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Advanced Drug Delivery Reviews 65(6): 880-890
Crommelin, D.J.A.; Park, K.; Florence, A. 2010: Pharmaceutical nanotechnology: Unmet needs in drug delivery. Journal of Controlled Release: Official Journal of the Controlled Release Society 141(3): 263-264
Edwards, N.V. 2008: Pharmaceutical new product development: the increasing role of in-licensing. Anesthesiology Clinics 26(4): 627
Nielsen, S.; Bruno, R.; Lintzeris, N.; Fischer, J.; Carruthers, S.; Stoové, M. 2011: Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?. Drug and Alcohol Review 30(3): 291-299
Monteagudo, E.; Langenheim, M.; Salerno, C.; Buontempo, F.án.; Bregni, C.; Carlucci, A. 2014: Pharmaceutical optimization of lipid-based dosage forms for the improvement of taste-masking, chemical stability and solubilizing capacity of phenobarbital. Drug Development and Industrial Pharmacy 40(6): 783-792
Castillo, J.C.; Humaidan, P.; Bernabéu, R. 2014: Pharmaceutical options for triggering of final oocyte maturation in ART. Biomed Research International 2014: 580171
Jones, C.M.; Mack, K.A.; Paulozzi, L.J. 2013: Pharmaceutical overdose deaths, United States, 2010. JAMA 309(7): 657-659
Furrow, M.E. 2008: Pharmaceutical patent life-cycle management after KSR V. Teleflex. Food and Drug Law Journal 63(1): 275-320
Meiners, C.M.M.d.A. 2008: Pharmaceutical patents and public health: challenges for the Brazilian antiretroviral treatment policy. Cadernos de Saude Publica 24(7): 1467-1478
Antoñanzas, F.; Juárez-Castelló, C.; Rodríguez-Ibeas, R. 2011: Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad. European Journal of Health Economics: Hepac: Health Economics in Prevention and Care 12(5): 393-395
Carroll, N.V. 2007: Pharmaceutical patient assistance programs: don't look a gift horse in the mouth or there's no such thing as a free lunch. Journal of Managed Care Pharmacy: Jmcp 13(7): 614-616
Tsai, Y.-W.; Wen, Y.-W.; Huang, W.-F.; Kuo, K.N.; Chen, P.-F.; Shih, H.-W.; Lee, Y.-C. 2010: Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes. European Journal of Health Economics: Hepac: Health Economics in Prevention and Care 11(3): 279-290
Michielan, L.; Moro, S. 2010: Pharmaceutical perspectives of nonlinear QSAR strategies. Journal of Chemical Information and Modeling 50(6): 961-978
Lowen, T. 2011: Pharmaceutical pipeline. Minnesota Medicine 94(10): 16-18
Stawny, M.; Olijarczyk, R.; Jaroszkiewicz, E.; Jelińska, A. 2013: Pharmaceutical point of view on parenteral nutrition. Thescientificworldjournal 2013: 415310
Lin, Y-Ren.; Liu, T-Hsuan.; Liu, T-An.; Chang, Y-Jun.; Chou, C-Chung.; Wu, H-Ping. 2011: Pharmaceutical poisoning exposure and outcome analysis in children admitted to the pediatric emergency department. Pediatrics and Neonatology 52(1): 11-17
Barros, P.P. 2010: Pharmaceutical policies in European countries. Advances in Health Economics and Health Services Research 22: 3-27
Vogler, S.; Zimmermann, N.; Leopold, C.; de Joncheere, K. 2011: Pharmaceutical policies in European countries in response to the global financial crisis. Southern Med Review 4(2): 69-79
Gasman, N. 2008: Pharmaceutical policies in Mexico: 20 years is nothing. Salud Publica de Mexico 50(Suppl 4): S423-S426
Austvoll-Dahlgren, A.; Aaserud, M.; Vist, G.; Ramsay, C.; Oxman, A.D.; Sturm, H.; Kösters, J.P.; Vernby, A. 2008: Pharmaceutical policies: effects of cap and co-payment on rational drug use. Cochrane Database of Systematic Reviews 1: Cd007017
Acosta, A.; Ciapponi, Aín.; Aaserud, M.; Vietto, V.; Austvoll-Dahlgren, A.; Kösters, J.Peter.; Vacca, C.; Machado, M.; Diaz Ayala, D.Hazbeydy.; Oxman, A.D. 2014: Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Cochrane Database of Systematic Reviews 2014(10): Cd005979
Anonymous 2010: Pharmaceutical policies: effects of restrictions on reimbursement. Obstetrics and Gynecology 117(1): 172-173
Kakihara, H.; Ibuka, Y.; Ma, X. 2013: Pharmaceutical policy and health economics. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(2): 95-99
Sun, Q.; Santoro, M.A.; Meng, Q.; Liu, C.; Eggleston, K. 2008: Pharmaceutical policy in China. Health Affairs 27(4): 1042-1050
Boonen, L.H.H.M.; van der Geest, S.ép.A.; Schut, F.T.; Varkevisser, M. 2010: Pharmaceutical policy in the Netherlands: from price regulation towards managed competition. Advances in Health Economics and Health Services Research 22: 53-76
Rudisill, C.; Vandoros, S.; Antoun, J.G. 2014: Pharmaceutical policy reform in the Russian Federation. Journal of Health Politics Policy and Law 39(3): 691-705
Paton, C. 2010: Pharmaceutical policy, policy for (and management of) human resources and the link between the two. International Journal of Health Planning and Management 25(1): 1
Piñón-Segundo, E.; Nava-Arzaluz, Mía.G.; Lechuga-Ballesteros, D. 2012: Pharmaceutical polymeric nanoparticles prepared by the double emulsion- solvent evaporation technique. Recent Patents on Drug Delivery and Formulation 6(3): 224-235
Daems, R.; Maes, E.; Mehra, M.; Carroll, B.; Thomas, A. 2014: Pharmaceutical portfolio management: global disease burden and corporate performance metrics. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 17(6): 732-738
Schanz, S.J. 2007: Pharmaceutical postmarket review: fact or fiction?. Food and Drug Law Journal 62(3): 493-500
Kannan, R.R.R.; Arumugam, R.; Anantharaman, P. 2013: Pharmaceutical potential of a fucoidan-like sulphated polysaccharide isolated from Halodule pinifolia. International Journal of Biological Macromolecules 62: 30-34
De Santis, I.; Del Busso, M. 2006: Pharmaceutical pottery in the Museum of History of Medicine of Rome "la Sapienza". Medicina Nei Secoli 18(1): 313-330
López-Sánchez, M.; Ruedas-Rama, M.ía.J.é; Ruiz-Medina, A.; Molina-Díaz, A.; Ayora-Cañada, M.ía.J.é 2008: Pharmaceutical powders analysis using FT-Raman spectrometry: simultaneous determination of sulfathiazole and sulfanilamide. Talanta 74(5): 1603-1607
Pimenta, T.ân.S.; Costa, E.á A. 2008: Pharmaceutical practice in Bahia in the latter half of the 19th century. Historia Ciencias Saude--Manguinhos 15(4): 1013-1023
Magidoff, R. 1948: Pharmaceutical practice in Soviet Russia. American Professional Pharmacist 14(2): 150-155
Shukla, K.; Dwivedi, M.; Kumar, N. 2010: Pharmaceutical preparation of Saubhagya Shunthi Churna: a herbal remedy for puerperal women. International Journal of Ayurveda Research 1(1): 25-29
Luurtsema, G.; Boellaard, R.; Greuter, H.N.J.M.; Rijbroek, A.; Takkenkamp, K.; de Geest, F.G.M.; Buijs, F.L.; Harry Hendrikse, N.; Franssen, E.J.F.; van Lingen, A.; Lammertsma, A.A. 2010: Pharmaceutical preparation of oxygen-15 labelled molecular oxygen and carbon monoxide gasses in a hospital setting. Journal of Clinical Pharmacy and Therapeutics 35(1): 63-69
Wild, F. 2013: Pharmaceutical prescription for multiple sclerosis : evaluation of pharmaceutical consumption at private health insurance. Der Nervenarzt 84(2): 202-208
Sanfélix-Gimeno, G.; Peiró, S.; Meneu, R. 2012: Pharmaceutical prescription in primary care. SESPAS report 2012. Gaceta Sanitaria 26 Suppl. 1: 41-45
Timur, A.; Picone, G. 2009: Pharmaceutical price differences in the EU: investigation from cardiovascular disease drugs. Expert Review of Pharmacoeconomics and Outcomes Research 9(3): 251-256
Yfantopoulos, J. 2008: Pharmaceutical pricing and reimbursement reforms in Greece. European Journal of Health Economics: Hepac: Health Economics in Prevention and Care 9(1): 87-97
Danzon, P.M.; Mulcahy, A.W.; Towse, A.K. 2015: Pharmaceutical pricing in emerging markets: effects of income, competition, and procurement. Health Economics 24(2): 238-252
Mrazek, M.F. 2002: Pharmaceutical pricing in the developing world: issues of access to medicines. Expert Review of Pharmacoeconomics and Outcomes Research 2(1): 43-50
Stella, P.; Gold-von Simson, G. 2014: Pharmaceutical pricing, cost containment and new treatments for rare diseases in children. Orphanet Journal of Rare Diseases 9: 152
Tironi, P. 2010: Pharmaceutical pricing: a review of proposals to improve access and affordability of prescription drugs. Annals of Health Law 19(2): 311-365 Preceding i
Wu, J.; Xu, J.; Liu, G.; Wu, J. 2014: Pharmaceutical pricing: an empirical study of market competition in Chinese hospitals. Pharmacoeconomics 32(3): 293-303
Krznaric, Z.; Ljubas Kelecic, D.; Rustemovic, N.; Vranesic Bender, D.; Ostojic, R.; Markos, P.; Scarpignato, C. 2011: Pharmaceutical principles of acid inhibitors: unmet needs. Digestive Diseases 29(5): 469-475
Hernández Rodríguez, M.Ángel.; Orueta Sánchez, Rón. 2013: Pharmaceutical prior authorization: real need or computerized antiquity?. Atencion Primaria 45(2): 81-83
Erntoft, S. 2011: Pharmaceutical priority setting and the use of health economic evaluations: a systematic literature review. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 14(4): 587-599
Chaube, A.; Prajapati, P.K.; Dixit, S.K. 1996: Pharmaceutical processing in panchakarma vis -a-vis polio myelitis. Ancient Science of Life 16(1): 50-59
Jain, D.; Pathak, D.; Pathak, K. 2009: Pharmaceutical product development technologies based on the biopharmaceutical classification system. Die Pharmazie 64(8): 483-490
Hiyama, Y. 2010: Pharmaceutical product quality control and good manufacturing practices. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 128: 1-16
Bunniran, S.; McCaffrey, D.J.; Bentley, J.P.; Bouldin, A.S. 2009: Pharmaceutical product withdrawal: attributions of blame and its impact on trust. Research in Social and Administrative Pharmacy: Rsap 5(3): 262-273
Ogawa, T.; Uchino, T.; Takahashi, D.; Izumi, T.; Otsuka, M. 2012: Pharmaceutical production of tableting granules in an ultra-small-scale high-shear granulator as a pre-formulation study. Drug Development and Industrial Pharmacy 38(11): 1390-1393
Youk, A.O.; Buchanich, J.M.; Marsh, G.M.; Cunningham, M.; Esmen, N.A. 2009: Pharmaceutical production workers and the risks of mortality from respiratory system cancer and lymphatic and hematopoietic tissue cancers. Journal of Occupational and Environmental Medicine 51(8): 903-915
Al-Achi, A.; Greenwood, R.; Nzazi, G. 2000: Pharmaceutical profile of vitamin C tablets and capsules. International Journal of Pharmaceutical Compounding 4(5): 400-403
Kerns, E.H. 2013: Pharmaceutical profiling case study in disruption. Acs Medicinal Chemistry Letters 4(2): 150-152
Troy, D.E.; Gottlieb, S. 2008: Pharmaceutical promotion and First Amendment rights. New England Journal of Medicine 359(5): 536; Author Reply 536-537
Kesselheim, A.S.; Avorn, J. 2008: Pharmaceutical promotion to physicians and First Amendment rights. New England Journal of Medicine 358(16): 1727-1732
Sá, R.d.C.ás.d.S.E.; Almeida, R.N.ób.d.; Bhattacharyya, J. 2013: Pharmaceutical properties and toxicology of Dioclea grandiflora. Pharmaceutical Biology 51(5): 659-667
Gao, J.; Liu, Z.J.; Chen, T.; Zhao, D. 2014: Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract of Radix astragali. Pharmaceutical Biology 52(9): 1217-1222
Chen, J.; Zhang, T.; Cai, B.; Chen, M.; Fang, Y. 2010: Pharmaceutical properties of novel liposomes containing total alkaloids from seed of Strychnos nux-vomica. Zhongguo Zhong Yao Za Zhi 35(1): 35-39
Milne, R. 2012: Pharmaceutical prospects: biopharming and the geography of technological expectations. Social Studies of Science 42(2): 290-306
Shibata, H.; Saito, H.; Yomota, C.; Kawanishi, T. 2009: Pharmaceutical quality evaluation of lipid emulsions containing PGE1: alteration in the number of large particles in infusion solutions. International Journal of Pharmaceutics 378(1-2): 167-176
Vial, J.ér.ôm.; Cohen, M.él.; Sassiat, P.; Thiébaut, D. 2008: Pharmaceutical quality of docetaxel generics versus originator drug product: a comparative analysis. Current Medical Research and Opinion 24(7): 2019-2033
Arnet, I.; Altermatt, M.; Roggo, Y.; Schnetzler, G. 2015: Pharmaceutical quality of eight generics of ceftriaxone preparation for injection in Eastern Asia. Journal of ChemoTherapy 27(6): 337-342
Taylor, P.W.; Arnet, I.; Fischer, A.; Simpson, I.N. 2010: Pharmaceutical quality of nine generic orlistat products compared with Xenical(r). Obesity Facts 3(4): 231-237
Young, S.A.; Thrimawithana, T.R.; Antia, U.; Fredatovich, J.D.; Na, Y.; Neale, P.T.; Roberts, A.F.; Zhou, H.; Russell, B. 2013: Pharmaceutical quality of "party pills" raises additional safety concerns in the use of illicit recreational drugs. New Zealand Medical Journal 126(1376): 61-70
Seear, M. 2012: Pharmaceutical quality: an urgent and unresolved issue. Lancet. Infectious Diseases 12(6): 428-429
Anonymous 2012: Pharmaceutical quality: big pharma also at fault. Prescrire International 21(124): 54
Simmons, S. 2010: Pharmaceutical reduction of breast cancer risk. Nurse Practitioner 35(9): 10-11
Kim, H.-J.; Ruger, J.P. 2008: Pharmaceutical reform in South Korea and the lessons it provides. Health Affairs 27(4): W260-W269
Jeong, H.-S. 2009: Pharmaceutical reforms: implications through comparisons of Korea and Japan. Health Policy 93(2-3): 165-171
Johnson, P.E. 2008: Pharmaceutical reimbursement: an overview. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(2 Suppl 1: S4-10
Zhang, D.Q.; Gersberg, R.M.; Hua, T.; Zhu, J.; Tuan, N.A.; Tan, S.K. 2012: Pharmaceutical removal in tropical subsurface flow constructed wetlands at varying hydraulic loading rates. Chemosphere 87(3): 273-277
Harris, G. 2009: Pharmaceutical representatives do influence physician behaviour. Family Practice 26(3): 169-170
Idris, K.M.; Mustafa, A.F.; Yousif, M.A. 2012: Pharmaceutical representatives' beliefs and practices about their professional practice: a study in Sudan. Eastern Mediterranean Health Journal 18(8): 821-826
Light, D.W.; Lexchin, J.R. 2012: Pharmaceutical research and development: what do we get for all that money?. Bmj 345: E4348
Antonucci, R.; Pilloni, M.D.; Atzori, L.; Fanos, V. 2012: Pharmaceutical research and metabolomics in the newborn. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 25(Suppl 5): 22-26
Auby, P. 2008: Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective. Child and Adolescent Psychiatry and Mental Health 2(1): 38
Mano, T. 2009: Pharmaceutical research in the early stages of drug discovery--significance and practice. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 133(3): 149-153
Swaan, P.W. 2009: Pharmaceutical research-looking ahead. Pharmaceutical Research 26(3): 491
Thomson, D.L. 1946: Pharmaceutical research; the past and future. American Professional Pharmacist 8: 737
Fatta-Kassinos, D.; Meric, S.; Nikolaou, A. 2011: Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Analytical and Bioanalytical Chemistry 399(1): 251-275
Radović, T.; Grujić, S.; Dujaković, N.; Radišić, M.; Vasiljević, T.; Petković, A.đe.; Boreli-Zdravković, D.; Dimkić, M.; Laušević, M. 2012: Pharmaceutical residues in the Danube River Basin in Serbia - a two-year survey. Water Science and Technology: a Journal of the International Association on Water Pollution Research 66(3): 659-665
Guerrero-Preston, R.; Brandt-Rauf, P. 2008: Pharmaceutical residues in the drinking water supply: modeling residue concentrations in surface waters of drugs prescribed in the United States. Puerto Rico Health Sciences Journal 27(3): 236-240
Sacher, F.; Ehmann, M.; Gabriel, S.; Graf, C.; Brauch, H-Jürgen. 2008: Pharmaceutical residues in the river Rhine--results of a one-decade monitoring programme. Journal of Environmental Monitoring: Jem 10(5): 664-670
Bogner, R.H.; Kleinebudde, P.; Nail, S. 2010: Pharmaceutical review articles: from good to great. Pharmaceutical Development and Technology 15(5): 439-441
Poulson, L.K.; Nissen, L.; Coombes, I. 2010: Pharmaceutical review using telemedicine--a before and after feasibility study. Journal of Telemedicine and Telecare 16(2): 95-99
Aydinkarahaliloglu, N.D.; Aykac, E.; Kasap, Y.; Durmus, N.; Babacanoglu, C.; Basgut, C.E.; Artiran, G.; Kerman, S. 2013: Pharmaceutical risk management in Turkey: the first national overview. Regulatory Toxicology and Pharmacology: Rtp 67(3): 344-350
Cook, J.P.; Vernon, J.A.; Manning, R. 2008: Pharmaceutical risk-sharing agreements. Pharmacoeconomics 26(7): 551-556
McAllister, R.A. 1983: Pharmaceutical sales. Canadian Veterinary Journal 24(9): 298
Mintzes, B.; Lexchin, J.; Wilkes, M.S.; Beaulieu, M-Dominique.; Reynolds, E.; Sutherland, J.; Durrieu, Gève. 2014: Pharmaceutical sales representatives and patient safety. Journal of General Internal Medicine 28(11): 1395
Peterson, A.F. 1946: Pharmaceutical sales training and professional relations. American Journal of Pharmaceutical Education 10: 173-202
Tilborg, A.ël.; Norberg, B.; Wouters, J. 2014: Pharmaceutical salts and cocrystals involving amino acids: a brief structural overview of the state-of-art. European Journal of Medicinal Chemistry 74: 411-426
Thompson, D.F.; Nahata, M.C. 2012: Pharmaceutical science faculty publication records at research-intensive pharmacy colleges and schools. American journal of pharmaceutical education 76(9): 173
Ooi, K.; Takamura, N. 2010: Pharmaceutical science in acute care that requires clinical sense. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 130(4): 575-576
Buckley, J.P. 1966: Pharmaceutical sciences (np). Science 151(3712): 874-875
Ma, Y.; Luo, Y.; Song, L.; Qin, F.; Hou, L. 2013: Pharmaceutical screening of the effective fraction from Smilax for treatment of chronic pelvic inflammatory disease. Nan Fang Yi Ke da Xue Xue Bao 33(1): 145-149
Frimas, C.é 2012: Pharmaceutical services at the Hôtel-Dieu d'Amboise during the 17th and 18th centuries: an evolution into the hospital environment?. Revue de la Societe Francaise d'Histoire des Hopitaux 143: 27-30
Emmerick, I.C.M.; Luiza, V.L.; Pepe, V.L.E. 2009: Pharmaceutical services evaluation in Brazil: broadening the results of a WHO methodology. Ciencia and Saude Coletiva 14(4): 1297-1306
Suárez-Mutis, M.C.; de Souza, P.P.; Freitas, L.íc.F.; Miranda, E.S.; Campos, M.ôn.R.; Osorio-de-Castro, C.G. 2011: Pharmaceutical services for endemic situations in the Brazilian Amazon: organization of services and prescribing practices for Plasmodium vivax and Plasmodium falciparum non-complicated malaria in high-risk municipalities. Malaria Journal 10: 335
Higuchi, M.; Matsuo, K.; Ureshino, Y.; Ogata, K.; Futagami, K.; Kitamura, K.; Nishino, H. 2009: Pharmaceutical services for patients receiving AC chemotherapy. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(2): 241-245
Escutia Gutiérrez, R.; Cortéz Álvarez, César.R.; Alvarez Álvarez, R.M.; Flores Hernández, J.Lv.; Gutiérrez Godínez, Jéssica.; López Y López, Jé.G. 2007: Pharmaceutical services in a Mexican pain relief and palliative care institute. Pharmacy Practice 5(4): 174-178
Tanret, I.; Duh, D. 2012: Pharmaceutical sheet. Symphytum officinale L., dermal use (Flexagile cream). Journal de Pharmacie de Belgique 1: 41-42
Antal, I.án.; Zelkó, R.án. 2008: Pharmaceutical significance of amorphous materials. Acta Pharmaceutica Hungarica 78(3): 121-133
Boumil, M.M.; Cutrell, E.S.; Lowney, K.E.; Berman, H.A. 2012: Pharmaceutical speakers' bureaus, academic freedom, and the management of promotional speaking at academic medical centers. Journal of Law Medicine and Ethics: a Journal of the American Society of Law Medicine and Ethics 40(2): 311-325
Radecki, R.Patrick. 2011: Pharmaceutical sponsorship bias influences thrombolytic literature in acute ischemic stroke. Western Journal of Emergency Medicine 12(4): 435-441
Snyder, H.E. 2012: Pharmaceutical spray drying: solid-dose process technology platform for the 21st century. Therapeutic Delivery 3(7): 901-912
Muthu, M.S.; Feng, S.-S. 2009: Pharmaceutical stability aspects of nanomedicines. Nanomedicine 4(8): 857-860
Parmar, K.K.G.; Galib; Patgiri, B.J. 2012: Pharmaceutical standardization of Jala Shukti Bhasma and Mukta Shukti Bhasma. Ayu 33(1): 136-142
Tanna, S.P.; Patgiri, B.; Shukla, V.J.; Prajapati, P.K. 2012: Pharmaceutical standardization of Mamajjaka (Enicostemma littorale Auct. non Bl) Ghana. Ayu 33(2): 294-298
Gokarn, R.A.; Rajput, D.S.; Patgiri, B. 2012: Pharmaceutical standardization of Samaguna Bali Jarita Rasasindura prepared by conventional and modified method. Ancient Science of Life 31(3): 123-128
Gokarn, R.A.; Rajput, D.S.; Yadav, P.; Galib; Patgiri, B.; Prajapati, P.K. 2013: Pharmaceutical standardization of Svarṇa vaṅga. Ancient Science of Life 33(2): 97-102
Motheral, B.R. 2011: Pharmaceutical step-therapy interventions: a critical review of the literature. Journal of Managed Care Pharmacy: Jmcp 17(2): 143-155
Sauve, A.A. 2009: Pharmaceutical strategies for activating sirtuins. Current Pharmaceutical Design 15(1): 45-56
Njarðarson, J.T. 2012: Pharmaceutical structure montages as catalysts for design and discovery. Future Medicinal Chemistry 4(8): 951-954
Singh, N.; Reddy, K.R.C. 2010: Pharmaceutical study of Lauha Bhasma. Ayu 31(3): 387-390
Dhundi, S.N.; Patgiri, B.; Prajapati, P.K.; Shukla, V.J.; Ravishankar, B. 2012: Pharmaceutical study of Triguna and Shadguna Balijarita Makaradhwaja. Ayu 33(3): 412-417
Bhojashettar, S.; Jadar, P.G.; Rao, V.N. 2012: Pharmaceutical study of Yashadabhasma. Ancient Science of Life 31(3): 90-94
Taki, H.; Ogawa, K.; Nikai, T. 2008: Pharmaceutical study of suppository formulations for improved in vivo kinetics of rifampicin. Kekkaku: 83(6): 451-456
Feng, Y.; Lin, X.; Shen, L.; Hong, Y.-L. 2013: Pharmaceutical study on multi-component traditional Chinese medicines. Zhongguo Zhong Yao Za Zhi 38(5): 629-632
Yu, X.; Li, C.; Shi, Y.; Yu, M. 2010: Pharmaceutical supply chain in China: current issues and implications for health system reform. Health Policy 97(1): 8-15
Jaberidoost, M.; Nikfar, S.; Abdollahiasl, A.; Dinarvand, R. 2013: Pharmaceutical supply chain risks: a systematic review. Daru: Journal of Faculty of Pharmacy Tehran University of Medical Sciences 21(1): 69
Okumura, J.; Nishita, Y.; Kimura, K. 2008: Pharmaceutical supply for disaster victims who need chronic disease management in region with aging population based on lessons learned from the Noto Peninsula Earthquake in 2007. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 128(9): 1275-1283
Varga, D. 1954: Pharmaceutical supply in 1954. A Gyogyszeresz 9(2): 24-25
Lane, A.T. 2006: Pharmaceutical support of dermatology residency electives: slippery slope or synergy?. Virtual Mentor: Vm 8(8): 509-511
Harsha, S. 2013: Pharmaceutical suspension containing both immediate/sustained-release amoxicillin-loaded gelatin nanoparticles: preparation and in vitro characterization. Drug Design Development and Therapy 7: 1027-1033
Remon, J.P. 2007: Pharmaceutical technology and pharmaceutical care in the dispensary. Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 69(3): 131-148
Leung, M.Y.; Halpern, M.T.; West, N.D. 2012: Pharmaceutical technology assessment: perspectives from payers. Journal of Managed Care Pharmacy: Jmcp 18(3): 256-264
Allémann, E.; Delie, F.; Lange, N. 2012: Pharmaceutical technology at the service of targeted drug delivery. Chimia 66(5): 308-312
Puthli, S.P. 2010: Pharmaceutical technology management--profitable business avenue. Expert Opinion on Drug Delivery 7(1): 1-5
Youn, Y.S.; Lee, B.-J. 2011: Pharmaceutical technology, biopharmaceutics and drug delivery. Therapeutic Delivery 2(3): 297-299
Goepel, M. 2009: Pharmaceutical therapy for bladder dysfunction disorders. Der Urologe. Ausg. a 48(3): 227
Visco, C.J.; Cheng, D.S.; Kennedy, D.J. 2011: Pharmaceutical therapy for radiculopathy. Physical Medicine and Rehabilitation Clinics of North America 22(1): 127-137
Yang, M.; Song, L.; Wang, J.; Tong, X.-q.; Zou, Y.-h. 2009: Pharmaceutical therapy for the severe hemodynamic depression with carotid artery stenting. Beijing da Xue Xue Bao. Yi Xue Ban 41(3): 373-375
Lehmann, G.; Wolf, G. 2014: Pharmaceutical therapy of bone metabolism disorders in chronic kidney disease mineral bone disorder (CKD-MBD) with special respect to antiresorptive substances. Zeitschrift für Rheumatologie 73(4): 329-334
Láng, I.án.; Kahán, Z.; Pintér, T.ás.; Dank, M.; Boér, K.; Pajkos, G.áb.; Faluhelyi, Z.; Pikó, B.él.; Eckhardt, S.án.; Horváth, Z. 2010: Pharmaceutical therapy of breast cancer. Magyar Onkologia 54(3): 237-254
Madureira, T.ân.V.; Barreiro, J.C.; Rocha, M.J.ão.; Cass, Q.B.; Tiritan, M.E. 2009: Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography-ion trap tandem mass spectrometry. Journal of Chromatography. a 1216(42): 7033-7042
Ferrer, E. 2010: Pharmaceutical trademarks: navigating through the FDA's pilot program. Drug News and Perspectives 23(5): 333-336
Anonymous 2010: Pharmaceutical training for clinicians. DiseaseModelsandMechanisms 3(7-8): 401
Bartus, R.T.; Dean, R.L. 2009: Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps. Psychopharmacology 202(1-3): 15-36
Fountoulakis, K.N. 2010: Pharmaceutical treatment of acute bipolar depression. F1000 Medicine Reports 2
Schmid, S.C.; Gschwend, J.E.; Retz, M. 2014: Pharmaceutical treatment of advanced urinary bladder cancer: new developments in 2014. Der Urologe. Ausg. a 53(10): 1535-1542
Sinha, A.-M.; Brachmann, J.; Schmidt, M. 2008: Pharmaceutical treatment of atrial fibrillation. Herzschrittmachertherapie and Elektrophysiologie 19(2): 50-59
Túry, F.; Németh, A. 2009: Pharmaceutical treatment of binge eating disorder. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 11(2): 55-56
Köhler, S.; Bauer, M.; Bschor, T. 2014: Pharmaceutical treatment of bipolar depression. Evidence from clinical guidelines and treatment recommendations. Der Nervenarzt 85(9): 1075-1083
Pedersen, L.; Palshof, T. 2009: Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review. Ugeskrift for Laeger 171(39): 2830-2833
Axelsson, P.B.; Bjerrum, F.; Løkkegaard, E.C.L. 2014: Pharmaceutical treatment of lactation deficiency lacks evidence. Ugeskrift for Laeger 176(9a): V06130415
Carlsen, K.-H.åk.; Carlsen, K.C.L. 2008: Pharmaceutical treatment strategies for childhood asthma. Current Opinion in Allergy and Clinical Immunology 8(2): 168-176
Romain, O. 2013: Pharmaceutical updates. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 20(3): 329-332
Mullins, C.D. 2009: Pharmaceutical use and outcomes in children. Clinical Therapeutics 31(2): 420
Morgan, S.; Macgibbon, B. 2007: Pharmaceutical use and outcomes: always a need for a sober second look. Healthcare Policy 3(1): 10-22
Zathurecky, L. 1954: Pharmaceutical use of Kuzmice bentonite. A Gyogyszeresz 9(8): 141-144
Garzás-Martín de Almagro, M.C.; López-Malo de Molina, M.D.; Abellón Ruiz, J.; Fernández García, I.; Isla Tejera, B. 2008: Pharmaceutical validation and error detection in the prescription of antineoplastics in oncohematological patients. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 32(5): 286-289
Chniti, A.; Boussadi, A.; Degoulet, P.; Albert, P.; Charlet, J. 2012: Pharmaceutical validation of medication orders using an OWL Ontology and Business Rules. Studies in Health Technology and Informatics 180: 1224-1226
Principe, P.P. 1995: Pharmaceutical value estimates. Science 268(5217): 1551
Pore, S.M. 2014: Pharmaceutical waste from hospitals and homes: need for better strategies. Indian Journal of Pharmacology 46(4): 459-460
Morris, K. 2011: Pharmaceutical waste problem solved, or not. Ohio Nurses Review 86(4): 12-14
Vallini, G.; Townend, W.K. 2010: Pharmaceutical waste: as in the Titanic we are only seeing the tip of the iceberg. Waste Management and Research: the Journal of the International Solid Wastes and Public Cleansing Association Iswa 28(9): 767-768
Anonymous 2007: Pharmaceutical waste: environmental and regulatory considerations. Healthcare hazard management monitor: HHMM: the newsletter of the Center for Healthcare Environmental Management 20(10): 1-7
Wang, K.; Liu, S.; Zhang, Q.; He, Y. 2009: Pharmaceutical wastewater treatment by internal micro-electrolysis--coagulation, biological treatment and activated carbon adsorption. Environmental Technology 30(13): 1469-1474
Davis, J.J.; Cross, E.; Crowley, J. 2007: Pharmaceutical websites and the communication of risk information. Journal of Health Communication 12(1): 29-39
Ploug, T.; Holm, Søren. 2013: Pharmaceutical "nudging"--reinterpreting the ethics of evaluative conditioning. American Journal of Bioethics: Ajob 13(5): 25-27
Ahmed, A.B.A.; Adel, M.; Karimi, P.; Peidayesh, M. 2014: Pharmaceutical, cosmeceutical, and traditional applications of marine carbohydrates. Advances in Food and Nutrition Research 73: 197-220
De Klerck, K.; Vander Heyden, Y.; Mangelings, D. 2014: Pharmaceutical-enantiomers resolution using immobilized polysaccharide-based chiral stationary phases in supercritical fluid chromatography. Journal of Chromatography. a 1328: 85-97
Simpson, B.; Khatri, R.; Ravindran, D.; Udalagama, T. 2015: Pharmaceuticalisation and ethical review in South Asia: issues of scope and authority for practitioners and policy makers. Social Science and Medicine 131: 247-254
Martín, J.; Santos, J.L.; Aparicio, I.; Alonso, E. 2015: Pharmaceutically active compounds in sludge stabilization treatments: anaerobic and aerobic digestion, wastewater stabilization ponds and composting. Science of the Total Environment 503-504: 97-104
Zhang, L.; Liu, J.; Tian, T.; Gao, Y.; Ji, X.; Li, Z.; Luan, Y. 2013: Pharmaceutically active ionic liquid self-assembled vesicles for the application as an efficient drug delivery system. Chemphyschem: a European Journal of Chemical Physics and Physical Chemistry 14(15): 3454-3457
Bica, K.; Rodríguez, H.éc.; Gurau, G.; Cojocaru, O.A.; Riisager, A.; Fehrmann, R.; Rogers, R.D. 2012: Pharmaceutically active ionic liquids with solids handling, enhanced thermal stability, and fast release. Chemical Communications 48(44): 5422-5424
Manivasagan, P.; Venkatesan, J.; Sivakumar, K.; Kim, S.-K. 2014: Pharmaceutically active secondary metabolites of marine actinobacteria. Microbiological Research 169(4): 262-278
Ye, H.; Charpin-El Hamri, G.; Zwicky, K.; Christen, M.; Folcher, M.; Fussenegger, M. 2013: Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America 110(1): 141-146
Otagiri, M.; Chuang, V.Tuan.Giam. 2009: Pharmaceutically important pre- and posttranslational modifications on human serum albumin. Biological and Pharmaceutical Bulletin 32(4): 527-534
Dam, A.K.; Datta, N.; Mohanty, U.R.; Khanna, P. 2013: Pharmaceutically less and holistically more. JAMA Internal Medicine 173(11): 948
Khandare, J.; Haag, R. 2010: Pharmaceutically used polymers: principles, structures, and applications of pharmaceutical delivery systems. Handbook of Experimental Pharmacology 197: 221-250
Raveendran, S.; Yoshida, Y.; Maekawa, T.; Kumar, D.S. 2013: Pharmaceutically versatile sulfated polysaccharide based bionano platforms. Nanomedicine: Nanotechnology Biology and Medicine 9(5): 605-626
Busch, S.H.; Barry, C.L. 2009: Pediatric antidepressant use after the black-box warning. Health Affairs 28(3): 724-733
Masuyama, K. 2013: Pharmaceuticals and Medical Devices Agency (PMDA)'s new action for Pharmaceutical Affairs Consultation on Research and Development (R&D) Strategy. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 133(2): 183-186
Morgan, G. 1987: Pharmaceuticals and agriculture. Canadian Veterinary Journal 28(5): 240
Rottman, S.J. 2008: Pharmaceuticals and chronic diseases in disaster preparedness. Prehospital and Disaster Medicine 23(5): 459-460
Sui, Q.; Wang, D.; Zhao, W.; Huang, J.; Yu, G.; Cao, X.; Qiu, Z.; Lu, S. 2015: Pharmaceuticals and consumer products in four wastewater treatment plants in urban and suburb areas of Shanghai. Environmental Science and Pollution Research International 22(8): 6086-6094
Meghea, A. 2008: Pharmaceuticals and cosmeceuticals based on soft nanotechnology techniques with antioxidative, immunostimulative and other therapeutic activities. Recent Patents on Nanotechnology 2(2): 137-145
Benotti, M.J.; Snyder, S.A. 2009: Pharmaceuticals and endocrine disrupting compounds: implications for ground water replenishment with recycled water. Ground Water 47(4): 499-502
Justo, A.; González, O.; Aceña, J.; Pérez, S.; Barceló, D.; Sans, C.; Esplugas, S. 2013: Pharmaceuticals and organic pollution mitigation in reclamation osmosis brines by UV/H2O2 and ozone. Journal of Hazardous Materials 263 Pt 2: 268-274
Zheng, S.-K.; Li, X.-F. 2013: Pharmaceuticals and personal care products (PPCPs) in the effluent of sewage treatment plants. Huan Jing Ke Xue= Huanjing Kexue 34(8): 3316-3326
Blair, B.D.; Crago, J.P.; Hedman, C.J.; Klaper, R.D. 2013: Pharmaceuticals and personal care products found in the Great Lakes above concentrations of environmental concern. Chemosphere 93(9): 2116-2123
Lv, M.; Sun, Q.; Hu, A.; Hou, L.; Li, J.; Cai, X.; Yu, C.-P. 2014: Pharmaceuticals and personal care products in a mesoscale subtropical watershed and their application as sewage markers. Journal of Hazardous Materials 280: 696-705
Baron, P.A.; Love, D.C.; Nachman, K.E. 2014: Pharmaceuticals and personal care products in chicken meat and other food animal products: a market-basket pilot study. Science of the Total Environment 490: 296-300
Oulton, R.L.; Kohn, T.; Cwiertny, D.M. 2010: Pharmaceuticals and personal care products in effluent matrices: a survey of transformation and removal during wastewater treatment and implications for wastewater management. Journal of Environmental Monitoring: Jem 12(11): 1956-1978
Bu, Q.; Wang, B.; Huang, J.; Deng, S.; Yu, G. 2013: Pharmaceuticals and personal care products in the aquatic environment in China: a review. Journal of Hazardous Materials 262: 189-211
Kookana, R.S.; Moggridge, B.; Mihinui, R.; Gray, B.; Northcott, G.; Boxall, A. 2013: Pharmaceuticals and personal care products in the environment: cultural and spiritual perspectives. Integrated Environmental Assessment and Management 9(1): 164-166
Boxall, A.B.A.; Rudd, M.A.; Brooks, B.W.; Caldwell, D.J.; Choi, K.; Hickmann, S.; Innes, E.; Ostapyk, K.; Staveley, J.P.; Verslycke, T.; Ankley, G.T.; Beazley, K.F.; Belanger, S.E.; Berninger, J.P.; Carriquiriborde, P.; Coors, A.; Deleo, P.C.; Dyer, S.D.; Ericson, J.F.; Gagné, Fçois.; Giesy, J.P.; Gouin, T.; Hallstrom, L.; Karlsson, M.V.; Larsson, D.G.Joakim.; Lazorchak, J.M.; Mastrocco, F.; McLaughlin, A.; McMaster, M.E.; Meyerhoff, R.D.; Moore, R.; Parrott, J.L.; Snape, J.R.; Murray-Smith, R.; Servos, M.R.; Sibley, P.K.; Straub, Jürg.Oliver.; Szabo, N.D.; Topp, E.; Tetreault, G.R.; Tr 2012: Pharmaceuticals and personal care products in the environment: what are the big questions?. Environmental Health Perspectives 120(9): 1221-1229
Brooks, B.W.; Huggett, D.B.; Boxall, A.B.A. 2009: Pharmaceuticals and personal care products: research needs for the next decade. Environmental Toxicology and Chemistry 28(12): 2469-2472
Rodriguez-Mozaz, S.; Ricart, M.; Köck-Schulmeyer, M.; Guasch, H.; Bonnineau, C.; Proia, L.; de Alda, M.L.; Sabater, S.; Barceló, D.à 2015: Pharmaceuticals and pesticides in reclaimed water: Efficiency assessment of a microfiltration-reverse osmosis (MF-RO) pilot plant. Journal of Hazardous Materials 282: 165-173
Gilpin, R.K.; Gilpin, C.S. 2007: Pharmaceuticals and related drugs. Analytical Chemistry 79(12): 4275-4293
Gilpin, R.K.; Gilpin, C.S. 2009: Pharmaceuticals and related drugs. Analytical Chemistry 81(12): 4679-4694
Gilpin, R.K.; Gilpin, C.S. 2011: Pharmaceuticals and related drugs. Analytical Chemistry 83(12): 4489-4507
Zito, J.M. 2012: Pharmaceuticals and the health of the public: use, safety, cost, access, ethics, and quality. Medical Care 50(11): 907-909
Stewart, A.; Cordell, G.A. 2007: Pharmaceuticals and the strategic national stockpile program. Dental Clinics of North America 51(4): 857
Rivera-Utrilla, J.é; Sánchez-Polo, M.; Ferro-García, M.ía.Án.; Prados-Joya, G.; Ocampo-Pérez, R.úl. 2013: Pharmaceuticals as emerging contaminants and their removal from water. a review. Chemosphere 93(7): 1268-1287
Agunbiade, F.O.; Moodley, B. 2014: Pharmaceuticals as emerging organic contaminants in Umgeni River water system, KwaZulu-Natal, South Africa. Environmental Monitoring and Assessment 186(11): 7273-7291
Mennigen, J.A.; Stroud, P.; Zamora, J.M.; Moon, T.W.; Trudeau, V.L. 2011: Pharmaceuticals as neuroendocrine disruptors: lessons learned from fish on Prozac. Journal of Toxicology and Environmental Health. Part B Critical Reviews 14(5-7): 387-412
Grung, M.; Langford, K.; Thomas, K.V. 2012: Pharmaceuticals as pollution. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 132(10): 1249-1251
Jönsson, B.; Wilking, N. 2010: Pharmaceuticals can be cost-effective in the long run. Lakartidningen 107(16): 1081-1085
Pisu, M.; Richman, J.; Allison, J.J.; Williams, O.Dale.; Kiefe, C.I. 2009: Pharmaceuticals companies' medication assistance programs: potentially useful but too burdensome to use?. Southern Medical Journal 102(2): 139-144
Barrett, A.M.; Levy, C.E.; Gonzalez Rothi, L.J. 2007: Pharmaceuticals for poststroke and brain injury rehabilitation. American Journal of Physical Medicine and Rehabilitation 86(8): 603-604
Price, D.W.; Raebel, M.A.; Conner, D.A.; Wright, L.A.; Carroll, N.M. 2009: Pharmaceuticals from development to practice: learnings from an online curriculum. American Journal of Managed Care 15(12): E109-E114
Hill, R.T.; Fenical, W. 2010: Pharmaceuticals from marine natural products: surge or ebb?. Current Opinion in Biotechnology 21(6): 777-779
Pomati, F. 2007: Pharmaceuticals in drinking water: is the cure worse than the disease?. Environmental Science and Technology 41(24): 8204
Leal, J.E.; Thompson, A.N.; Brzezinski, W.A. 2010: Pharmaceuticals in drinking water: local analysis of the problem and finding a solution through awareness. Journal of the American Pharmacists Association: Japha 50(5): 600-603
Frédéric, O.; Yves, P. 2014: Pharmaceuticals in hospital wastewater: their ecotoxicity and contribution to the environmental hazard of the effluent. Chemosphere 115: 31-39
Lahti, M.; Oikari, A. 2011: Pharmaceuticals in settleable particulate material in urban and non-urban waters. Chemosphere 85(5): 826-831
Leung, H.W.; Jin, L.; Wei, S.; Tsui, M.M.P.; Zhou, B.; Jiao, L.; Cheung, P.C.; Chun, Y.K.; Murphy, M.B.; Lam, P.K.S. 2013: Pharmaceuticals in tap water: human health risk assessment and proposed monitoring framework in China. Environmental Health Perspectives 121(7): 839-846
Corcoran, J.; Winter, M.J.; Tyler, C.R. 2010: Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish. Critical Reviews in Toxicology 40(4): 287-304
Agamuthu, P.; Fauziah, S.H. 2011: Pharmaceuticals in the environment, a prescription for disaster?. Waste Management and Research: the Journal of the International Solid Wastes and Public Cleansing Association Iswa 29(4): 349-350
Eissen, M.; Backhaus, D. 2011: Pharmaceuticals in the environment: an educational perspective. Environmental Science and Pollution Research International 18(9): 1555-1566
Brooks, B.W.; Berninger, J.P.; Kristofco, L.A.; Ramirez, A.J.; Stanley, J.K.; Valenti, T.W. 2012: Pharmaceuticals in the environment: lessons learned for reducing uncertainties in environmental risk assessment. Progress in Molecular Biology and Translational Science 112: 231-258
Küster, A.; Adler, N. 2014: Pharmaceuticals in the environment: scientific evidence of risks and its regulation. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 369(1656)
Collado, N.; Rodriguez-Mozaz, S.; Gros, M.; Rubirola, A.; Barceló, D.; Comas, J.; Rodriguez-Roda, I.; Buttiglieri, G. 2014: Pharmaceuticals occurrence in a WWTP with significant industrial contribution and its input into the river system. Environmental Pollution 185: 202-212
Tawfik, K.A.; Jabeen, A. 2013: Pharmaceuticals safety practices-a comparative pilot study. International Journal of Health Sciences 7(3): 317-324
Rosi-Marshall, E.J.; Kincaid, D.W.; Bechtold, H.A.; Royer, T.V.; Rojas, M.; Kelly, J.J. 2013: Pharmaceuticals suppress algal growth and microbial respiration and alter bacterial communities in stream biofilms. Ecological Applications: a Publication of the Ecological Society of America 23(3): 583-593
Rowe, S.M.; Clancy, J.P. 2009: Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 23(3): 165-174
Friedman, G.D.; Jiang, S.-F.; Udaltsova, N.; Chan, J.; Quesenberry, C.P.; Habel, L.A. 2009: Pharmaceuticals that cause mammary gland tumors in animals: findings in women. Breast Cancer Research and Treatment 116(1): 187-194
Mathis, J.M.; Golovac, S.; Cho, C.H. 2010: Pharmaceuticals used in image-guided spine interventions. Neuroimaging Clinics of North America 20(2): 215-222
Kleywegt, S.; Pileggi, V.; Yang, P.; Hao, C.; Zhao, X.; Rocks, C.; Thach, S.; Cheung, P.; Whitehead, B. 2011: Pharmaceuticals, hormones and bisphenol a in untreated source and finished drinking water in Ontario, Canada--occurrence and treatment efficiency. Science of the Total Environment 409(8): 1481-1488
Stone, G.W. 2009: Ischaemia versus bleeding: the art of clinical decision-making. Lancet 373(9665): 695-696
Schaider, L.A.; Rudel, R.A.; Ackerman, J.M.; Dunagan, S.C.; Brody, J.G. 2014: Pharmaceuticals, perfluorosurfactants, and other organic wastewater compounds in public drinking water wells in a shallow sand and gravel aquifer. Science of the Total Environment 468-469: 384-393
Kumar, A.; Xagoraraki, I. 2010: Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system. Science of the Total Environment 408(23): 5972-5989
Jorgensen, P.D. 2013: Pharmaceuticals, political money, and public policy: a theoretical and empirical agenda. Journal of Law Medicine and Ethics: a Journal of the American Society of Law Medicine and Ethics 41(3): 561-570
Nishtar, S. 2006: Pharmaceuticals--strategic considerations in health reforms in Pakistan. Jpma. Journal of the Pakistan Medical Association 56(12 Suppl 4: S100-S111
Cohen, J. 2013: Pharmaceuticals. Advocates protest the cost of a hepatitis C cure. Science 342(6164): 1302-1303
Stone, R. 2009: Pharmaceuticals. Betting on biotech to transform Guangdong, China's export hub. Science 325(5936): 21
Haugh, R. 2010: Pharmaceuticals. Disease foundations prime the drug pump. Hospitals and Health Networks 84(2): 19
Kean, S. 2011: Pharmaceuticals. Pfizer's shakeup means less money for research. Science 331(6018): 658
Anonymous 1983: Pharmacia fine chemicals. Analytical Chemistry 55(13): 1284A
Wan, X.; Chen, X. 2009: Molecular cloning and expression analysis of a CXC chemokine gene from large yellow croaker Pseudosciaena crocea. Veterinary Immunology and Immunopathology 127(1-2): 156-161
Inoue, S.; Hashimoto, N.; Hoshi, S.; Matsubara, M. 1985: Separation of trans-1,2-cyclohexanediaminetetra-acetic acid chelates of bismuth(III), iron(III) and copper(II) by reversed-phase paired-ion chromatography. Talanta 32(12): 1093-1096
Boyles, J.H. 1981: Allergy problems from ;hidden' corn. Western Journal of Medicine 134(1): 86
Cunha, F. 1935: Pharmacies and Prescriptions of the Sixteenth Century. California and Western Medicine 43(1): 36-39
Shiraishi, T.; Ebihara, T.; Kushida, K. 2009: Pharmacies and home-care--today's status quo and problems. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(Suppl 1): 92-94
Curtò, L.; Perrone, G.; Saitta, G. 2014: Pharmacies and structured self-monitoring of blood glucose: Farm&Dia group experience (a survey in Southern Italy). European Journal of Internal Medicine 25(5): E59-E60
Kushida, K.; Shiraishi, T.; Yamamaru, J.; Ebihara, T. 2008: Pharmacies as healthcare delivering facilities in home care. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(Suppl 1): 65-67
Hammett, T.M.; Phan, S.; Gaggin, J.; Case, P.; Zaller, N.; Lutnick, A.; Kral, A.H.; Fedorova, E.V.; Heimer, R.; Small, W.; Pollini, R.; Beletsky, L.; Latkin, C.; Des Jarlais, D.C. 2014: Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries. Bmc Health Services Research 14: 261
Henderson, J. 1948: Pharmacies become health information centers. Journal of the American Pharmaceutical Association. American Pharmaceutical Association 9(6): 348
Barlas, S. 2013: Pharmacies cannot directly bill medicare for compounded drugs sent to physicians. P and T: a Peer-Reviewed Journal for Formulary Management 38(1): 7
Józsa, L.ás.ó 2009: Pharmacies in Byzantium. Lege Artis Medicinae: Uj Magyar Orvosi Hirmondo 19(2): 167-168
Rostotsky, J. 1945: Pharmacies in Soviet war hospitals. Australasian Journal of Pharmacy 26: 650
Nicolas, M.èl. 2012: Pharmacies of the past in Istanbul. Revue d'Histoire de la Pharmacie 60(373): 29-40
Rich, D.S. 2010: Pharmacies' noncompliance with 2009 Joint Commission hospital accreditation requirements. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 67(2): 144-147
Jacobs, M.; Sherry, P.S.; Taylor, L.M.; Amato, M.; Tataronis, G.R.; Cushing, G. 2012: Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study. Journal of the American Pharmacists Association: Japha 52(5): 613-621
Raynal, Cécile.; Lefebvre, T.; Tixier, L. 2007: Pharmacist Louis Tixier (1870-1958) and the beginnings of Hydroxydase. Revue d'histoire de la pharmacie 55(354): 233-247
Petroianu, G.A.; Salzer, T. 2011: Pharmacist Theodor Salzer (1833-1900) and the discovery of bisphosphonates. Die Pharmazie 66(10): 804-807
Legris, M-Ève.; Séguin, Némie.Charbonneau.; Desforges, K.; Sauvé, P.; Lord, A.; Bell, R.; Berbiche, D.; Desrochers, J-François.; Lemieux, J-Philippe.; Morin-Bélanger, C.; Ste-Marie Paradis, Fçois.; Lalonde, L. 2011: Pharmacist Web-based training program on medication use in chronic kidney disease patients: impact on knowledge, skills, and satisfaction. Journal of continuing education in the health professions 31(3): 140-150
Miller, K.; McGraw, M.A.; Tomsey, A.; Hegde, G.G.; Shang, J.; O'Neill, J.M.; Venkat, A. 2014: Pharmacist addition to the post-ED visit review of discharge antimicrobial regimens. American Journal of Emergency Medicine 32(10): 1270-1274
Mogensen, C.Backer.; Olsen, I.; Thisted, A.Rehn. 2013: Pharmacist advice is accepted more for medical than for surgical patients in an emergency department. Danish Medical Journal 60(8): A4682
Zaller, N.; Jeronimo, A.; Bratberg, J.; Case, P.; Rich, J.D. 2010: Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI. Journal of Urban Health: Bulletin of the new York Academy of Medicine 87(6): 942-953
McKinnon, A.; Jorgenson, D. 2009: Pharmacist and physician collaborative prescribing: for medication renewals within a primary health centre. Canadian Family Physician Medecin de Famille Canadien 55(12): E86-E91
Jacobson Vann, J.C.; Christofferson, S.; Humble, C.G.; Wegner, S.E.; Feaganes, J.R.; Trygstad, T.K. 2010: Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program. Journal of Managed Care Pharmacy: Jmcp 16(4): 250-263
Kelly, D.V.; Bishop, L.; Young, S.; Hawboldt, J.; Phillips, L.; Keough, T.M. 2013: Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project. Canadian Pharmacists Journal: Cpj 146(4): 218-226
Petit, D.W. 1971: Pharmacist and the physician. California Medicine 115(1): 96
Ohsawa, M.; Kawamura, K. 2013: Pharmacist as a real "gatekeeper" for the prevention of suicide, overdosage and depression: what should we need?. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 133(6): 597-598
Shimane, T. 2013: Pharmacist as gatekeeper: combating medication abuse and dependence. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 133(6): 617-630
Cretton-Scott, E.; Johnson, L.; King, S. 2011: Pharmacist attire and its impact on patient preference. Pharmacy Practice 9(2): 66-71
Brewer, N.T.; Chung, J.K.; Baker, H.M.; Rothholz, M.C.; Smith, J.S. 2014: Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention. Gynecologic Oncology 132 Suppl. 1: S3-S8
Cai, H.; Dai, H.; Hu, Y.; Yan, X.; Xu, H. 2013: Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials. Bmc Health Services Research 13: 461
De Araújo, A.d.L.A.é; Pereira, L.R.ég.L.; Ueta, J.M.; de Freitas, O. 2008: Pharmacist care in the Brazilian primary health care system. Ciencia and Saude Coletiva 13 Suppl: 611-617
Koshman, S.L.; Charrois, T.L.; Simpson, S.H.; McAlister, F.A.; Tsuyuki, R.T. 2008: Pharmacist care of patients with heart failure: a systematic review of randomized trials. Archives of Internal Medicine 168(7): 687-694
Jameson, J.P.; Baty, P.J. 2010: Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. American Journal of Managed Care 16(4): 250-255
Flynn, D.P. 2008: Pharmacist conscience clauses and access to oral contraceptives. Journal of Medical Ethics 34(7): 517-520
Tan, E.C.K.; Stewart, K.; Elliott, R.A.; George, J. 2014: Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS). Research in Social and Administrative Pharmacy: Rsap 10(4): 623-632
Preslaski, C.R.; Lat, I.; MacLaren, R.; Poston, J. 2013: Pharmacist contributions as members of the multidisciplinary ICU team. Chest 144(5): 1687-1695
Thompson, C.A. 2012: Pharmacist converted frustration about drug shortages into action. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 69(3): 182-184
Feifer, R.A.; Greenberg, L.; Rosenberg-Brandl, S.; Franzblau-Isaac, E. 2010: Pharmacist counseling at the start of therapy: patient receptivity to offers of in-person and subsequent telephonic clinical support. Population Health Management 13(4): 189-193
Cocohoba, J.M.; Althoff, K.N.; Cohen, M.; Hu, H.; Cunningham, C.O.; Sharma, A.; Greenblatt, R.M. 2012: Pharmacist counseling in a cohort of women with HIV and women at risk for HIV. Patient Preference and Adherence 6: 457-463
Bisharat, B.; Hafi, L.; Baron-Epel, O.; Armaly, Z.; Bowirrat, A. 2012: Pharmacist counseling to cardiac patients in Israel prior to discharge from hospital contribute to increasing patient's medication adherence closing gaps and improving outcomes. Journal of Translational Medicine 10: 34
Kudla, N. 2014: Pharmacist demand and the need for expanded postgraduate training. Journal of the American Pharmacists Association: Japha 54(3): 215
Barker, A.; Barlis, P.; Berlowitz, D.; Page, K.; Jackson, B.; Lim, W.K. 2012: Pharmacist directed home medication reviews in patients with chronic heart failure: a randomised clinical trial. International Journal of Cardiology 159(2): 139-143
Bhattacharya, D.; Wright, D.J.; Purvis, J.R. 2008: Pharmacist domiciliary visiting in England: identifying the characteristics associated with continuation. Pharmacy World and Science: Pws 30(1): 9-16
Polgreen, L.A. 2012: Pharmacist earnings by gender: a small gap or a big issue?. Research in Social and Administrative Pharmacy: Rsap 8(4): 272-273
Kitahara, T. 2012: Pharmacist education from the view point of infection control pharmacist. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan 132(12): 1339-1343
Greig, D.M. 1933: Clinical Studies in the Pathology of Bone. No. II.-Localized Unilateral Spondylitis. Edinburgh Medical Journal 40(9): 413-416
Greig, D.M. 1934: Clinical Studies in the Pathology of Bone. No. IV.-A Plated Fracture. Edinburgh Medical Journal 41(1): 43-44
Ajdukovic, M.; Crook, M.; Angley, C.; Stupans, I.; Soulsby, N.; Doecke, C.; Anderson, B.; Angley, M. 2007: Pharmacist elicited medication histories in the Emergency Department: Identifying patient groups at risk of medication misadventure. Pharmacy Practice 5(4): 162-168
Sipkoff, M. 2009: Spend a little more on selected patients for payoff down the line. Managed Care 18(8): 20
Greig, D.M. 1934: Clinical Studies in the Pathology of Bone. No. V.-An Epidural Abscess. Edinburgh Medical Journal 41(2): 120-121
Hogue, M.D.; Bugdalski-Stutrud, C.; Smith, M.; Tomecki, M.; Burns, A.; Kliethermes, M.Ann.; Beatty, S.; Beiergrohslein, M.; Trygstad, T.; Trewet, C. 2013: Pharmacist engagement in medical home practices: report of the APhA-APPM Medical Home Workgroup. Journal of the American Pharmacists Association: Japha 53(2): E118-E124
Traynor, K. 2014: Pharmacist fits on high-intensity transitional care team. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 71(13): 1066-1068
Mularski, K.S.; Yeh, C.P.; Bains, J.K.; Mosen, D.M.; Hill, A.K.; Mularski, R.A. 2012: Pharmacist glycemic control team improves quality of glycemic control in surgical patients with perioperative dysglycemia. Permanente Journal 16(1): 28-33
Werble, W. 1947: Pharmacist heads Army's new Medical Service Corps. American Druggist 116(5): 92
Traynor, K. 2008: Pharmacist helps autoworkers manage diabetes on the job. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(21): 1990-1991
Vink, J.; Morton, D.; Ferreri, S. 2011: Pharmacist identification of medication-related problems in the home care setting. Consultant Pharmacist: the Journal of the American Society of Consultant Pharmacists 26(7): 477-484
Jellinek, S.P.; Cohen, V.; Fancher, L.B.; Likourezos, A.; Lyke, M.; Peterson, K.; Lashley, E.; Davidson, S.J. 2010: Pharmacist improves timely administration of medications to boarded patients in the emergency department. Journal of Emergency Nursing 36(2): 105-110
Brook-Barclay, L.; Delaney, C.L.; Scicchitano, M.; Quinn, S.; Spark, J.I. 2014: Pharmacist influence on prescribing in peripheral arterial disease (PIPER). Vascular Medicine 19(2): 118-124
Jackson, A.N.; Orr, K.K.; Bratberg, J.P.; Silverblatt, F. 2014: Pharmacist initiation of postexposure doxycycline for Lyme disease prophylaxis. Journal of the American Pharmacists Association: Japha 54(1): 69-73
Bolesta, S.; Trombetta, D.P.; Longyhore, D.S. 2011: Pharmacist instruction of physical assessment for pharmacy students. American Journal of Pharmaceutical Education 75(2): 29
Hashemipour, Z.; Delgado, G.; Dehoorne-Smith, M.; Edwin, S.B. 2013: Pharmacist integration into cardiac arrest response teams. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 70(8): 662; 664 666-667
Kozminski, M.; Busby, R.; McGivney, M.S.; Klatt, P.M.; Hackett, S.R.; Merenstein, J.H. 2011: Pharmacist integration into the medical home: qualitative analysis. Journal of the American Pharmacists Association: Japha 51(2): 173-183
Abramowitz, P.W.; Shane, R.; Daigle, L.A.; Noonan, K.A.; Letendre, D.E. 2012: Pharmacist interdependent prescribing: a new model for optimizing patient outcomes. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 69(22): 1976-1981
Landau, S.; Besinque, K.; Chung, F.; Dries-Daffner, I.; Maderas, N.M.; McGhee, B.T.; Foster, D.G. 2009: Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States. Journal of the American Pharmacists Association: Japha 49(1): 43-50
Al Hamarneh, Y.N.; Charrois, T.; Lewanczuk, R.; Tsuyuki, R.T. 2013: Pharmacist intervention for glycaemic control in the community (the RxING study). Bmj Open 3(9): E003154
Chan, A.L.; Hsieh, H.-J.; Lin, S.-J. 2009: Pharmacist intervention in activated protein C therapy for severe sepsis: influence on health and economic outcomes. International Journal of Clinical Pharmacology and Therapeutics 47(4): 229-235
Alsabbagh, M.W.; Lemstra, M.; Eurich, D.; Wilson, T.W.; Robertson, P.; Blackburn, D.F. 2012: Pharmacist intervention in cardiac rehabilitation: a randomized controlled trial. Journal of Cardiopulmonary Rehabilitation and Prevention 32(6): 394-399
Marino, E.L.; Alvarez-Rubio, L.; Miro, S.; Modamio, P.; Banos, F.; Lastra, C.F.; Alberdi-Leniz, A. 2009: Pharmacist intervention in treatment of patients with genotype 1 chronic hepatitis C. Journal of Managed Care Pharmacy: Jmcp 15(2): 147-150
Morgado, M.; Rolo, S.; Castelo-Branco, M. 2011: Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. International Journal of Clinical Pharmacy 33(1): 132-140
Ibañez-Cuevas, V.; Lopez-Briz, E.; Guardiola-Chorro, M.T. 2008: Pharmacist intervention reduces gastropathy risk in patients using NSAIDs. Pharmacy World and Science: Pws 30(6): 947-954
Amariles, P.; Sáez-Benito, B.L.; Faus, M.J. 2007: Pharmacist interventions focus in high impact journals. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 31(6): 380-382
Zhang, H.-X.; Li, X.; Huo, H.-Q.; Liang, P.; Zhang, J.-P.; Ge, W.-H. 2014: Pharmacist interventions for prophylactic antibiotic use in urological inpatients undergoing clean or clean-contaminated operations in a Chinese hospital. Plos one 9(2): E88971
Dolder, C.; Szymanski, B.; Symanski, B.; Wooton, T.; McKinsey, J. 2008: Pharmacist interventions in an inpatient geriatric psychiatry unit. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(19): 1795-1796
Reddel, H.K.; Bosnic-Anticevich, S.Z.; Amour, C.L.; Basheti, I. 2008: Pharmacist interventions in asthma. European Respiratory Journal 32(3): 812; Author Reply 812
Shen, J.; Sun, Q.; Zhou, X.; Wei, Y.; Qi, Y.; Zhu, J.; Yan, T. 2011: Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital. International Journal of Clinical Pharmacy 33(6): 929-933
Morgado, M.P.; Morgado, S.R.; Mendes, L.C.; Pereira, Lísa.J.; Castelo-Branco, M. 2011: Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(3): 241-253
Santschi, V.ér.; Chiolero, A.; Paradis, G.; Colosimo, A.L.; Burnand, B. 2012: Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care 35(12): 2706-2717
Rollins, C.J. 2015: Pharmacist interventions: unique perspective versus taking the lead in nutrition support when knowledge and skills overlap with other healthcare disciplines. JPEN. Journal of Parenteral and Enteral Nutrition 39(4): 381-382
Cooper, B.E. 2007: Pharmacist involvement in a rapid-response team at a community hospital. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(7): 694; 697-698
Pucci, A. 2013: Pharmacist involvement in establishing a patient-centered medical home. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 70(10): 842-844
Hoy, S. 2010: Pharmacist involvement in fall prevention. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 67(16): 1312
Babb, V.J.; Babb, J. 2003: Pharmacist involvement in healthy people 2010. Journal of the American Pharmaceutical Association 43(1): 56-60
Benavides, S.; Rodriguez, J.C.; Maniscalco-Feichtl, M. 2009: Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Annals of PharmacoTherapy 43(1): 85-97
Chahine, E.B.; Nornoo, A.O. 2012: Pharmacist involvement in medical missions: planning, execution, and assessment. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 69(8): 636; 638 640-643
Wal, P.; Wal, A.; Bhandari, A.; Pandey, U.; Rai, A.K. 2013: Pharmacist involvement in the patient care improves outcome in hypertension patients. Journal of Research in Pharmacy Practice 2(3): 123-129
Young, D. 2007: Pharmacist leads new security office. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(11): 1130 1134
Choe, H.M.; Bernstein, S.J.; Mueller, B.A.; Walker, P.C.; Stevenson, J.G.; Standiford, C.J. 2009: Pharmacist leads primary care team to improve diabetes care. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 66(7): 622-624
Romanelli, F. 2010: Pharmacist licensure: time to step it up?. American Journal of Pharmaceutical Education 74(5)
Sease, J.M.; Franklin, M.A.; Gerrald, K.R. 2013: Pharmacist management of patients with diabetes mellitus enrolled in a rural free clinic. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 70(1): 43-47
Wertheimer, A.I. 2014: Pharmacist manpower planning: whose responsibility is it?. International Journal of Pharmacy Practice 22(5): 305-306
Bergsbaken, J.; Schulz, L.T.; Trapskin, P.J.; Marx, J.; Safdar, N. 2014: Pharmacist participation in infection prevention: an innovative approach to monitoring compliance with the Five Moments for Hand Hygiene in a large academic medical center. American Journal of Infection Control 42(3): 331-332
Wallace, K.L.; Beckett, R.D.; Sheehan, A.H. 2014: Pharmacist perception and use of UpToDate®. Journal of the Medical Library Association: Jmla 102(4): 296-300
Tansriprapasiri, K.; Speedie, S.M. 2008: Pharmacist perceptions of a medication error reporting system in Thai hospitals. AMIA .. Annual Symposium Proceedings. AMIA Symposium 2008: 1151
Maitreemit, P.; Pongcharoensuk, P.; Kapol, N.; Armstrong, E.P. 2008: Pharmacist perceptions of new competency standards. Pharmacy Practice 6(3): 113-120
Wheeler, A.; Hale, A.; Jensen, M.; Coombes, I.; Stokes, J.; Stowasser, D.; Nissen, L. 2010: Pharmacist prescribers. Journal of Primary Health Care 2(1): 72-73
de Lemos, Mário.L. 2008: Pharmacist prescribing. Cmaj: Canadian Medical Association Journal 178(1): 65
Lynas, K. 2013: Pharmacist prescribing for minor ailments could significantly relieve pressure on ERs, say New Brunswick pharmacists. Canadian Pharmacists Journal: Cpj 146(2): 70-72
McCann, L.; Haughey, S.; Parsons, C.; Lloyd, F.; Crealey, G.; Gormley, G.J.; Hughes, C.M. 2011: Pharmacist prescribing in Northern Ireland: a quantitative assessment. International Journal of Clinical Pharmacy 33(5): 824-831
Gardner, J.S.; Downing, D.F.; Blough, D.; Miller, L.; Le, S.; Shotorbani, S. 2008: Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study. Journal of the American Pharmacists Association: Japha 48(2): 212-226
Hale, A.; Gibbs, H.; Coombes, I.; Collins, R.; Maycock, E.; Nissen, L. 2014: Pharmacist prescribing of venous thromboembolism prophylaxis in a surgical pre-admission clinic. Anaesthesia and Intensive Care 42(4): 519-520
Bacovsky, R.A. 2012: Pharmacist prescribing: has the momentum started?. Canadian Journal of Hospital Pharmacy 65(6): 421-426
Jabbal, R. 2010: Pharmacist prescribing: improving access to care in mental health. Journal of the Canadian Academy of Child and Adolescent Psychiatry 19(1): 3-4
Nissen, L. 2011: Pharmacist prescribing: what are the next steps?. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(24): 2357-2361
Blair, M.M.; Carmichael, J.; Young, E.; Thrasher, K. 2007: Pharmacist privileging in a health system: Report of the Qualified Provider Model Ad Hoc Committee. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(22): 2373-2381
Pincock, L.L.; Montello, M.J.; Tarosky, M.J.; Pierce, W.F.; Edwards, C.W. 2011: Pharmacist readiness roles for emergency preparedness. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(7): 620-623
Saad, A.H.; Sweet, B.V.; Stumpf, J.L.; Gruppen, L.; Oh, M.; Stevenson, J.G. 2007: Pharmacist recognition of and adherence to medication-use policies and safety practices. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(19): 2050-2054
Kirwin, J.L.; Cunningham, R.J.; Sequist, T.D. 2010: Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial. Journal of Managed Care Pharmacy: Jmcp 16(2): 104-113
Gavaza, P.; Brown, C.M.; Lawson, K.A.; Rascati, K.L.; Steinhardt, M.; Wilson, J.P. 2012: Pharmacist reporting of serious adverse drug events to the Food and Drug Administration. Journal of the American Pharmacists Association: Japha 52(5): E109-E112
Naunton, M.; Kyle, G.; Owoka, F.; Naunton-Boom, K. 2014: Pharmacist review prevents evolving metformin-associated lactic acidosis. Journal of Clinical Pharmacy and Therapeutics 39(5): 567-570
Terriff, C.M.; Newton, S. 2008: Pharmacist role in emergency preparedness. Journal of the American Pharmacists Association: Japha 48(6): 702; 707
Hale, K.M.; Murawski, M.M.; Huerta, J. 2009: Pharmacist roles in combating prescription drug abuse. Journal of the American Pharmacists Association: Japha 49(5): 589-592
Sisson, E.; Kuhn, C. 2009: Pharmacist roles in the management of patients with type 2 diabetes. Journal of the American Pharmacists Association: Japha 49(Suppl 1): S41-S45
Knight, D.E.; Draeger, R.W.; Heaton, P.C.; Patel, N.C. 2008: Pharmacist screening for depression among patients with diabetes in an urban primary care setting. Journal of the American Pharmacists Association: Japha 48(4): 518-521
Cannon-Breland, M.L.; Westrick, S.C.; Kavookjian, J.; Berger, B.A.; Shannon, D.M.; Lorenz, R.A. 2013: Pharmacist self-reported antidepressant medication counseling. Journal of the American Pharmacists Association: Japha 53(4): 390-399
Tan, E.C.K.; Stewart, K.; Elliott, R.A.; George, J. 2014: Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Research in Social and Administrative Pharmacy: Rsap 10(4): 608-622
Durfee, S.M. 2012: Pharmacist specialty certification. Jpen. Journal of Parenteral and Enteral Nutrition 36(2 Suppl): 51s-52s
Dawoud, D.; Griffiths, P.; Maben, J.; Goodyer, L.; Greene, R. 2011: Pharmacist supplementary prescribing: a step toward more independence?. Research in Social and Administrative Pharmacy: Rsap 7(3): 246-256
Thompson, C.A.; Anderson, R. 2014: Pharmacist supporter Ron Anderson dies at 68. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 71(21): 1828-1830
Sherman, E.M.; Elrod, S.; Allen, D.; Eckardt, P. 2014: Pharmacist testers in multidisciplinary health care team expand HIV point-of-care testing program. Journal of Pharmacy Practice 27(6): 578-581
Holden, C. 1979: Pharmacist to head FDA. Science 205(4412): 1235
Young, D. 2007: Pharmacist travels medication safety path. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(9): 912; 916
Alkhateeb, F.M.; Clauson, K.A.; Latif, D.A. 2011: Pharmacist use of social media. International Journal of Pharmacy Practice 19(2): 140-142
Johnson, T.J. 2008: Pharmacist work force in 2020: implications of requiring residency training for practice. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(2): 166-170
Malone, D.C.; Abarca, J.; Skrepnek, G.H.; Murphy, J.E.; Armstrong, E.P.; Grizzle, A.J.; Rehfeld, R.A.; Woosley, R.L. 2007: Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions. Medical Care 45(5): 456-462
Ho, L.; Akada, K.; Messner, H.; Kuruvilla, J.; Wright, J.; Seki, J.T. 2013: Pharmacist's Role in Improving Medication Safety for Patients in an Allogeneic Hematopoietic Cell Transplant Ambulatory Clinic. Canadian Journal of Hospital Pharmacy 66(2): 110-117
Patanwala, A.E.; Hays, D.P. 2010: Pharmacist's activities on a trauma response team in the emergency department. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 67(18): 1536-1538
Ferris, D. 2010: Pharmacist's assistance after Haiti earthquake. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 67(14): 1138; 1141
Hugener-Sheffield, H. 2008: Pharmacist's awakening in Guatemala. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(2): 117-118
Pottie, K.; Haydt, S.; Farrell, B.; Kennie, N.; Sellors, C.; Martin, C.; Dolovich, L. 2009: Pharmacist's identity development within multidisciplinary primary health care teams in Ontario; qualitative results from the IMPACT project. Research in Social and Administrative Pharmacy: Rsap 5(4): 319-326
Badger, N.; Mullis, S.; Butler, K.; Tucker, D. 2007: Pharmacist's intervention for older hospitalized patients. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(17): 1794-1796
Laven, A.; Läer, S. 2013: Pharmacist's requirements for evidence-based self-medication guidelines. Medizinische Monatsschrift für Pharmazeuten 36(3): 102-110
Poon, L.H.; Lee, A.J.; Chiao, T.B.; Kang, G.A.; Heath, S.; Glass, G.A. 2012: Pharmacist's role in a Parkinson's disease and movement disorders clinic. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 69(6): 518-520
Packard, K.; Herink, M.; Kuhlman, P. 2012: Pharmacist's role in an interdisciplinary cardiac rehabilitation team. Journal of Allied Health 41(3): 113-117; 117a; 117b
Flores, E.K.; Henry, R.; Stewart, D.W. 2011: Pharmacist's role in an interdisciplinary falls clinic. Southern Medical Journal 104(2): 143-146
Gilmartin, C. 2007: Pharmacist's role in managing anemia in patients with chronic kidney disease: potential clinical and economic benefits. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(13 Suppl 8: S15
Hamrosi, K.K.; Raynor, D.K.; Aslani, P. 2014: Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?. Research in Social and Administrative Pharmacy: Rsap 10(4): 656-668
De Winter, S.; Spriet, I.; Indevuyst, C.; Vanbrabant, P.; Desruelles, D.; Sabbe, M.; Gillet, J.Bernard.; Wilmer, A.; Willems, L. 2010: Pharmacist- versus physician-acquired medication history: a prospective study at the emergency department. Quality and Safety in Health Care 19(5): 371-375
Reeder, T.A.; Mutnick, A. 2008: Pharmacist- versus physician-obtained medication histories. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(9): 857-860
Rabi, S.M.; Padiyara, R.S. 2008: Pharmacist-administered admission histories: focus on immunizations in medication reconciliation. Annals of PharmacoTherapy 42(5): 728-729
Picardo, C.; Ferreri, S. 2010: Pharmacist-administered subcutaneous depot medroxyprogesterone acetate: a pilot randomized controlled trial. Contraception 82(2): 160-167
Watanabe, N.; Yamamura, K.; Suzuki, Y.; Umegaki, H.; Shigeno, K.; Matsushita, R.; Sai, Y.; Miyamoto, K-Ichi.; Yamada, K. 2012: Pharmacist-based Donepezil Outpatient Consultation Service to improve medication persistence. Patient Preference and Adherence 6: 605-611
Feret, B.; Bratberg, J. 2008: Pharmacist-based intervention to prepare residents of assisted-living facilities for emergencies. Journal of the American Pharmacists Association: JAPhA 48(6): 780-783
Vinks, T.H.A.M.; Egberts, T.C.G.; de Lange, T.M.; de Koning, F.H.P. 2009: Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs and Aging 26(2): 123-133
Lee, Y.-Y.; Kuo, L.-N.; Chiang, Y.-C.; Hou, J.-Y.; Wu, T.-Y.; Hsu, M.-H.; Chen, H.-Y. 2013: Pharmacist-conducted medication reconciliation at hospital admission using information technology in Taiwan. International Journal of Medical Informatics 82(6): 522-527
Hayes, B.D.; Donovan, J.L.; Smith, B.S.; Hartman, C.A. 2007: Pharmacist-conducted medication reconciliation in an emergency department. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(16): 1720-1723
Hooper, R.; Adam, A.; Kheir, N. 2009: Pharmacist-documented interventions during the dispensing process in a primary health care facility in Qatar. Drug Healthcare and Patient Safety 1: 73-80
Greenwood, B.C.; Szumita, P.M.; Lowry, C.M. 2009: Pharmacist-driven aminoglycoside quality improvement program. Journal of ChemoTherapy 21(1): 42-45
Barnes, K.D.; Tayal, N.H.; Lehman, A.M.; Beatty, S.J. 2014: Pharmacist-driven renal medication dosing intervention in a primary care patient-centered medical home. PharmacoTherapy 34(12): 1330-1335
Russell, E.J.; Roberts, D.; Lee, M. 2010: Pharmacist-driven seasonal influenza immunization program for health care workers. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 67(23): 1984-1985
Leschisin, R.K.; Martin, B.A. 2007: Pharmacist-facilitated tobacco-cessation services in an inpatient setting. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(22): 2386-2389
Salvo, M.; Nigro, S.C.; Ward, D. 2012: Pharmacist-generated electronic consults to improve hypertension management in a multisite health centre: pilot study. Informatics in Primary Care 20(3): 181-184
Sauvageot, J.; Kirkpatrick, M.Ann.F.; Spray, J.W. 2008: Pharmacist-implemented pharmaceutical manufacturers' assistance programs: effects on health outcomes for seniors. Consultant Pharmacist: the Journal of the American Society of Consultant Pharmacists 23(10): 809-812
Bereznicki, B.J.; Peterson, G.M.; Jackson, S.L.; Walters, H.; Fitzmaurice, K.; Gee, P. 2008: Pharmacist-initiated general practitioner referral of patients with suboptimal asthma management. Pharmacy World and Science: Pws 30(6): 869-875
Marra, C.A.; Cibere, J.; Grubisic, M.; Grindrod, K.A.; Gastonguay, L.; Thomas, J.M.; Embley, P.; Colley, L.; Tsuyuki, R.T.; Khan, K.M.; Esdaile, J.M. 2012: Pharmacist-initiated intervention trial in osteoarthritis: a multidisciplinary intervention for knee osteoarthritis. Arthritis Care and Research 64(12): 1837-1845
Efjestad, A.S.; Molden, E.; Oksengård, A.R. 2013: Pharmacist-initiated management of antagonistic interactions between anticholinergic drugs and acetyl cholinesterase inhibitors in individuals with dementia. Journal of the American Geriatrics Society 61(9): 1624-1625
Winfrey, C.; Wortman, S.; Frede, S.; Kunze, N.; Conrad, W.F.; Heaton, P.C. 2011: Pharmacist-initiated peripheral arterial disease screening program in a community pharmacy setting. Journal of the American Pharmacists Association: Japha 51(3): 373-377
Mills, B.; Fensterheim, L.; Taitel, M.; Cannon, A. 2014: Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital. Vaccine 32(4): 521-525
Arcebido, R.; Wong, E.; Cohen, V.; Likourezos, A. 2013: Pharmacist-led discharge counseling on subcutaneous insulin use and administration. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 70(16): 1371-1373
Taveira, T.H.; Friedmann, P.D.; Cohen, L.B.; Dooley, A.G.; Khatana, S.Ahmed.M.; Pirraglia, P.A.; Wu, W-Chih. 2010: Pharmacist-led group medical appointment model in type 2 diabetes. Diabetes educator 36(1): 109-117
Banerjee, M.N.; Bolli, R.; Hare, J.M. 2018: Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future Directions. Circulation Research 123(2): 266-287
Ottenbros, S.; Teichert, M.; de Groot, R.; Griens, F.; Sodihardjo, F.; Wensing, M.; de Gier, J.J. 2014: Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients. International Journal of Clinical Pharmacy 36(2): 336-344
Hämmerlein, A.; Müller, U.; Schulz, M. 2011: Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients. Journal of Evaluation in Clinical Practice 17(1): 61-70
Thomas, R.; Huntley, A.L.; Mann, M.; Huws, D.; Elwyn, G.; Paranjothy, S.; Purdy, S. 2014: Pharmacist-led interventions to reduce unplanned admissions for older people: a systematic review and meta-analysis of randomised controlled trials. Age and Ageing 43(2): 174-187
Bruhn, H.; Bond, C.M.; Elliott, A.M.; Hannaford, P.C.; Lee, A.J.; McNamee, P.; Smith, B.H.; Watson, M.C.; Holland, R.; Wright, D. 2013: Pharmacist-led management of chronic pain in primary care: results from a randomised controlled exploratory trial. Bmj Open 3(4)
Wang, Y.; Huang, H.; Zeng, Y.; Wu, J.; Wang, R.; Ren, B.; Xu, F. 2013: Pharmacist-led medication education in cancer pain control: a multicentre randomized controlled study in Guangzhou, China. Journal of International Medical Research 41(5): 1462-1472
Elliott, R.A.; Martinac, G.; Campbell, S.; Thorn, J.; Woodward, M.C. 2012: Pharmacist-led medication review to identify medication-related problems in older people referred to an Aged Care Assessment Team: a randomized comparative study. Drugs and Aging 29(7): 593-605
Jegatheesan, D.; Cho, Y.; Johnson, D.W. 2018: Clinical Studies of Interventions to Mitigate Cardiovascular Risk in Peritoneal Dialysis Patients. Seminars in Nephrology 38(3): 277-290
Bauer, J.B.; Chun, D.S.; Karpinski, T.A. 2008: Pharmacist-led program to improve venous thromboembolism prophylaxis in a community hospital. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(17): 1643-1647
Williams, D.J.; Habib, A.G.; Warrell, D.A. 2018: Clinical studies of the effectiveness and safety of antivenoms. Toxicon: Official Journal of the International Society on Toxinology 150: 1-10
Kim, S.; Willett, L.; Hughes, F.; Sunderram, J.; Walker, J.A.; Shea, J.A. 2013: Pharmacist-led workshops to enhance pharmacotherapy knowledge for medical students. Teaching and Learning in Medicine 25(2): 118-121
Valgus, J.; Jarr, S.; Schwartz, R.; Rice, M.; Bernard, S.A. 2010: Pharmacist-led, interdisciplinary model for delivery of supportive care in the ambulatory cancer clinic setting. Journal of Oncology Practice 6(6): E1-E4
Baker, S.N.; Acquisto, N.M.; Ashley, E.Dodds.; Fairbanks, R.J.; Beamish, S.E.; Haas, C.E. 2012: Pharmacist-managed antimicrobial stewardship program for patients discharged from the emergency department. Journal of Pharmacy Practice 25(2): 190-194
Fuller, L.; Conrad, W.F.; Heaton, P.C.; Panos, R.; Eschenbacher, W.; Frede, S.M. 2012: Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting. Journal of the American Pharmacists Association: Japha 52(5): E59-E66
Bishop, M.A.; Streiff, M.B.; Ensor, C.R.; Tedford, R.J.; Russell, S.D.; Ross, P.A. 2014: Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. Asaio Journal 60(2): 193-198
Bouwmeester, C.; Chim, C. 2013: Pharmacist-managed oral anticoagulation therapy in the community setting. Consultant Pharmacist: the Journal of the American Society of Consultant Pharmacists 28(5): 280-294
Harris, I.M.; Philbrick, A.M.; Fallert, C.J.; Soliman, A.M. 2014: Pharmacist-managed protocol to implement simvastatin labeling changes in a family medicine clinic. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 71(15): 1248-1251
Oderda, L.; Holman, C.; Nichols, B.; Rupper, R.; Bair, B.; Hoffman, M.; Hicken, B. 2011: Pharmacist-managed telephone clinic review of antidementia medication effectiveness. Consultant Pharmacist: the Journal of the American Society of Consultant Pharmacists 26(4): 264-273
Milton-Brown, J.; Barnes, A.Smith.; Ndefo, U.Anadu.; Erowele, G.Ikezuagu. 2012: Pharmacist-managed weight-loss program using meal-replacement product. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 69(17): 1456 1458
Chong, W.Wen.; Aslani, P.; Chen, T.F. 2014: Pharmacist-patient communication on use of antidepressants: a simulated patient study in community pharmacy. Research in Social and Administrative Pharmacy: Rsap 10(2): 419-437
Howard-Thompson, A.; Farland, M.Z.; Byrd, D.C.; Airee, A.; Thomas, J.; Campbell, J.; Cassidy, R.; Morgan, T.; Suda, K.J. 2013: Pharmacist-physician collaboration for diabetes care: cardiovascular outcomes. Annals of PharmacoTherapy 47(11): 1471-1477
Farland, M.Zingone.; Byrd, D.C.; McFarland, M.Shawn.; Thomas, J.; Franks, A.S.; George, C.M.; Gross, B.N.; Guirguis, A.B.; Suda, K.J. 2013: Pharmacist-physician collaboration for diabetes care: the diabetes initiative program. Annals of PharmacoTherapy 47(6): 781-789
Albsoul-Younes, A.M.; Hammad, E.A.; Yasein, N.A.; Tahaineh, L.M. 2011: Pharmacist-physician collaboration improves blood pressure control. Saudi Medical Journal 32(3): 288-292
Strickland, J.M.; Huskey, A.; Brushwood, D.B. 2007: Pharmacist-physician collaboration in pain management practice. Journal of Opioid Management 3(6): 295-301
Weber, C.A.; Ernst, M.E.; Sezate, G.S.; Zheng, S.; Carter, B.L. 2010: Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Archives of Internal Medicine 170(18): 1634-1639
Siden, R.; Tamer, H.R.; Skyles, A.J.; Weadock, S.; Redic, K. 2012: Pharmacist-prepared dispensing guidelines for drugs used in clinical research. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 69(12): 1021-1026
Pinto, S.L.; Kumar, J.; Partha, G.; Bechtol, R.A. 2014: Pharmacist-provided medication therapy management (MTM) program impacts outcomes for employees with diabetes. Population Health Management 17(1): 21-27
Schommer, J.C.; Planas, L.G.; Johnson, K.A.; Doucette, W.R. 2008: Pharmacist-provided medication therapy management (part 1): provider perspectives in 2007. Journal of the American Pharmacists Association: Japha 48(3): 354-363
Schommer, J.C.; Planas, L.G.; Johnson, K.A.; Doucette, W.R. 2008: Pharmacist-provided medication therapy management (part 2): Payer perspectives in 2007. Journal of the American Pharmacists Association: Japha 48(4): 478-486
Darin, K.M.; Klepser, M.E.; Klepser, D.E.; Klepser, S.A.; Reeves, A.; Young, M.; Scarsi, K.K. 2015: Pharmacist-provided rapid HIV testing in two community pharmacies. Journal of the American Pharmacists Association: Japha 55(1): 81-88
Ward, M.A.; Xu, Y. 2011: Pharmacist-provided telephonic medication therapy management in an MAPD plan. American Journal of Managed Care 17(10): E399-E409
Traina, A.N.; Kane, M.P.; Bakst, G.; Abelseth, J.M.; Busch, R.S. 2011: Pharmacist-run zoledronic acid clinic. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(15): 1399-1403
Rona, B. 1951: Pharmacist-technician courses and their examinations. A Gyogyszeresz 6(7): 153-154
Divine, H.; Nicholas, A.; Johnson, C.L.; Perrier, D.G.; Steinke, D.T.; Blumenschein, K. 2008: PharmacistCARE: description of a pharmacist care service and lessons learned along the way. Journal of the American Pharmacists Association: Japha 48(6): 793-802
Horiguchi, N. 2008: Pharmacists (Yakuzaikan) in the Japanese Military System during the Meiji period. Yakushigaku Zasshi 43(1): 67-78
Anonymous 1911: Pharmacists and Secret Remedies. British medical journal 2(2640): 304-305
Guirguis, L.M.; Johnson, S.; Emberley, P. 2014: Pharmacists Connect and CARE: Transforming pharmacy customers into patients. Canadian Pharmacists Journal: Cpj 147(3): 149-153
Bahnassi, A. 2016: Pharmacists Views and Practices in Regard to Sales of Antibiotics Without a Prescription in Madinah, Saudi Arabia. Journal of patient safety 12(3): 159-164
Barlas, S. 2011: Pharmacists want a more Explicit Role in ACOs: Medicare's Hands Are Tied ... at Least Initially. P and T: a Peer-Reviewed Journal for Formulary Management 36(10): 685-687
Barlas, S. 2012: Pharmacists Welcome FDA's Opioids REMS: How Directly Will They Be Affected?. P and T: a Peer-Reviewed Journal for Formulary Management 37(9): 492
Cochran, G.; Field, C.; Lawson, K. 2015: Pharmacists who Screen and Discuss Opioid Misuse with Patients: Future Directions for Research and Practice. Journal of Pharmacy Practice 28(4): 404-412
Deas, C.; McCree, D.Hubbard. 2010: Pharmacists and HIV/AIDS prevention: review of the literature. Journal of the American Pharmacists Association: Japha 50(3): 411-415
Farrell, J.; Ries, N.M.; Boon, H. 2008: Pharmacists and Natural Health Products: a systematic analysis of professional responsibilities in Canada. Pharmacy Practice 6(1): 33-42
Cohen, H. 2011: Pharmacists and collaborative drug therapy management in new York State. Journal of Pharmacy Practice 24(6): 582-583
Anderson, R.M.; Bishop, L.J.; Darragh, M.; Gray, H.H.; Nolen, A.L.; Poland, S.C. 2006: Pharmacists and conscientious objection. Kennedy Institute of Ethics Journal 16(4): 379-396
Stewart, D.W. 2008: Pharmacists and execution. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(23): 2204-2205
Lexchin, J. 1986: Pharmacists and family physicians. Canadian Family Physician Medecin de Famille Canadien 32: 26
Stringer, K.; Curran, V.; Asghari, S. 2013: Pharmacists and family physicians: improving interprofessional collaboration through joint understanding of our competencies. Frontiers in Pharmacology 4: 151
Watson, T.; Hughes, C. 2012: Pharmacists and harm reduction: a review of current practices and attitudes. Canadian Pharmacists Journal: Cpj 145(3): 124-127.E2
Fuji, K.T.; Galt, K.A. 2008: Pharmacists and health information technology: emerging issues in patient safety. Hec Forum: An Interdisciplinary Journal on Hospitals' Ethical and Legal Issues 20(3): 259-275
Lipton, H.L. 2010: Pharmacists and health reform: go for it!. PharmacoTherapy 30(10): 967-972
Ernst, E. 2011: Pharmacists and homeopathic remedies. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(6): 478
Bains, S.; Rowe, H.; Wilby, K.J. 2014: Pharmacists and maternal-fetal medicine: development of a tool to characterize knowledge and current clinical practice. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 27(7): 753-755
Hobson, R.J.; Scott, J.; Sutton, J. 2010: Pharmacists and nurses as independent prescribers: exploring the patient's perspective. Family Practice 27(1): 110-120
Habek, D. 2008: Pharmacists and pharmacies in Bjelovar in the 18th-19th centuries. Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 62(3): 323-326
Goode, A.M.; Roberts, R.M. 2014: Pharmacists and physicians get smart about antibiotics: a prescription for change. Journal of the American Pharmacists Association: Japha 54(4): 324; 328
Komanduri, K.V. 2013: Pharmacists and physicians in hematopoietic stem cell transplantation: advances and opportunities to use collaborative practice agreements to improve care. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 19(4): 505-506
Neyarapally, G.A. 2014: Pharmacists and public health: other opportunities. Journal of the American Pharmacists Association: Japha 54(3): 214-215
Kaldy, J. 2009: Pharmacists and research: experts seek practitioner experience. Consultant Pharmacist: the Journal of the American Society of Consultant Pharmacists 24(7): 504-510
Neyarapally, G. 2013: Pharmacists and team-based care. Health Affairs 32(10): 1857
Maine, L.L.; Knapp, K.K.; Scheckelhoff, D.J. 2013: Pharmacists and technicians can enhance patient care even more once national policies, practices, and priorities are aligned. Health Affairs 32(11): 1956-1962
Seiden, H.S. 1985: Pharmacists and the 'real world'. Canadian Family Physician Medecin de Famille Canadien 31: 1804-1807
Smith, M.A. 2012: Pharmacists and the primary care workforce. Annals of PharmacoTherapy 46(11): 1568-1571
Richman, K.A. 2007: Pharmacists and the social contract. American Journal of Bioethics: Ajob 7(6): 15-16
Banerjee, A.K. 2009: Pharmacists are key to enhancing benefit risk for medicines. Archives of Internal Medicine 169(18): 1723; Author Reply 1723-1724
Forberg, J.L.; Tomsen, D.V. 2013: Pharmacists are part of the team in FAM. Ugeskrift for Laeger 175(20): 1443
Kmietowicz, Z. 2008: Pharmacists are to offer the pill in London pilot scheme. Bmj 337: A3016
Groth, C.M.; Acquisto, N.M. 2016: Pharmacists as Members of the Rapid Response Team. Journal of Pharmacy Practice 29(2): 116-120
Cohen, L. 2012: Pharmacists as diabetes educators and diabetes disease managers. Medicine and Health Rhode Island 95(9): 275-276
Odedina, F.T.; Warrick, C.; Vilme, H.; Young, S. 2008: Pharmacists as health educators and risk communicators in the early detection of prostate cancer. Research in Social and Administrative Pharmacy: Rsap 4(1): 59-66
Okubanjo, T.; Gonzalez, L.S. 2008: Pharmacists as investigators in FDA-regulated drug trials. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(11): 1010-1011
Ross, L.A. 2011: Pharmacists as mid-level practitioners/providers. Annals of PharmacoTherapy 45(6): 810-812
Fletcher, A.; Marra, F.; Kaczorowski, J. 2014: Pharmacists as vaccination providers: Friend or foe?. Canadian Pharmacists Journal: Cpj 147(3): 141-142
LeBlanc, Y.C. 2011: Pharmacists become an integral part of the patient care team. Caring: National Association for Home Care Magazine 30(8): 32-34
Smith, M.; Bates, D.W.; Bodenheimer, T.S. 2013: Pharmacists belong in accountable care organizations and integrated care teams. Health Affairs 32(11): 1963-1970
Newton, S. 2008: Pharmacists called to action during Iowa floods. Journal of the American Pharmacists Association: Japha 48(6): 707-708
Anonymous 2010: Pharmacists can assist in fall prevention programs. Healthcare Benchmarks and Quality Improvement 17(1): 7-9
Sipkoff, M. 2008: Pharmacists can be crucial to medical home. Managed Care 17(11): 14-15
Edmunds-Ogbuokiri, J. 2009: Pharmacists can help clinicians detect hidden substance abuse. HIV Clinician 21(2): 10-12
Lynas, K. 2013: Pharmacists can play a key role in implementing new national strategy to combat prescription drug abuse. Canadian Pharmacists Journal: Cpj 146(3): 128-129
Lavine, G. 2008: Pharmacists can play active role as hospitals prepare for CMS rule changes. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(7): 595-596
Anonymous 2010: Pharmacists conduct med rec at admission. Healthcare Benchmarks and Quality Improvement 17(6): 70-72
Pomp, E.; Samuelsen, P.-J. 2009: Pharmacists congratulate clinical pharmacologists. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 129(5): 431-432
Iihara, H.; Ishihara, M.; Matsuura, K.; Kurahashi, S.; Takahashi, T.; Kawaguchi, Y.; Yoshida, K.; Itoh, Y. 2012: Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic. Journal of Evaluation in Clinical Practice 18(4): 753-760
Nishihara, S. 2011: Pharmacists contribute to the safety of medicines. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 131(6): 865-869
Abood, R.R. 2010: Pharmacists correcting schedule Ii prescriptions: DEA flip-flops continue. Journal of Pain and Palliative Care PharmacoTherapy 24(4): 393-396
Reinke, T. 2013: Pharmacists demonstrate value of a problem-focused practice model. Managed Care 22(12): 8-9
Kelly, C.Y.; Clancy, C.M. 2009: Pharmacists emerge as key stakeholders in quality, patient safety efforts. Journal of the American Pharmacists Association: Japha 49(2): 146; 150
Traynor, K. 2013: Pharmacists find homes in medical homes. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 70(7): 569-570
Traynor, K. 2010: Pharmacists find satisfaction in dialysis clinics. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 67(6): 422-426
Boyle, C. 2012: Pharmacists from health practioners' perspectives. American Journal of Pharmaceutical Education 76(10): 186
Kwok, J.; Gue, D.; Curtis, J.; Jackson, S. 2014: Pharmacists have a key role in raising awareness around risks of intranasal desmopressin. Journal of the American Pharmacists Association: Japha 54(5): 460-462
Barlas, S. 2012: Pharmacists hope to bill under new medicare 'G' code: payment would be for transitional care after hospital discharge. P and T: a Peer-Reviewed Journal for Formulary Management 37(11): 609-650
Sen, S.; Bowen, J.F.; Ganetsky, V.S.; Hadley, D.; Melody, K.; Otsuka, S.; Vanmali, R.; Thomas, T. 2014: Pharmacists implementing transitions of care in inpatient, ambulatory and community practice settings. Pharmacy Practice 12(2): 439
Traynor, K. 2014: Pharmacists improve diabetes care. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 71(15): 1240-1242
Thompson, C.A. 2011: Pharmacists in Arkansas to judge individuals' need for pseudoephedrine. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(10): 862-863
Takagi, M. 2011: Pharmacists in community medicine: especially in cancer treatment. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 131(1): 45-49
Ackermann, E.; Douglas Williams, I.; Freeman, C. 2010: Pharmacists in general practice--a proposed role in the multidisciplinary team. Australian Family Physician 39(3): 163-164
Rutter, P.; Brown, D.; Howard, J.; Randall, C. 2014: Pharmacists in pharmacovigilance: can increased diagnostic opportunity in community settings translate to better vigilance?. Drug Safety 37(7): 465-469
Farris, K.B.; Johnson, K.A. 2010: Pharmacists in public health: It's a good start!. Journal of the American Pharmacists Association: Japha 50(2): 128-130
Lynas, K. 2012: Pharmacists join chorus of health care professionals concerned about cuts to refugee health benefits. Canadian Pharmacists Journal: Cpj 145(5): 213
Dixon, B. 2008: Pharmacists lend a hand. Lancet. Infectious Diseases 8(1): 11
Lonie, J.M.; Marzella, N.; Perry, R.; Shah, B.; Jariwala, J. 2015: Pharmacists levels of emotionality and career success correlates: an exploratory study. Journal of Pharmacy Practice 28(3): 256-260
Reinke, T. 2013: Pharmacists make inroads as members of medical homes. Managed Care 22(10): 19 26
Flanagan, P.; Virani, A.; Baker, W.; Roelants, H. 2010: Pharmacists making house calls: innovative role or overkill?. Canadian Journal of Hospital Pharmacy 63(6): 412-419
Traynor, K. 2008: Pharmacists matter in pandemic response. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(19): 1792-1793
McCartney, M. 2011: Pharmacists may be allowed to change prescriptions without consulting prescriber. Bmj 343: D7067
White, C.M. 2014: Pharmacists need recognition as providers to enhance patient care. Annals of PharmacoTherapy 48(2): 268-273
Lynas, K. 2012: Pharmacists not part of current regulatory change on prescribing controlled substances. Canadian Pharmacists Journal: Cpj 145(4): 156
Mattingly, T.Joseph.; Cain, J.; Fink, J.L. 2010: Pharmacists on Facebook: online social networking and the profession. Journal of the American Pharmacists Association: Japha 50(3): 424-427
Wong, A.W.-Y.; Zhang, S.; Li, S.K.-Y.; Zhang, C.; Chu, C.-H. 2017: Clinical studies on core-carrier obturation: a systematic review and meta-analysis. Bmc Oral Health 17(1): 167
Paul, C.L.; Tzelepis, F.; Walsh, R.A.; Turner, R. 2007: Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers. Drug and Alcohol Review 26(4): 429-433
Rigdon, B.A. 2012: Pharmacists on the front lines in the fight against meth. A 50-state comparison of the laws regulating the retail sale of pseudoephedrine. Journal of Legal Medicine 33(2): 253-283
Sminkey, P.V. 2014: Pharmacists on the team: tapping invaluable expertise to foster the triple aim. Professional Case Management 19(3): 148-150
Anonymous 2008: Pharmacists play greater role in patient care. Disease Management Advisor 14(2): 11
Traynor, K. 2010: Pharmacists prepare for flu season: pediatric dosing, unpredictable demand pose challenges. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 67(18): 1496-1499
Shi, Q.-p.; Ding, F.; Liu, Y.; Sang, R.; Zhu, J.-x.; Shi, P.-l.; Wang, M.-h.; Yuan, H.-y. 2013: Pharmacists promote rational use of antibiotic prophylaxis in Type i incision operations via application of drug use evaluation. International Journal of Clinical Pharmacology and Therapeutics 51(9): 704-710
Lavine, G. 2008: Pharmacists provide academic detailing to South Carolina health care providers. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(24): 2312-2314
Traynor, K. 2014: Pharmacists provide guidance on ED antimicrobial use. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 71(5): 354-355
Yadav, S. 2008: Pharmacists rather than GPs should be first contact for minor ailments, report says. Bmj 337: A775
Hashemi-Meshkini, A.; Keshavarz, K.; Nikfar, S.; Vazirian, I.; Kebriaeezadeh, A. 2013: Pharmacists remuneration models in iran and selected countries: a comparative study. Iranian Journal of Pharmaceutical Research: Ijpr 12(4): 995
Thompson, C.A. 2008: Pharmacists run telehealth clinic to keep veterans independent. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(14): 1310-1311
Anonymous 2014: Pharmacists see patients through discharge. Hospital case management: the monthly update on hospital-based care planning and critical paths 22(2): 16-17
Traynor, K. 2012: Pharmacists see positives in nontraditional residency programs. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 69(8): 632-633
Lundberg, G.D. 2008: Pharmacists should participate in care of patients with heart failure. Medscape Journal of Medicine 10(7): 156
Wise, J. 2012: Pharmacists should provide oral contraceptive services, says NHS report. Bmj 344: E3060
Watts, G. 2011: Pharmacists state ambition to expand their role in community health. Bmj 342: D274
Jorgenson, D.; Muller, A.; Whelan, A.Marie.; Buxton, K. 2011: Pharmacists teaching in family medicine residency programs: National survey. Canadian Family Physician Medecin de Famille Canadien 57(9): E341-E346
Traynor, K. 2014: Pharmacists team up for transitional care. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 71(18): 1524-1528
Diamond, F. 2011: Onerous regulations put ACOs on ropes. Managed Care 20(6): 14-18
Duval, S. 2007: Pharmacists to red flag risky drug interactions. Cmaj: Canadian Medical Association Journal 177(10): 1171
Munroe, J. 2011: Pharmacists unite!. Canadian Journal of Hospital Pharmacy 64(1): 91-92
Phansalkar, S.; Hoffman, J.M.; Nebeker, J.R.; Hurdle, J.F. 2007: Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(8): 842-849
Traynor, K. 2008: Pharmacists want FDA to create new intermediate drug category. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(1): 10-14
Barlas, S. 2011: Pharmacists want to become part of accountable care groups: medicare to define which professionals can join in 2012. P and T: a Peer-Reviewed Journal for Formulary Management 36(2): 63
Schulte, D. 2008: Pharmacists who question prescriptions from dentists. Journal of the Michigan Dental Association 90(1): 14
Traynor, K. 2013: Pharmacists work to boost patient satisfaction scores. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 70(10): 836; 838-839
Watson, R. 2010: Pharmacists would like compensation for expanded role in patient care. Bmj 341: C4893
Thompson, C.A. 2007: Pharmacists' CPT codes become permanent: next step is to set valuation for each code. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(23): 2410-2412
Rixon, S.; Braaf, S.; Williams, A.; Liew, D.; Manias, E. 2015: Pharmacists' Interprofessional Communication About Medications in Specialty Hospital Settings. Health Communication 30(11): 1065-1075
Ford, H.; von Waldner, T.; Perri, M. 2014: Pharmacists' Roles in Post-September 11th Disasters: A Content Analysis of Pharmacy Literature. Journal of Pharmacy Practice 27(4): 350-357
Wang, J.; Hong, S.H.; Meng, S.; Brown, L.M. 2011: Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis. Research in Social and Administrative Pharmacy: Rsap 7(4): 383-395
Brown, C.M.; Pena, A.; Resendiz, K. 2011: Pharmacists' actions when patients use complementary and alternative medicine with medications: A look at Texas-Mexico border cities. Journal of the American Pharmacists Association: Japha 51(5): 619-622
Paudyal, V.; Hansford, D.; Cunningham, S.; Stewart, D. 2014: Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making. Research in Social and Administrative Pharmacy: Rsap 10(1): 88-105
McKnight, A.G.; Thomason, A.R. 2009: Pharmacists' advancing roles in drug and disease management: a review of states' legislation. Journal of the American Pharmacists Association: Japha 49(4): 554-558
Puspitasari, H.P.; Aslani, P.; Krass, I. 2010: Pharmacists' and consumers' viewpoints on counselling on prescription medicines in Australian community pharmacies. International Journal of Pharmacy Practice 18(4): 202-208
Lee, S.S.; Schwemm, A.K.; Reist, J.; Cantrell, M.; Andreski, M.; Doucette, W.R.; Chrischilles, E.A.; Farris, K.B. 2009: Pharmacists' and pharmacy students' ability to identify drug-related problems using TIMER (Tool to Improve Medications in the Elderly via Review). American Journal of Pharmaceutical Education 73(3): 52
Fahmy, S.A.; Abdu, S.; Abuelkhair, M. 2010: Pharmacists' attitude, perceptions and knowledge towards the use of herbal products in Abu Dhabi, United Arab Emirates. Pharmacy Practice 8(2): 109-115
Abahussain, N.A.; Abahussain, E.A.; Al-Oumi, F.M. 2007: Pharmacists' attitudes and awareness towards the use and safety of herbs in Kuwait. Pharmacy Practice 5(3): 125-129
Mansoor, S.M.; Aslani, P.; Krass, I. 2014: Pharmacists' attitudes and perceived barriers to provision of adherence support in Australia. International Journal of Clinical Pharmacy 36(1): 136-144
Hanna, L.-A.; Hughes, C.M. 2012: Pharmacists' attitudes towards an evidence-based approach for over-the-counter medication. International Journal of Clinical Pharmacy 34(1): 63-71
Huston, S.A.; Porter, K.B.; Clements, T.; Shepherd, G. 2010: Pharmacists' attitudes towards pediatric cough and cold products and behind the counter status. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 15(2): 126-137
Ashley, M.J.; Victor, J.C.; Brewster, J. 2007: Pharmacists' attitudes, role perceptions and interventions regarding smoking cessation: findings from four Canadian provinces. Chronic Diseases in Canada 28(1-2): 20-28
Obara, T.; Ohkubo, T.; Tanaka, K.; Satoh, M.; Ishikura, K.; Kobayashi, M.; Metoki, H.; Asayama, K.; Kikuya, M.; Murai, Y.; Mano, N.; Oide, S.; Imai, Y. 2012: Pharmacists' awareness and attitude toward blood pressure measurement at home and in the pharmacy in Japan. Clinical and Experimental Hypertension 34(6): 447-455
O'Reilly, C.L.; Bell, J.S.; Chen, T.F. 2010: Pharmacists' beliefs about treatments and outcomes of mental disorders: a mental health literacy survey. Australian and New Zealand Journal of Psychiatry 44(12): 1089-1096
Tully, M.P.; Latif, S.; Cantrill, J.A.; Parker, D. 2007: Pharmacists' changing views of their supplementary prescribing authority. Pharmacy World and Science: Pws 29(6): 628-634
Dilworth, T.J.; Mott, D.; Young, H. 2009: Pharmacists' communication with Spanish-speaking patients: a review of the literature to establish an agenda for future research. Research in Social and Administrative Pharmacy: Rsap 5(2): 108-120
Crawford, S.Y.; Manuel, A.ée.M.; Wood, B.D. 2009: Pharmacists' considerations when serving Amish patients. Journal of the American Pharmacists Association: Japha 49(1): 86-94; Quiz: 95-97
Leversha, A.; Pedler, D. 2008: Pharmacists' contribution to medical education: Australian case study. Medical Education 42(11): 1131-1132
Janiczak, S.T. 2014: Pharmacists' contributions during transitions of care. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 71(18): 1536
Manolakis, P.Gasdek.; Skelton, J.B. 2010: Pharmacists' contributions to primary care in the United States collaborating to address unmet patient care needs: the emerging role for pharmacists to address the shortage of primary care providers. American Journal of Pharmaceutical Education 74(10): S7
Pullinger, W.; Franklin, B.D. 2010: Pharmacists' documentation in patients' hospital health records: issues and educational implications. International Journal of Pharmacy Practice 18(2): 108-115
Tsuyuki, R.T. 2013: Pharmacists' duty of care / Obligation de diligence du pharmacien. Canadian Pharmacists Journal: Cpj 146(3): 125-126
Clauson, K.A.; Seamon, M.J.; Fox, B.I. 2010: Pharmacists' duty to warn in the age of social media. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 67(15): 1290-1293
Carvajal, M.J.; Bernhardt, N.J.; Armayor, G.M. 2015: Pharmacists' earnings: their level and distribution. Research in Social and Administrative Pharmacy: Rsap 11(2): E57-E67
Boyle, M.; Myford, C. 2013: Pharmacists' expectations for entry-level practitioner competency. American Journal of Pharmaceutical Education 77(1): 5
Austin, Z.; Gregory, P.A.M.; Martin, J.C. 2010: Pharmacists' experience of conflict in community practice. Research in Social and Administrative Pharmacy: Rsap 6(1): 39-48
Kahan, M.; Wilson, L.; Wenghofer, E.F.; Srivastava, A.; Resnick, A.; Janecek, E.; Sheehan, C. 2011: Pharmacists' experiences with dispensing opioids: provincial survey. Canadian Family Physician Medecin de Famille Canadien 57(11): E448-E454
Held, A.D.; Woodall, L.J.; Hertig, J.B. 2014: Pharmacists' familiarity, utilization, and beliefs about Health Information Exchange: a survey of pharmacists in an Indiana pharmacy organization. Journal of the American Pharmacists Association: Japha 54(6): 625-629
Smith, J.D.; Clinard, V.; Barnes, C.L. 2011: Pharmacists' guide to infant formulas for term infants. Journal of the American Pharmacists Association: Japha 51(3): E28
Penm, J.; Chaar, B.; Rose, G.; Moles, R. 2015: Pharmacists' influences on prescribing: validating a clinical pharmacy services survey in the Western Pacific Region. Research in Social and Administrative Pharmacy: Rsap 11(1): 63-73
Verrue, C.L.R.; Petrovic, M.; Mehuys, E.; Remon, J.P.; Vander Stichele, R. 2009: Pharmacists' interventions for optimization of medication use in nursing homes : a systematic review. Drugs and Aging 26(1): 37-49
Abdel-Qader, D.H.; Harper, L.; Cantrill, J.A.; Tully, M.P. 2010: Pharmacists' interventions in prescribing errors at hospital discharge: an observational study in the context of an electronic prescribing system in a UK teaching hospital. Drug Safety 33(11): 1027-1044
Charpiat, B.; Bedouch, P.; Conort, O.; Juste, M.; Rose, F.X.; Roubille, R.; Allenet, B. 2014: Pharmacists' interventions on intravenous to oral conversion for potassium. International Journal of Clinical Pharmacy 36(3): 513-518
Holmes, E.R. 2010: Pharmacists' interventions: so many factors, so little time. Research in Social and Administrative Pharmacy: Rsap 6(1): 3-5
Traynor, K. 2014: Pharmacists' investigational drug services aid Ebola response. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 71(23): 2000-2006
Kheir, N.; Gad, H.Y.; Abu-Yousef, S.E. 2014: Pharmacists' knowledge and attitudes about natural health products: a mixed-methods study. Drug Healthcare and Patient Safety 6: 7-14
Chang, Z.G.; Kennedy, D.T.; Holdford, D.A.; Small, R.E.; Chang, Z.G.; Kennedy, D.T.; Holdford, D.A.; Small, R.E. 2007: Pharmacists' knowledge and attitudes toward herbal medicine. 2000. Annals of PharmacoTherapy 41(7): 1272-1276
Dolan, S.M.; Cox, S.; Tepper, N.; Ruddy, D.; Rasmussen, S.A.; MacFarlane, K. 2012: Pharmacists' knowledge, attitudes, and practices regarding influenza vaccination and treatment of pregnant women. Journal of the American Pharmacists Association: Japha 52(1): 43-51
Rizo, M.; Seamon, M. 2013: Pharmacists' liability: what my pharmacy law professor did not cover. International journal of pharmaceutical compounding 17(4): 290-293
Gardner, B.; Graner, K. 2009: Pharmacists' medication reconciliation-related clinical interventions in a children's hospital. Joint Commission Journal on Quality and Patient Safety 35(5): 278-282
Peterson-Clark, G.; Aslani, P.; Williams, K.A. 2010: Pharmacists' online information literacy: an assessment of their use of Internet-based medicines information. Health Information and Libraries Journal 27(3): 208-216
Safaeian, L.; Mostafavi, S.Abolfazl.; Changiz, T.; Mirzadeh, M. 2014: Pharmacists' opinions and self-reporting performance regarding the professional tasks and responsibilities in Isfahan, Iran. Journal of Education and Health Promotion 3: 2
Cvijovic, K.; Boon, H.; Jaeger, W.; Vohra, S. 2010: Pharmacists' participation in research: a case of trying to find the time. International Journal of Pharmacy Practice 18(6): 377-383
O'Brocta, R. 2010: Pharmacists' participation in the development of an experiential program. Journal of Pharmacy Practice 23(4): 371-373
Yusuff, K.B.; Tayo, F.; Aina, B.A. 2010: Pharmacists' participation in the documentation of medication history in a developing setting: An exploratory assessment with new criteria. Pharmacy Practice 8(2): 139-145
Blazejewski, L.; Vaidya, V.; Pinto, S.; Gaither, C. 2013: Pharmacists' perceived barriers providing non-dispensing services to underserved populations. Journal of Community Health 38(5): 812-822
Paudyal, V.; Hansford, D.; Cunningham, S.; Stewart, D. 2012: Pharmacists' perceived integration into practice of over-the-counter simvastatin five years post reclassification. International Journal of Clinical Pharmacy 34(5): 733-738
Munzenberger, P.J.; Thomas, R.L.; Edwin, S.B.; Tutag-Lehr, V. 2011: Pharmacists' perceived knowledge and expertise in selected pediatric topics. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 16(1): 47-54
Fang, Y.; Yang, S.; Feng, B.; Ni, Y.; Zhang, K. 2011: Pharmacists' perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China. Health and Social Care in the Community 19(2): 189-197
Buxton, E.C. 2014: Pharmacists' perception of synchronous versus asynchronous distance learning for continuing education programs. American Journal of Pharmaceutical Education 78(1): 8
Buxton, E.C.; De Muth, J.E. 2013: Pharmacists' perceptions of a live continuing education program comparing distance learning versus local learning. Research in Social and Administrative Pharmacy: Rsap 9(2): 230-235
Inquilla, C.C.; Szeinbach, S.; Seoane-Vazquez, E.; Kappeler, K.H. 2007: Pharmacists' perceptions of computerized prescriber-order-entry systems. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(15): 1626-1632
Hanson, A.L.; Bruskiewitz, R.H.; Demuth, J.E. 2007: Pharmacists' perceptions of facilitators and barriers to lifelong learning. American Journal of Pharmaceutical Education 71(4): 67
Hoch, M.A.; Hudmon, K.Suchanek.; Lee, L.; Cupp, R.; Aragon, L.; Tyree, R.A.; Corelli, R.L. 2012: Pharmacists' perceptions of participation in a community pharmacy-based nicotine replacement therapy distribution program. Journal of Community Health 37(4): 848-854
Loewen, P.; Merrett, F.; Lemos, J.D. 2010: Pharmacists' perceptions of the impact of care they provide. Pharmacy Practice 8(2): 89-95
Al Hamarneh, Y.N.; Rosenthal, M.; McElnay, J.C.; Tsuyuki, R.T. 2011: Pharmacists' perceptions of their professional role: insights into hospital pharmacy culture. Canadian Journal of Hospital Pharmacy 64(1): 31-35
Kritikos, V.S.; Reddel, H.K.; Bosnic-Anticevich, S.Z. 2010: Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services. International Journal of Pharmacy Practice 18(4): 209-216
Lee, C.; Segal, R.; Kimberlin, C.; Smith, W.T.; Weiler, R.M. 2014: Pharmacists' perspective on providing care when patients engage in unhealthy behaviors. Journal of the American Pharmacists Association: Japha 54(2): 159-162
Ryder, P.T.; Meyerson, B.E.; Coy, K.C.; von Hippel, C.D.J. 2013: Pharmacists' perspectives on HIV testing in community pharmacies. Journal of the American Pharmacists Association: Japha 53(6): 595-600
Komperda, K.E.; Padiyara, R.S. 2011: Pharmacists' perspectives on postgraduate training. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(18): 1681-1682
Khanna, R.; Mahabaleshwarkar, R.; Holmes, E.R.; Jariwala, K. 2015: Pharmacists' perspectives on the Patient Protection and Affordable Care Act. Research in Social and Administrative Pharmacy: Rsap 11(1): 111-120
Grindrod, K.A.; Marra, C.A.; Colley, L.; Tsuyuki, R.T.; Lynd, L.D. 2010: Pharmacists' preferences for providing patient-centered services: a discrete choice experiment to guide health policy. Annals of PharmacoTherapy 44(10): 1554-1564
Flynn, A.J.; Haines, S. 2012: Pharmacists' requirement for continuity of the clinical narrative in the electronic medical record. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 69(12): 1027-1029
Salter, S.M.; Delfante, B.; de Klerk, S.; Sanfilippo, F.M.; Clifford, R.M. 2014: Pharmacists' response to anaphylaxis in the community (PRAC): a randomised, simulated patient study of pharmacist practice. Bmj Open 4(7): E005648
Hattingh, H.L. 2009: Pharmacists' responsibility and potential liability regarding generic substitition. Medicine and Law 28(4): 697-704
Kaur, J.; Olkhova, E.; Malviya, V.N.; Grell, E.; Michel, H. 2014: A L-lysine transporter of high stereoselectivity of the amino acid-polyamine-organocation (APC) superfamily: production, functional characterization, and structure modeling. Journal of Biological Chemistry 289(3): 1377-1387
Scheerder, G.; De Coster, I.; Van Audenhove, C. 2008: Pharmacists' role in depression care: a survey of attitudes, current practices, and barriers. Psychiatric Services 59(10): 1155-1160
Cohen, M.R. 2010: Pharmacists' role in ensuring safe and effective hospital use of insulin. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 67(16 Suppl 8: S17-S21
Macaulay, T.E.; Cook, A.M.; Fink, J.L.; Rapp, R.P.; Vincent, W.R. 2009: Pharmacists' role in facilitating evidence-based prescribing for unlabeled use of medications. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 66(19): 1735-1739
Smith, M. 2009: Pharmacists' role in improving diabetes medication management. Journal of Diabetes Science and Technology 3(1): 175-179
Bohenek, W.S.; Grossbart, S.R. 2008: Pharmacists' role in improving quality of care. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(16): 1566-1570
Patanwala, A.E.; Thomas, M.C.; Casanova, T.J.; Thomas, R. 2012: Pharmacists' role in procedural sedation and analgesia in the emergency department. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 69(15): 1336-1342
Plevin, D.M.; Ward, H.M.; Ward, M.B.; Sorich, M.J.; McKinnon, R.A. 2010: Pharmacists' role in targeted cancer therapy in Australia and implications for pharmacy education. American Journal of Pharmaceutical Education 74(9): 168
Cheng, J.W.M.; Cooke-Ariel, H. 2014: Pharmacists' role in the care of patients with heart failure: review and future evolution. Journal of Managed Care Pharmacy: Jmcp 20(2): 206-213
Messaadi, N.; Pansu, A.; Cohen, O.; Cottencin, O. 2013: Pharmacists' role in the continued care of patients under opiate substitution treatment. Therapie 68(6): 393-400
Zhang, Y.; Wang, Y.; Xiao, Z.; Xu, F. 2015: Pharmacists' roles in cancer pain control: a model in developing China. Research in Social and Administrative Pharmacy: Rsap 11(3): E144-E145
Mehta, B.; Kliethermes, M.; Moczygemba, L.R.; Andanar, D.; Bode, L.E. 2014: Pharmacists' roles in patient-centered medical homes. Journal of the American Pharmacists Association: Japha 54(3): 217; 220; 222-224
Rosenthal, M.M.; Breault, R.R.; Austin, Z.; Tsuyuki, R.T. 2011: Pharmacists' self-perception of their professional role: insights into community pharmacy culture. Journal of the American Pharmacists Association: Japha 51(3): 363-367
Kibicho, J.; Owczarzak, J. 2011: Pharmacists' strategies for promoting medication adherence among patients with HIV. Journal of the American Pharmacists Association: Japha 51(6): 746-755
Fleming, M.L.; Barner, J.C.; Brown, C.M.; Shepherd, M.D.; Strassels, S.A.; Novak, S. 2014: Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions. Journal of the American Pharmacists Association: Japha 54(3): 241-250
Ness, G.L.; Riggins, J.; Sheehan, A.H. 2014: Pharmacists' use of electronic handheld drug information applications. Annals of PharmacoTherapy 48(10): 1392-1393
Downard, S.; Galt, K.A.; Reel, A.B. 2007: Pharmacists' use of electronic health records: Silent leaders no more. Journal of the American Pharmacists Association: Japha 47(6): 680
Dasgupta, A.; Sansgiry, S.S.; Sherer, J.T.; Wallace, D.; Sikri, S. 2010: Pharmacists' utilization and interest in usage of personal digital assistants in their professional responsibilities. Health Information and Libraries Journal 27(1): 37-45
Martini, N.; Basdew, K.; Kammona, A.; Shen, A.; Taylor, C.; McIntosh, T.R.; Barnes, J. 2014: Pharmacists' views on and experiences with bowel cancer screening kits in Auckland, New Zealand. International Journal of Pharmacy Practice 22(4): 257-264
Rahimi, B.; Timpka, T. 2011: Pharmacists' views on integrated electronic prescribing systems: associations between usefulness, pharmacological safety, and barriers to technology use. European Journal of Clinical Pharmacology 67(2): 179-184
Armour, C.; Brillant, M.; Krass, I. 2007: Pharmacists' views on involvement in pharmacy practice research: Strategies for facilitating participation. Pharmacy Practice 5(2): 59-66
Barlas, S. 2014: Pharmacists, Deluged With Requirements, Pressure FDA to Standardize REMS Programs. P and T: a Peer-Reviewed Journal for Formulary Management 39(1): 12-13
Delafuente, J.C. 2014: Pharmacists, nurses, and the interdisciplinary team. Consultant Pharmacist: the Journal of the American Society of Consultant Pharmacists 29(4): 222
Manasse, H.R.; Speedie, M.K. 2007: Pharmacists, pharmaceuticals, and policy issues shaping the work force in pharmacy. American Journal of Pharmaceutical Education 71(5): 82
Wright, D.J. 2013: Pharmacists: 'label with care'. International Journal of Pharmacy Practice 21(5): 275-276
Wiebe, C. 2007: Pharmacists: a "secret weapon" for reducing drug errors. Medgenmed: Medscape General Medicine 9(2): 10
Oliphant, C.S.; Twilla, J.D. 2013: Pharmacists: an important resource to improve core measure performance. Hospital Topics 91(3): 65-68
Gatton, O.Davis. 2013: Pharmacists: medication experts who help prevent disease. North Carolina Medical Journal 74(5): 428-429
Vaillancourt, R.ég. 2011: Pharmacists: the guardians of safe medication use. Canadian Journal of Hospital Pharmacy 64(1): 5-9
Sircar, N.N. 1984: Pharmaco - therapeutics of dasemani drugs. Ancient Science of Life 3(3): 132-135
Eisinger, Fçois.; Cancel-Tassin, Géraldine.; Azzouzi, A.Rahmene.; Gravis, G.; Rossi, D.; Cussenot, O. 2013: Pharmaco and diet based prostate cancer prevention. Bulletin du Cancer 100(5): 497-507
Paige, A.J.W.; Brown, R. 2008: Pharmaco(epi)genomics in ovarian cancer. Pharmacogenomics 9(12): 1825-1834
Faludi, G.; Gonda, X.; Bagdy, G.; Dome, P. 2012: Pharmaco- and therapygenetic aspects in the treatment of anxiety disorders beyond the serotonergic system: a brief review. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 14(4): 221-229
Mattison, D.R.; Karyakina, N.; Goodman, M.; LaKind, J.S. 2014: Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps. Critical Reviews in Toxicology 44(8): 696-724
Pietrzak, B.ła.; Czarnecka, E. 2010: Pharmaco-EEG-based assessment of the interaction between ethanol and oxcarbazepine. Pharmacological Reports: Pr 62(2): 278-286
Swatzyna, R.J.; Kozlowski, G.P.; Tarnow, J.D. 2015: Pharmaco-EEG: a Study of Individualized Medicine in Clinical Practice. Clinical Eeg and Neuroscience 46(3): 192-196
Shahid, M.; Khardori, N.; Tripathi, T.; Bergman, S. 2010: Pharmaco-EcoMicrobiology: a newer component of medical sciences bridging pharmacovigilance, ecology, and environmental microbiology. Journal of Infection and Public Health 3(1): 1-4
Heinrichs-Graham, E.; Franzen, J.D.; Knott, N.L.; White, M.L.; Wetzel, M.W.; Wilson, T.W. 2014: Pharmaco-MEG evidence for attention related hyper-connectivity between auditory and prefrontal cortices in ADHD. Psychiatry Research 221(3): 240-245
Meduna, L.J. 1947: Pharmaco-dynamic treatment of psychoneuroses; a preliminary report. Diseases of the Nervous System 8(2): 37-40
Tran, G.; Hack, S.P.; Kerr, A.; Stokes, L.; Gibbs, P.; Price, T.; Todd, C. 2013: Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia. Asia-Pacific Journal of Clinical Oncology 9(3): 239-248
Belîi, A.; Cobâleţchi, S.; Casian, V.; Belîi, N.; Severin, G.; Chesov, I.; Bubulici, E. 2012: Pharmaco-economic aspects of perioperative pain management. Annales Francaises d'Anesthesie et de Reanimation 31(1): 60-66
Simoens, S. 2012: Pharmaco-economic aspects of sipuleucel-T. Human Vaccines and Immunotherapeutics 8(4): 506-508
De Portu, S.; Citarella, A.; Cammarota, S.; Menditto, E.; Mantovani, L.G. 2011: Pharmaco-economic consequences of losartan therapy in patients undergoing diabetic end stage renal disease in EU and USA. Clinical and Experimental Hypertension 33(3): 174-178
Chernysheva, T.V.; Bagirova, G.G. 2008: Pharmaco-economic efficiency of the treatment of patients with acute vertebrogenic lumbar pain syndrome. Klinicheskaia Meditsina 86(10): 39-42
Wilke, M.H.; Grube, R. 2010: Pharmaco-economic evaluation of antibiotic therapy strategies in DRG-based healthcare systems - a new approach. European Journal of Medical Research 15(12): 564-570
Garneata, L. 2009: Pharmaco-economic evaluation of keto acid/amino acid-supplemented protein-restricted diets. Journal of Renal Nutrition: the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation 19(5 Suppl): S19-S21
Boecking, W.; Klamar, A.; Kitzmann, F.; Kirch, W. 2012: Pharmaco-economic impact of demographic change on pharmaceutical expenses in Germany and France. Bmc Public Health 12: 894
Bottomley, J.M.; Raymond, F.D. 2007: Pharmaco-economic issues for diabetes therapy. Best Practice and Research. Clinical Endocrinology and Metabolism 21(4): 657-685
Piscitelli, P.; Chitano, G.; Greco, M.; Benvenuto, M.; Sbenaglia, E.; Colì, G.; Migliore, A.; Granata, M.; Iolascon, G.; Gimigliano, R.; Baggiani, A.; Distante, A.; Tarantino, U.; Rizzuti, C.; Brandi, M.L. 2010: Pharmaco-economic issues in the treatment of severe osteoporosis. Clinical Cases in Mineral and Bone Metabolism: the Official Journal of the Italian Society of Osteoporosis Mineral Metabolism and Skeletal Diseases 7(1): 61-64
Ruiz García, A.; Gordillo López, F.J.; Arranz Martínez, E.; Hermosa Hernán, J.C. 2011: Pharmaco-economic optimization of cholesterol-lowering treatment with statins. Medicina Clinica 137(3): 119-125
Mal'chikova, S.V.; Tarlovskaia, E.I.; Avksent'eva, M.V. 2011: Pharmaco-economical aspects of treatment of patients with arterial hypertension with fixed perindopril/amlodipine combination. Kardiologiia 51(10): 40-45
Tarricone, R. 2011: Pharmaco-economics and decision making in health care. the case of "Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis". Internal and Emergency Medicine 6(6): 581-582
Singh, P.M.; Trikha, A.; Sinha, R.; Ramachandran, R.; Rewari, V.; Borle, A. 2013: Pharmaco-economics: Minute-based cost of sevoflurane in pediatric short procedures and its relation to demographic variables. Journal of Anaesthesiology Clinical Pharmacology 29(3): 328-332
Biswas, S.; Mondal, K.Kumar.; Halder, S.; Sarkar, S.Sourendra.; Maiti, T.; Lahiri, S.Kumar.; Haldar, S. 2010: Pharmaco-epidcemiology of drugs utilised for cataract surgery in a government medical college and hospital. Journal of the Indian Medical Association 108(12): 829-832
Dhabali, A.A.H.; Awang, R.; Zyoud, S.H. 2011: Pharmaco-epidemiologic study of the prescription of contraindicated drugs in a primary care setting of a university: a retrospective review of drug prescription. International Journal of Clinical Pharmacology and Therapeutics 49(8): 500-509
Anonymous 1994: Pharmaco-epidemiological approaches to the study of signals. International Journal of Risk and Safety in Medicine 5(2): 167-193
Mignini, F.; Sabbatini, M.; Pascucci, C.; Petrelli, F.; Grappasonni, I.; Vanacore, N. 2013: Pharmaco-epidemiological description of the population of the Marche Region (central Italy) treated with the antipsychotic drug olanzapine. Annali Dell'istituto Superiore di Sanita 49(1): 42-49
Bensouda-Grimaldi, L.; Chalumeau, M.; Mikaeloff, Y.; Pons, G. 2008: Pharmaco-epidemiology to evaluate medicines in pediatric patients. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 15(5): 814-816
Le Couteur, D.G.; Kendig, H. 2008: Pharmaco-epistemology for the prescribing geriatrician. Australasian Journal on Ageing 27(1): 3-7
Cubells, J.F.; Deoreo, E.H.; Harvey, P.D.; Garlow, S.J.; Garber, K.; Adam, M.P.; Martin, C.L. 2011: Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome. American Journal of Medical Genetics. Part a 155a (4): 805-810
Bhaskar, S.B.; Bajwa, S.J.S. 2013: Pharmaco-genomics and anaesthesia: Mysteries, correlations and facts. Indian Journal of Anaesthesia 57(4): 336-337
Liang, H-Lung.; Chiang, C-Ling.; Chen, M.Chiung-Yu.; Lin, Y-Huie.; Huang, J-Shyung.; Pan, H-Ben. 2014: Pharmaco-induced vasospasm therapy for acute lower gastrointestinal bleeding: a preliminary report. European journal of radiology 83(10): 1811-1815
Oliveros, E.ía.; Dahya, Z.; Peña, C.; Mehta, S. 2011: Pharmaco-invasive approach for acute myocardial infarction. Indian Heart Journal 63(1): 13-19
Doonan, A.L.; Newell, M.C.; Larson, D.M.; Henry, T.D. 2010: Pharmaco-invasive strategies expand access to percutaneous coronary intervention in ST-elevation myocardial infarction. Progress in Cardiovascular Diseases 53(3): 188-194
Tofield, A. 2009: Pharmaco-invasive vs. facilitated percutaneous coronary intervention strategies for ST-segment-elevation acute myocardial infarction patients in the new ESC Guidelines. European heart journal 30(23): 2817
Bartley, A.C.; Edgar, D.W.; Wood, F.M. 2009: Pharmaco-management of inhalation injuries for burn survivors. Drug Design Development and Therapy 2: 9-16
Goel, S.; Nath, R.; Pandit, N. 2014: Pharmaco-mechanical management of acute massive pulmonary embolism in a postpartum female. Indian Heart Journal 66(3): 378-381
Malgor, R.D.; Gasparis, A.P. 2012: Pharmaco-mechanical thrombectomy for early thrombus removal. Phlebology 27(Suppl 1): 155-162
Jagadeeshwaran, A.R.; Arora, D.; Kumar, V.R.A.; Kumar, G.R.; Balamurugan, T.; Prabu, P.S. 2012: Pharmaco-prosthodontics revisited. Journal of Pharmacy and Bioallied Sciences 4(Suppl 2): S338-S340
Ghatpande, S.S.; Choudhary, P.K.; Quinn, C.T.; Goodman, S.R. 2008: Pharmaco-proteomic study of hydroxyurea-induced modifications in the sickle red blood cell membrane proteome. Experimental Biology and Medicine 233(12): 1510-1517
Ning, M.M.; Lopez, M.; Sarracino, D.; Cao, J.; Karchin, M.; McMullin, D.; Wang, X.; Buonanno, F.S.; Lo, E.H. 2013: Pharmaco-proteomics opportunities for individualizing neurovascular treatment. Neurological Research 35(5): 448-456
Hazuková, R.; Praus, R.; Cermáková, E.; Fűrmanová, V.; Vojáček, J.; Pleskot, M. 2012: Pharmaco-refractory chronic heart failure--the need for drug level tailored management. Medical Hypotheses 79(5): 560-563
Osorio, I.; Frei, M.G.; Sornette, D.; Milton, J. 2009: Pharmaco-resistant seizures: self-triggering capacity, scale-free properties and predictability?. European Journal of Neuroscience 30(8): 1554-1558
Ritter, R. 1954: The practicing dentist discards the classical articulation theory. Zahn- Mund- und Kieferheilkunde in Vortragen 14(6): 9-23
Rom, P.; Scheele, K.W. 1954: Studiosus pharmaciae; the work and significance of Scheele. A Gyogyszeresz 9(2): 22-23 Concl
Armand-Branger, S.; Poisson, N.; Gaudoneix-Taïeb, M.; Ramos, O. 2009: Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit. L'Encephale 35(4): 370-376
Russo, R.; Autore, G.; Severino, L. 2009: Pharmaco-toxicological aspects of herbal drugs used in domestic animals. Natural Product Communications 4(12): 1777-1784
Ziemann, U. 2013: Pharmaco-transcranial magnetic stimulation studies of motor excitability. Handbook of Clinical Neurology 116: 387-397
Degli Esposti, L.; Sangiorgi, D.; Mencacci, C.; Spina, E.; Pasina, C.; Alacqua, M.; la Tour, F. 2014: Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study. Bmc Psychiatry 14: 282
Jirasomprasert, T.; Morales, N.P.; Limenta, L.M.G.; Sirijaroonwong, S.; Yamanont, P.; Wilairat, P.; Fucharoen, S.; Chantharaksri, U. 2009: Pharmaco/ferrokinetic-related pro-oxidant activity of deferiprone in beta-thalassemia. Free Radical Research 43(5): 485-491
Jurcic, J.G. 2018: Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies. Current Radiopharmaceuticals 11(3): 192-199
Chisholm-Burns, M.A.; Spivey, C.A. 2008: Pharmacoadherence: a new term for a significant problem. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(7): 661-667
Golder, W.; Gilet, F.ço. 2014: Pharmacoangiography: from late techniques to present and future applications. Presse Medicale 43(2): 212-214
Baker, K.D.; Edwards, T.M.; Rickard, N.S. 2011: Pharmacobehavioural evidence for nitric oxide and noradrenaline interactions with ryanodine receptors during memory formation in the young chick. Behavioral Neuroscience 125(2): 175-183
Black, T.; Philips, G.; Burbridge, R. 2013: Pharmacobezoar in a patient on an oral phosphate binder. Gastrointestinal Endoscopy 77(3): 511-512
Toni García, M.; Zugasti Murillo, A.; Pueyo Royo, A.; Petrina Jáuregui, E. 2011: Pharmacobezoar induced by enteral nutrition. Endocrinologia y Nutricion: Organo de la Sociedad Espanola de Endocrinologia y Nutricion 58(5): 249-251
Liaw, G.W.; Chen, C.H.; Tseng, Y.J.; Zong, H.D. 2011: Pharmacobezoar of the esophagus. Clinical Toxicology 49(4): 348-349
Simpson, S.-E. 2011: Pharmacobezoars described and demystified. Clinical Toxicology 49(2): 72-89
White, E.; McKenna, J.; Cavanaugh, A.; Breitwieser, G.E. 2009: Pharmacochaperone-mediated rescue of calcium-sensing receptor loss-of-function mutants. Molecular Endocrinology 23(7): 1115-1123
Málaga-Diéguez, L.; Yang, Q.; Bauer, J.; Pankevych, H.; Freissmuth, M.; Nanoff, C. 2010: Pharmacochaperoning of the A1 adenosine receptor is contingent on the endoplasmic reticulum. Molecular Pharmacology 77(6): 940-952
Ma, Z-Tang.; Yang, X-Wei.; Zhang, Y.; Liu, J-Xun. 2014: Pharmacochemistry and integrated pharmacokinetics of six alkaloids after oral administration of huang-lian-jie-du-tang decoction. Journal of Asian Natural Products Research 16(5): 483-496
Jacobson, K.A.; Deflorian, F.; Mishra, S.; Costanzi, S. 2011: Pharmacochemistry of the platelet purinergic receptors. Purinergic Signalling 7(3): 305-324
Diniz-Freitas, M.; García-Caballero, T.; Antúnez-López, J.; Gándara-Rey, J.M.; García-García, A. 2007: Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma. Oral Diseases 13(3): 285-290
Jørgensen, J.T.øs.; Nielsen, K.V.; Ejlertsen, B. 2007: Pharmacodiagnostics and targeted therapies - a rational approach for individualizing medical anticancer therapy in breast cancer. Oncologist 12(4): 397-405
Li, J.; Meng, X.; Fan, X.; Lai, X.; Zhang, Y.; Zeng, Y. 2010: Pharmacodyamic material basis of rhizoma coptidis on insulin resistance. Zhongguo Zhong Yao Za Zhi 35(14): 1855-1858
Kim, B.-H.; Kim, J.-R.; Kim, M.-G.; Kim, K.-P.; Lee, B.-Y.; Jang, I.-J.; Shin, S.-G.; Yu, K.-S. 2010: Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studies. Clinical Therapeutics 32(1): 193-205
Moschos, S.J.; Sander, C.A.; Wang, W.; Reppert, S.L.; Drogowski, L.M.; Jukic, D.M.; Rao, U.N.M.; Athanassiou, C.; Buzoianu, M.; Mandic, M.; Richman, L.; McKinney, L.; Leininger, J.; Tice, D.A.; Hammershaimb, L.; Kirkwood, J.M. 2010: Pharmacodynamic (phase 0) study using etaracizumab in advanced melanoma. Journal of ImmunoTherapy 33(3): 316-325
Wensing, G.; Ochmann, K.; Boettcher, M.; Schäfer, A.; Kuhlmann, J. 2007: Pharmacodynamic Effects of an Angiotensin Ii Receptor-Antagonist in Phase I-Comparison between Healthy Subjects and Patients with Hypertension. Biomarker Insights 2: 81-93
Chakraborty, M.; Kamath, J.V.; Bhattacharjee, A. 2014: Pharmacodynamic Interaction of Green Tea Extract with Hydrochlorothiazide against Cyclophosphamide-Induced Myocardial Damage. Toxicology International 21(2): 196-202
Basri, D.Fredalina.; Khairon, R. 2012: Pharmacodynamic Interaction of Quercus infectoria Galls Extract in Combination with Vancomycin against MRSA Using Microdilution Checkerboard and Time-Kill Assay. Evidence-BasedComplementaryandAlternativeMedicine:Ecam 2012: 493156
Sabo, A.; Stilinovic, N.; Vukmirovic, S.; Bukumiric, Z.; Capo, I.; Jakovljevic, V. 2010: Pharmacodynamic action of a commercial preparation of the mushroom Coprinus comatus in rats. PhytoTherapy Research: Ptr 24(10): 1532-1537
Barnes, T.C.; Beutner, R. 1949: Pharmacodynamic action of acetylcholine. Nature 164(4159): 109
Oliveira, D. 1949: Pharmacodynamic action of vitamins and pharmaceuticals. Hospital (Rio de Janeiro) 35(5): 757-762
Zhanel, G.G.; Voth, D.; Nichol, K.; Karlowsky, J.A.; Noreddin, A.M.; Hoban, D.J. 2009: Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model. Journal of Antimicrobial ChemoTherapy 64(2): 364-369
Zhanel, G.G.; Denisuik, A.; Vashisht, S.; Yachison, C.; Adam, H.J.; Hoban, D.J. 2014: Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum β-lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model. Journal of Antimicrobial ChemoTherapy 69(9): 2448-2452
Chu, P.-C.; Chai, W.-Y.; Hsieh, H.-Y.; Wang, J.-J.; Wey, S.-P.; Huang, C.-Y.; Wei, K.-C.; Liu, H.-L. 2013: Pharmacodynamic analysis of magnetic resonance imaging-monitored focused ultrasound-induced blood-brain barrier opening for drug delivery to brain tumors. Biomed Research International 2013: 627496
Pérez-Ruixo, J.J.é; Krzyzanski, W.; Hing, J. 2008: Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects. Clinical Pharmacokinetics 47(6): 399-415
Saleh, M.I.; Widness, J.A.; Veng-Pedersen, P. 2011: Pharmacodynamic analysis of stress erythropoiesis: change in erythropoietin receptor pool size following double phlebotomies in sheep. Biopharmaceutics and Drug Disposition 32(3): 131-139
Martini, C.; Yassen, A.; Olofsen, E.; Passier, P.; Stoker, M.; Dahan, A. 2012: Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groups. Journal of Pain Research 5: 51-59
Vafadari, R.; Quaedackers, M.E.; Kho, M.M.; Mol, W.M.; Chan, G.; Weimar, W.; Baan, C.C. 2012: Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients. Transplantation 94(5): 465-472
Asdaq, S.Mohammed.Basheeruddin.; Inamdar, M.Naseeruddin. 2011: Pharmacodynamic and Pharmacokinetic Interactions of Propranolol with Garlic (Allium sativum) in Rats. Evidence-Based Complementary and Alternative Medicine: Ecam 2011: 824042
Friedbichler, K.; Hofmann, M.H.; Kroez, M.; Ostermann, E.; Lamche, H.R.; Koessl, C.; Borges, E.; Pollak, M.N.; Adolf, G.ün.; Adam, P.J. 2014: Pharmacodynamic and antineoplastic activity of Bi 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin. Molecular Cancer Therapeutics 13(2): 399-409
Bagai, A.; Chua, D.; Cohen, E.A.; Saw, J.; Verma, S.; Vijayaraghavan, R.; Welsh, R.; Fitchett, D. 2014: Pharmacodynamic and clinical implications of switching between P2Y12 receptor antagonists: considerations for practice. Critical Pathways in Cardiology 13(4): 156-158
Nelson, D.A.; Nelson, K.T.; Miller, M.W.; Dupe, R.; Chahwala, S.B.; Kennedy, A.; Chander, C.; Fossum, T.W. 2008: Pharmacodynamic and efficacy profile of TGN 255, a novel direct thrombin inhibitor, in canine cardiopulmonary bypass and simulated mitral valve repair. Journal of Extra-Corporeal Technology 40(2): 116-122
Singh, A.V.; Palladino, M.A.; Lloyd, G.K.; Potts, B.C.; Chauhan, D.; Anderson, K.C. 2010: Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model. British Journal of Haematology 149(4): 550-559
Gaur, S.; Wang, Y.; Kretzner, L.; Chen, L.; Yen, T.; Wu, X.; Yuan, Y-Ching.; Davis, M.; Yen, Y. 2014: Pharmacodynamic and pharmacogenomic study of the nanoparticle conjugate of camptothecin CRLX101 for the treatment of cancer. Nanomedicine: Nanotechnology Biology and Medicine 10(7): 1477-1486
Lampropoulou, A.; Zannis, V.I.; Kypreos, K.E. 2012: Pharmacodynamic and pharmacokinetic analysis of apoE4 [L261A, W264A, F265A, L268A, V269A], a recombinant apolipoprotein e variant with improved biological properties. Biochemical Pharmacology 84(11): 1451-1458
Bialer, M. 2009: Pharmacodynamic and pharmacokinetic characteristics of intravenous drugs in status epilepticus. Epilepsia 50(Suppl 12): 44-48
Jaksch, W.; Messerer, B.; Keck, B.; Lischka, A.; Urlesberger, B. 2014: Pharmacodynamic and pharmacokinetic characteristics of pain therapy in neonates: Austrian interdisciplinary recommendations on pediatric perioperative pain management. Schmerz 28(1): 25-30
Roldán Schilling, V.; Vicente García, V. 2012: Pharmacodynamic and pharmacokinetic characteristics. Mechanism of action of the new oral anticoagulants. Medicina Clinica 139(Suppl 2): 10-12
Rigel, D.F.; Fu, F.; Beil, M.; Hu, C.-W.; Liang, G.; Jeng, A.Y. 2010: Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone. Journal of Pharmacology and Experimental Therapeutics 334(1): 232-243
Strandell, J.; Wahlin, S. 2011: Pharmacodynamic and pharmacokinetic drug interactions reported to VigiBase, the WHO global individual case safety report database. European Journal of Clinical Pharmacology 67(6): 633-641
Segrt, Z.; Dordević, S.; Jaćević, V.; Kilibarda, V.; Vucinić, S.; Jović-Stosić, J.; Potrebić, O.; Vukcević-Perković, N. 2009: Pharmacodynamic and pharmacokinetic effects of flumazenil and theophylline application in rats acutely intoxicated by diazepam. Vojnosanitetski Pregled 66(2): 141-148
Zuurman, L.; Passier, P.C.C.M.; de Kam, M.L.; Kleijn, H.J.; Cohen, A.F.; van Gerven, J.M.A. 2010: Pharmacodynamic and pharmacokinetic effects of the intravenous CB1 receptor agonist Org 26828 in healthy male volunteers. Journal of Psychopharmacology 24(11): 1689-1696
Zuurman, L.; Passier, P.C.C.M.; de Kam, M.l.; Kleijn, H.J.; Cohen, A.F.; van Gerven, J.M.A. 2009: Pharmacodynamic and pharmacokinetic effects of the intravenously administered CB1 receptor agonist Org 28611 in healthy male volunteers. Journal of Psychopharmacology 23(6): 633-644
Ito, K.; Kinoshita, K.; Yamamura, N.; Tomizawa, A.; Inaba, F.; Morikawa-Inomata, Y.; Tabata, K.; Shibakawa, N. 2009: Pharmacodynamic and pharmacokinetic evaluation of CS-526 in cynomolgus monkeys. Biological and Pharmaceutical Bulletin 32(12): 2010-2017
Brainard, B.M.; Kleine, S.A.; Papich, M.G.; Budsberg, S.C. 2010: Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs. American Journal of Veterinary Research 71(7): 822-830
Cawello, W.; Rosenkranz, B.; Schmid, B.; Wierich, W. 2013: Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers. Epilepsia 54(3): 530-536
Parra-Ruiz, J.; Hernández-Quero, Jé. 2012: Pharmacodynamic and pharmacokinetic evaluation of respiratory fluoroquinolones. Guideline to selection of the most appropriate fluoroquinolone. Revista espanola de quimioterapia: publicacion oficial de la Sociedad Espanola de Quimioterapia 25(4): 245-251
Dudra-Jastrzebska, M.; Andres-Mach, M.M.; Sielski, M.; Ratnaraj, N.; Patsalos, P.N.; Czuczwar, S.J.; Luszczki, J.J. 2009: Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis. European Journal of Pharmacology 605(1-3): 87-94
Zarnowska, I.; Luszczki, J.J.; Zarnowski, T.; Buszewicz, G.; Madro, R.; Czuczwar, S.J.; Gasior, M. 2009: Pharmacodynamic and pharmacokinetic interactions between common antiepileptic drugs and acetone, the chief anticonvulsant ketone body elevated in the ketogenic diet in mice. Epilepsia 50(5): 1132-1140
Wu, T.; Nagaya, Y.; Hanada, T. 2014: Pharmacodynamic and pharmacokinetic interactions of perampanel and other antiepileptic drugs in a rat amygdala kindling model. Seizure 23(9): 732-739
Kanner, A.M.; Gidal, B.E. 2008: Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs. International Review of Neurobiology 83: 397-416
Mazzei, T.; Novelli, A.; Arrigucci, S. 2009: Pharmacodynamic and pharmacokinetic of antibiotics for treatment of skin and soft tissue infections. Le Infezioni in Medicina 17(Suppl 4): 37-57
Gupta, S.; Malhotra, S.; Sinha, S.; Singh, S.K.; Singh, R.K.; Krishna, S.; Chhabra, P.; Chaira, T.; Kannayiram, J.; Sharma, P.; Aeron, S.; Kaur, J.; Kumar, N.; Sattigeri, J.; Shirumalla, R.K.; Paliwal, J.; Dastidar, S.G.; Cliffe, I.A.; Ray, A.; Bhatnagar, P. 2011: Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: a novel, long acting muscarinic receptor antagonist. European Journal of Pharmacology 658(2-3): 219-228
Wang, J.-H.; Wang, Z.-M.; Jiang, X.; Xue, B.-Y.; Li, C.-Y. 2007: Pharmacodynamic and toxicologic comparative study of crude and processed radix aristolochice. Zhongguo Zhong Yao Za Zhi 32(5): 428-433
Crandon, J.L.; Nicolau, D.P. 2011: Pharmacodynamic approaches to optimizing beta-lactam therapy. Critical Care Clinics 27(1): 77-93
Ceelen, W.P.; Påhlman, L.; Mahteme, H. 2007: Pharmacodynamic aspects of intraperitoneal cytotoxic therapy. Cancer Treatment and Research 134: 195-214
Bantar, C.; Canigia, L.F.án.; Berger, M.ía.A.; Soutric, J.L.; Arenoso, H.éc.J. 2009: Pharmacodynamic assessment of Amoxicillin-Sulbactam against Acinetobacter baumannii: searching the optimal dose and infusion time through a human ex-vivo model. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 13(5): 348-352
Yokoi, H.; Kimura, T.; Isshiki, T.; Ogawa, H.; Ikeda, Y. 2012: Pharmacodynamic assessment of a novel P2Y12 receptor antagonist in Japanese patients with coronary artery disease undergoing elective percutaneous coronary intervention. Thrombosis Research 129(5): 623-628
Chen, T.; Lee, M.-J.; Kim, Y.S.; Lee, S.; Kummar, S.; Gutierrez, M.; Hewitt, S.M.; Trepel, J.B.; Levin, I.W. 2008: Pharmacodynamic assessment of histone deacetylase inhibitors: infrared vibrational spectroscopic imaging of protein acetylation. Analytical Chemistry 80(16): 6390-6396
Michelson, A.D.; Frelinger, A.L.; Braunwald, E.; Downey, W.E.; Angiolillo, D.J.; Xenopoulos, N.P.; Jakubowski, J.A.; Li, Y.; Murphy, S.A.; Qin, J.; McCabe, C.H.; Antman, E.M.; Wiviott, S.D. 2009: Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMi 38 trial. European Heart Journal 30(14): 1753-1763
Salem, A.H.; Elkhatib, W.F.; Noreddin, A.M. 2011: Pharmacodynamic assessment of vancomycin-rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis. Journal of Pharmacy and Pharmacology 63(1): 73-79
Li, S. 2012: Pharmacodynamic bioequivalence testing. Journal of Clinical Pharmacy and Therapeutics 37(5): 497-498
Gainor, J.F.; Longo, D.L.; Chabner, B.A. 2014: Pharmacodynamic biomarkers: falling short of the mark?. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(10): 2587-2594
Koyama, N.; Saito, K.; Nishioka, Y.; Yusa, W.; Yamamoto, N.; Yamada, Y.; Nokihara, H.; Koizumi, F.; Nishio, K.; Tamura, T. 2014: Pharmacodynamic change in plasma angiogenic proteins: a dose-escalation phase 1 study of the multi-kinase inhibitor lenvatinib. Bmc Cancer 14: 530
Liu, L.; Min, S.; Li, W.; Wei, K.; Luo, J.; Wu, G.; Ao, L.; Cao, J.; Wang, B.; Wang, Z. 2014: Pharmacodynamic changes with vecuronium in sepsis are associated with expression of α7- and γ-nicotinic acetylcholine receptor in an experimental rat model of neuromyopathy. British Journal of Anaesthesia 112(1): 159-168
Golenkov, A.K.; Mitina, T.A.; Kogarko, I.N.; Liubimova, N.V.; Klinushkina, E.F.; Baryshnikov, A.I. 2009: Pharmacodynamic characteristics of velcade efficacy in resistant and recurrent multiple myeloma: determination of free light chains of blood serum immunoglobulins. Terapevticheskii Arkhiv 81(7): 37-41
Banks, M.L.; Buzard, S.K.; Gehret, C.M.; Monroy, A.N.; Kenaston, M.A.; Mills, E.M.; Sprague, J.E. 2009: Pharmacodynamic characterization of insulin on MDMA-induced thermogenesis. European Journal of Pharmacology 615(1-3): 257-261
Inoue, S.; Aiba, T.; Masaoka, Y.; Shimizu, K.; Komori, Y.; Mio, M.; Takatori, S.; Kawasaki, H.; Kurosaki, Y. 2011: Pharmacodynamic characterization of nitric oxide-mediated vasodilatory activity in isolated perfused rat mesenteric artery bed. Biological and Pharmaceutical Bulletin 34(9): 1487-1492
Tap, W.D.; Gong, K.-W.; Dering, J.; Tseng, Y.; Ginther, C.; Pauletti, G.; Glaspy, J.A.; Essner, R.; Bollag, G.; Hirth, P.; Zhang, C.; Slamon, D.J. 2010: Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma. Neoplasia 12(8): 637-649
Kuti, J.L.; Kiffer, C.R.V.; Mendes, C.M.F.; Nicolau, D.P. 2008: Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 14(2): 116-123
Pelliccia, F.; Rosano, G.; Marazzi, G.; Vitale, C.; Spoletini, I.; Franzoni, F.; Speziale, G.; Polacco, M.; Greco, C.; Gaudio, C. 2014: Pharmacodynamic comparison of pitavastatin versus atorvastatin on platelet reactivity in patients with coronary artery disease treated with dual antiplatelet therapy. Circulation Journal: Official Journal of the Japanese Circulation Society 78(3): 679-684
Lee, S.; Chung, J.Y.; Hong, K.S.; Yang, S.-H.; Byun, S.-Y.; Lim, H.-S.; Shin, S.-G.; Jang, I.-J.; Yu, K.-S. 2012: Pharmacodynamic comparison of two formulations of Acarbose 100-mg tablets. Journal of Clinical Pharmacy and Therapeutics 37(5): 553-557
Kim, M.H.; Zhang, H.-Z.; Jung, D.K. 2013: Pharmacodynamic comparisons for single loading doses of prasugrel (30 mg) and clopidogrel (600 mg) in healthy Korean volunteers. Circulation Journal: Official Journal of the Japanese Circulation Society 77(5): 1253-1259
Wolf, C.; Sidhu, J.; Otoul, C.; Morris, D.L.; Cnops, J.; Taubel, J.; Bennett, B. 2013: Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 study. Plos one 8(3): E58438
Becker, D.E. 2012: Pharmacodynamic considerations for moderate and deep sedation. Anesthesia Progress 59(1): 28-42
Stoll, H.C. 1948: Pharmacodynamic considerations of atropine and related compounds. American Journal of the Medical Sciences 215(5): 577-592
Konstandin, M.H.; Sommerer, C.; Doesch, A.; Zeier, M.; Meuer, S.C.; Katus, H.A.; Dengler, T.J.; Giese, T. 2007: Pharmacodynamic cyclosporine A-monitoring: relation of gene expression in lymphocytes to cyclosporine blood levels in cardiac allograft recipients. Transplant International: Official Journal of the European Society for Organ Transplantation 20(12): 1036-1043
Sha, S.; Polidori, D.; Farrell, K.; Ghosh, A.; Natarajan, J.; Vaccaro, N.; Pinheiro, J.; Rothenberg, P.; Plum-Mörschel, L. 2015: Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double-blind, crossover study. Diabetes Obesity and Metabolism 17(2): 188-197
Kamal, M.A.; Smith, D.E.; Cook, J.; Feltner, D.; Moton, A.; Ouellet, D. 2010: Pharmacodynamic differentiation of lorazepam sleepiness and dizziness using an ordered categorical measure. Journal of Pharmaceutical Sciences 99(8): 3628-3641
Sommerer, C.; Zeier, M.; Czock, D.; Schnitzler, P.; Meuer, S.; Giese, T. 2011: Pharmacodynamic disparities in tacrolimus-treated patients developing cytomegalus virus viremia. Therapeutic Drug Monitoring 33(4): 373-379
O'Donoghue, M.L.; Braunwald, E.; Antman, E.M.; Murphy, S.A.; Bates, E.R.; Rozenman, Y.; Michelson, A.D.; Hautvast, R.W.; Ver Lee, P.N.; Close, S.L.; Shen, L.; Mega, J.L.; Sabatine, M.S.; Wiviott, S.D. 2009: Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet 374(9694): 989-997
Rose, W.E.; Knier, R.M.; Hutson, P.R. 2010: Pharmacodynamic effect of clinical vancomycin exposures on cell wall thickness in heterogeneous vancomycin-intermediate Staphylococcus aureus. Journal of Antimicrobial ChemoTherapy 65(10): 2149-2154
Tousek, P.; Kocka, V.; Sulzenko, J.; Bednar, F.; Linkova, H.; Widimsky, P. 2013: Pharmacodynamic effect of clopidogrel in patients undergoing transcatheter aortic valve implantation. Biomed Research International 2013: 386074
Jeong, Y-H.; Park, Y.; Muse, W.C.; Kwon, T.J.; Koh, J-S.; Hwang, S-J.; Kwak, C.H.; Hwang, J-Y. 2012: Pharmacodynamic effect of clopidogrel therapy and switching to cilostazol in patients with the CYP2C19 loss-of-function allele (ACCEL-SWITCH) study. Journal of thrombosis and haemostasis: JTH 10(8): 1685-1688
Schneider, D.J.; Seecheran, N.; Raza, S.S.; Keating, F.K.; Gogo, P. 2015: Pharmacodynamic effects during the transition between cangrelor and prasugrel. Coronary Artery Disease 26(1): 42-48
Schneider, D.J.; Agarwal, Z.; Seecheran, N.; Keating, F.K.; Gogo, P. 2014: Pharmacodynamic effects during the transition between cangrelor and ticagrelor. JACC. Cardiovascular Interventions 7(4): 435-442
Fink, M.; Noble, D. 2010: Pharmacodynamic effects in the cardiovascular system: the modeller's view. Basic and Clinical Pharmacology and Toxicology 106(3): 243-249
Rollini, F.; Tello-Montoliu, A.; Patel, R.; Darlington, A.; Wilson, R.E.; Franchi, F.; Muñiz-Lozano, A.; Desai, B.; Bender, N.; Sakariassen, K.S.; Angiolillo, D.J. 2014: Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation. Journal of Thrombosis and Thrombolysis 37(2): 131-138
Tello-Montoliu, A.; Rollini, F.; Desai, B.; Pasqualino, G.; Patel, R.; Sorensen, A.S.; Sakariassen, K.S.; Angiolillo, D.J. 2012: Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers. Journal of Thrombosis and Thrombolysis 34(3): 297-299
Pelliccia, F.; Rosano, G.; Marazzi, G.; Vitale, C.; Spoletini, I.; Franzoni, F.; Speziale, G.; Polacco, M.; Greco, C.; Gaudio, C. 2014: Pharmacodynamic effects of atorvastatin versus rosuvastatin in coronary artery disease patients with normal platelet reactivity while on dual antiplatelet therapy--the PEARL randomized cross-over study. European Journal of Pharmacology 725: 18-22
Sha, S.; Devineni, D.; Ghosh, A.; Polidori, D.; Hompesch, M.; Arnolds, S.; Morrow, L.; Spitzer, H.; Demarest, K.; Rothenberg, P. 2014: Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes. Plos one 9(9): E110069
Rollini, F.; Franchi, F.; Tello-Montoliu, A.; Patel, R.; Darlington, A.; Ferreiro, J.é L.; Cho, J.R.; Muñiz-Lozano, A.; Desai, B.; Zenni, M.M.; Guzman, L.A.; Bass, T.A.; Angiolillo, D.J. 2014: Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients. JACC. Cardiovascular Interventions 7(4): 426-434
Park, Y.; Jung, J.Mu.; Tantry, U.S.; Kim, K.; Koh, J.Sin.; Park, J.Rang.; Hwang, S-Jae.; Kwak, C.Hwan.; Hwang, J-Yong.; Kim, S.; Gurbel, P.A.; Jeong, Y-Hoon. 2014: Pharmacodynamic effects of cilostazol versus clopidogrel in stented patients under proton pump inhibitor co-administration: the ACCEL-PARAZOL study. Journal of atherosclerosis and thrombosis 21(11): 1121-1139
Kamar, N.; Gennero, I.; Spataru, L.; Esposito, L.; Guitard, J.; Lavayssière, L.; Cointault, O.; Gandia, P.; Durand, D.; Rostaing, L. 2008: Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 23(11): 3720-3726
Jennings, L.K.; Michelson, A.D.; Jacoski, M.V.; Tyagi, A.; Grgurevich, S.; Li, J.S.; Picolo Investigators 2012: Pharmacodynamic effects of clopidogrel in pediatric cardiac patients: a comparative study of platelet aggregation response. Platelets 23(6): 430-438
Ferreiro, J.é L.; Ueno, M.; Capodanno, D.; Desai, B.; Dharmashankar, K.; Darlington, A.; Charlton, R.K.; Bass, T.A.; Angiolillo, D.J. 2010: Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover study. CIRCULATION. Cardiovascular Interventions 3(5): 436-441
Held, T.K.; Gundert-Remy, U. 2010: Pharmacodynamic effects of haematopoietic cytokines: the view of a clinical oncologist. Basic and Clinical Pharmacology and Toxicology 106(3): 210-214
Vatsalya, V.; Issa, J.E.; Hommer, D.W.; Ramchandani, V.A. 2012: Pharmacodynamic effects of intravenous alcohol on hepatic and gonadal hormones: influence of age and sex. Alcoholism Clinical and Experimental Research 36(2): 207-213
Babalonis, S.; Lofwall, M.R.; Nuzzo, P.A.; Walsh, S.L. 2016: Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans. Addiction Biology 21(1): 146-158
Tello-Montoliu, A.; Tomasello, S.D.; Ferreiro, J.é L.; Ueno, M.; Seecheran, N.; Desai, B.; Kodali, M.; Charlton, R.K.; Box, L.C.; Zenni, M.M.; Guzman, L.A.; Bass, T.A.; Angiolillo, D.J. 2012: Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: results of a prospective randomized study. Journal of the American College of Cardiology 59(19): 1681-1687
Aquilante, C.L.; Kosmiski, L.A.; Zineh, I.; Rome, L.C.; Knutsen, S.D. 2010: Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome. PharmacoTherapy 30(3): 236-247
Hsieh, W.-S.; Soo, R.; Peh, B.-K.; Loh, T.; Dong, D.; Soh, D.; Wong, L.-S.; Green, S.; Chiao, J.; Cui, C.-Y.; Lai, Y.-F.; Lee, S.-C.; Mow, B.; Soong, R.; Salto-Tellez, M.; Goh, B.-C. 2009: Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(4): 1435-1442
Darlington, A.; Tello-Montoliu, A.; Rollini, F.; Ueno, M.; Ferreiro, J.é L.; Patel, R.; Desai, B.; Guzman, L.A.; Bass, T.A.; Angiolillo, D.J. 2014: Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease. Thrombosis and Haemostasis 111(2): 258-265
Boulton, C.; Meiser, K.; David, O.J.; Schmouder, R. 2012: Pharmacodynamic effects of steady-state fingolimod on antibody response in healthy volunteers: a 4-week, randomized, placebo-controlled, parallel-group, multiple-dose study. Journal of Clinical Pharmacology 52(12): 1879-1890
Sjöstrand, M.; Ericsson, H.; Hartford, M.; Norjavaara, E.; Eriksson, J.W. 2013: Pharmacodynamic effects of the oral glucokinase activator AZD6370 after single doses in healthy volunteers assessed with euglycaemic clamp. Diabetes Obesity and Metabolism 15(1): 35-41
Koh, J-Sin.; Kim, I-Sook.; Tantry, U.S.; Yoon, S-Eun.; Park, Y.; Cho, S.Yeong.; Lee, E-Ju.; Park, J.Rang.; Hwang, S-Jae.; Kwak, C.Hwan.; Hwang, J-Yong.; Gurbel, P.A.; Jeong, Y-Hoon. 2014: Pharmacodynamic efficacy and safety of adjunctive cilostazol loading to clopidogrel and aspirin loading: the results of the ACCEL-LOADING (Accelerated Platelet Inhibition by Cilostazol Loading) study. International journal of cardiology 174(1): 129-132
Di Cosimo, S.; Baselga, J. 2007: Pharmacodynamic endpoints in primary breast cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 18(Suppl 9): Ix21-Ix23
Afonso, T.; Giguère, S.; Rapoport, G.; Berghaus, L.J.; Barton, M.H.; Coleman, A.E. 2013: Pharmacodynamic evaluation of 4 angiotensin-converting enzyme inhibitors in healthy adult horses. Journal of Veterinary Internal Medicine 27(5): 1185-1192
Alcala-Canto, Y.; Ramos-Martinez, E.; Tapia-Perez, G.; Gutierrez, L.; Sumano, H. 2014: Pharmacodynamic evaluation of a reference and a generic toltrazuril preparation in broilers experimentally infected with Eimeria tenella or E. acervulina. British Poultry Science 55(1): 44-53
Tripathi, M.; Pandey, M. 2009: Pharmacodynamic evaluation of augmentation effect of isoflurane on mivacurium. Journal of the Indian Medical Association 107(6): 350-353
Kiffer, C.R.; Pignatari, A.C. 2011: Pharmacodynamic evaluation of commonly prescribed oral antibiotics against respiratory bacterial pathogens. Bmc Infectious Diseases 11: 286
Keel, R.A.; Kuti, J.L.; Sahm, D.F.; Nicolau, D.P. 2011: Pharmacodynamic evaluation of I.v. antimicrobials against Pseudomonas aeruginosa samples collected from U.S. hospitals. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(17): 1619-1625
Mittal, G.; Chandraiah, G.; Ramarao, P.; Ravi Kumar, M.N.V. 2009: Pharmacodynamic evaluation of oral estradiol nanoparticles in estrogen deficient (ovariectomized) high-fat diet induced hyperlipidemic rat model. Pharmaceutical Research 26(1): 218-223
Angiolillo, D.J.; Curzen, N.; Gurbel, P.; Vaitkus, P.; Lipkin, F.; Li, W.; Jakubowski, J.A.; Zettler, M.; Effron, M.B.; Trenk, D. 2014: Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 Study (Switching Anti Platelet-2). Journal of the American College of Cardiology 63(15): 1500-1509
Ekshyyan, O.; Mills, G.M.; Lian, T.; Amirghahari, N.; Rong, X.; Lowery-Nordberg, M.; Abreo, F.; Veillon, D.M.; Caldito, G.; Speicher, L.; Glass, J.; Nathan, C.-A.O. 2010: Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma. Head and Neck 32(12): 1619-1628
Louie, A.; Boyne, M.T.; Patel, V.; Huntley, C.; Liu, W.; Fikes, S.; Kurhanewicz, S.; Rodriquez, J.; Robbins, N.; Brown, D.; Baluya, D.; Drusano, G.L. 2015: Pharmacodynamic evaluation of the activities of six parenteral vancomycin products available in the United States. Antimicrobial Agents and ChemoTherapy 59(1): 622-632
Laizure, S.C.; Parker, R.B. 2009: Pharmacodynamic evaluation of the cardiovascular effects after the coadministration of cocaine and ethanol. Drug Metabolism and Disposition: the Biological Fate of Chemicals 37(2): 310-314
Kamar, N.; Glander, P.; Nolting, J.; Böhler, T.; Hambach, P.; Liefeldt, L.; Rostaing, L.; Neumayer, H.-H.; Budde, K. 2009: Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantation. Clinical Journal of the American Society of Nephrology: Cjasn 4(5): 936-942
Novotny-Diermayr, V.; Sausgruber, N.; Loh, Y.K.; Pasha, M.K.; Jayaraman, R.; Hentze, H.; Yong, W.-P.; Goh, B.-C.; Toh, H.-C.; Ethirajulu, K.; Zhu, J.; Wood, J.M. 2011: Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue. Molecular Cancer Therapeutics 10(7): 1207-1217
Koomanachai, P.; Kim, A.; Nicolau, D.P. 2009: Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model. Journal of Antimicrobial ChemoTherapy 63(5): 982-987
Liu, F.-z.; Shi, H.; Shi, Y.-j.; Liu, Y.; Jin, Y.-h.; Gao, Y.-j.; Guo, S.-s.; Cui, X.-l. 2010: Pharmacodynamic experiment of the antivirus effect of Houttuynia cordata injection on influenza virus in mice. Yao Xue Xue Bao 45(3): 399-402
Hoskins, J.M.; Rosner, G.L.; Ratain, M.J.; McLeod, H.L.; Innocenti, F. 2009: Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan. Pharmacogenomics 10(7): 1139-1146
López-Rodríguez, R.; Cabaleiro, T.; Ochoa, D.; Román, M.; Borobia, A.M.; Carcas, A.J.; Ayuso, C.; Novalbos, J.ús.; Abad-Santos, F. 2013: Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers. Pharmacogenomics 14(10): 1203-1214
Sommerer, C.; Hartschuh, W.; Enk, A.; Meuer, S.; Zeier, M.; Giese, T. 2008: Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients. Clinical Transplantation 22(5): 549-554
Ley, B.; Wernsdorfer, G.; Frank, C.; Sirichaisinthop, J.; Congpuong, K.; Wernsdorfer, W.H. 2008: Pharmacodynamic interaction between 4-aminoquinolines and retinol in Plasmodium falciparum in vitro. Wiener Klinische Wochenschrift 120(19-20 Suppl 4: 74-79
Leeb, A.; Wernsdorfer, G.; Satimai, W.; Wiedermann, U.; Congpuong, K.; Wernsdorfer, W.H. 2010: Pharmacodynamic interaction between lumefantrine and desbutyl-benflumetol in Plasmodium falciparum in vitro. Wiener Klinische Wochenschrift 122(Suppl 3): 61-65
Gruber, M.; Wernsdorfer, G.; Satimai, W.; Wiedermann, U.; Congpuong, K.; Wernsdorfer, W.H. 2009: Pharmacodynamic interaction between mefloquine and retinol in Plasmodium falciparum in vitro. Wiener Klinische Wochenschrift 121(Suppl 3): 27-31
Raffelsberger, J.; Wernsdorfer, G.; Sirichaisinthop, J.; Kollaritsch, H.; Congpuong, K.; Wernsdorfer, W.H. 2008: Pharmacodynamic interaction between monodesbutyl-benflumetol and artemisinin as well as proguanil in Plasmodium falciparum in vitro. Wiener Klinische Wochenschrift 120(19-20 Suppl 4: 90-94
Vadgama, V.K.; Patel, Y.A.; Patel, T.K.; Tripathi, C.B. 2011: Pharmacodynamic interaction between pantoprazole and vecuronium at neuromuscular junction. Autonomic and Autacoid Pharmacology 31(1-2): 31-35
Yang, L.; Wei, B.; Zhang, L.-p.; Bi, S.-s.; Lu, W.; Guo, X.-y. 2010: Pharmacodynamic interaction between propofol and remifentanil on the tolerance response to electrical tetanus stimuli. Beijing da Xue Xue Bao. Yi Xue Ban 42(5): 547-553
Brigo, F. 2013: Pharmacodynamic interaction between stiripentol and benzodiazepines: from molecular to clinical studies. Epilepsy and Behavior: E&b 29(3): 586
Tang, M.; Zhang, W. 2009: Pharmacodynamic interaction model and its clinical application. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 26(3): 692-696
Nivitabishekam, S.N.; Asad, M.; Prasad, V.S. 2009: Pharmacodynamic interaction of Momordica charantia with rosiglitazone in rats. Chemico-Biological Interactions 177(3): 247-253
Abdelkhalek, N.K.M.; Ghazy, E.W.; Abdel-Daim, M.M. 2015: Pharmacodynamic interaction of Spirulina platensis and deltamethrin in freshwater fish Nile tilapia, Oreochromis niloticus: impact on lipid peroxidation and oxidative stress. Environmental Science and Pollution Research International 22(4): 3023-3031
Asdaq, S.M.B.; Inamdar, M.N. 2010: Pharmacodynamic interaction of captopril with garlic in isoproterenol-induced myocardial damage in rat. PhytoTherapy Research: Ptr 24(5): 720-725
Asdaq, S.M.B.; Inamdar, M.N. 2009: Pharmacodynamic interaction of garlic with hydrochlorothiazide in rats. Indian Journal of Physiology and Pharmacology 53(2): 127-136
Chakraborty, M.; Kamath, J.V. 2014: Pharmacodynamic interaction of green tea extract with hydrochlorothiazide against ischemia-reperfusion injury-induced myocardial infarction. Journal of Advanced Pharmaceutical Technology and Research 5(3): 134-139
Balderas, Jé.Luis.; Reza, V.; Ugalde, M.; Guzmán, L.; Serrano, M.Isabel.; Aguilar, A.; Navarrete, Aés. 2008: Pharmacodynamic interaction of the sedative effects of Ternstroemia pringlei (Rose) Standl. with six central nervous system depressant drugs in mice. Journal of Ethnopharmacology 119(1): 47-52
Mateen, A.A.; Rani, P.Usha.; Naidu, M.U.R.; Chandrashekar, E. 2011: Pharmacodynamic interaction study of Allium sativum (garlic) with cilostazol in patients with type II diabetes mellitus. Indian Journal of Pharmacology 43(3): 270-274
Ikeda, R.; Igari, Y.; Fuchigami, Y.; Wada, M.; Kuroda, N.; Nakashima, K. 2011: Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain. European Journal of Pharmacology 660(2-3): 318-325
Czuczwar, S.J.; Kaplanski, J.; Swiderska-Dziewit, G.; Gergont, A.; Kroczka, S.; Kacinski, M. 2009: Pharmacodynamic interactions between antiepileptic drugs: preclinical data based on isobolography. Expert Opinion on Drug Metabolism and Toxicology 5(2): 131-136
Nimmagadda, S.; Glunde, K.; Pomper, M.G.; Bhujwalla, Z.M. 2009: Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells. Neoplasia 11(5): 477-484
Hennessy, B.T.; Lu, Y.; Poradosu, E.; Yu, Q.; Yu, S.; Hall, H.; Carey, M.S.; Ravoori, M.; Gonzalez-Angulo, A.M.; Birch, R.; Henderson, I.C.; Kundra, V.; Mills, G.B. 2007: Pharmacodynamic markers of perifosine efficacy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(24): 7421-7431
Guy, R.H.; Tur, E.; Bugatto, B.; Gaebel, C.; Sheiner, L.B.; Maibach, H.I. 1984: Pharmacodynamic measurements of methyl nicotinate percutaneous absorption. Pharmaceutical Research 1(2): 76-81
Abraham, A.K.; Maurer, T.S.; Kalgutkar, A.S.; Gao, X.; Li, M.; Healy, D.R.; Petersen, D.N.; Griffith, D.A.; Mager, D.E. 2011: Pharmacodynamic model of parathyroid hormone modulation by a negative allosteric modulator of the calcium-sensing receptor. Aaps Journal 13(2): 265-273
Hazra, A.; DuBois, D.C.; Almon, R.R.; Snyder, G.H.; Jusko, W.J. 2008: Pharmacodynamic modeling of acute and chronic effects of methylprednisolone on hepatic urea cycle genes in rats. Gene Regulation and Systems Biology 2: 1-19
Tam, V.H.; Ledesma, K.R.; Vo, G.; Kabbara, S.; Lim, T.-P.; Nikolaou, M. 2008: Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development. Antimicrobial Agents and ChemoTherapy 52(11): 3987-3993
Lin, H.-Y.; Landersdorfer, C.B.; London, D.; Meng, R.; Lim, C.-U.; Lin, C.; Lin, S.; Tang, H.-Y.; Brown, D.; Van Scoy, B.; Kulawy, R.; Queimado, L.; Drusano, G.L.; Louie, A.; Davis, F.B.; Mousa, S.A.; Davis, P.J. 2011: Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system. Plos Computational Biology 7(2): E1001073
Hilton, E.C.Y.; Baverel, P.G.; Woodcock, A.; Van Der Graaf, P.H.; Smith, J.A. 2013: Pharmacodynamic modeling of cough responses to capsaicin inhalation calls into question the utility of the C5 end point. Journal of Allergy and Clinical Immunology 132(4): 847
Andraud, M.; Chauvin, C.; Sanders, P.; Laurentie, M. 2011: Pharmacodynamic modeling of in vitro activity of marbofloxacin against Escherichia coli strains. Antimicrobial Agents and ChemoTherapy 55(2): 756-761
Koomanachai, P.; Bulik, C.C.; Kuti, J.L.; Nicolau, D.P. 2010: Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States. Clinical Therapeutics 32(4): 766-779
Hahn, J.-O.; Khosravi, S.; Dosani, M.; Dumont, G.A.; Mark Ansermino, J. 2011: Pharmacodynamic modeling of propofol-induced tidal volume depression in children. Journal of Clinical Monitoring and Computing 25(4): 275-284
Freise, K.J.; Schmidt, R.L.; Widness, J.A.; Veng-Pedersen, P. 2008: Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular response. Journal of Pharmacokinetics and Pharmacodynamics 35(5): 527-552
Garrido, Mía.J.; Cendrós, J-María.; Ramis, J.; Peraire, Cón.; Obach, R.; Trocóniz, Iñaki.F. 2012: Pharmacodynamic modeling of the effects of lanreotide Autogel on growth hormone and insulin-like growth factor 1. Journal of Clinical Pharmacology 52(4): 487-498
Jackson, R.C. 2012: Pharmacodynamic modelling of biomarker data in oncology. Isrn Pharmacology 2012: 590626
Zanderigo, E.; Caruso, A.; Bouillon, T.; Luginbuhl, M.; Morari, M. 2006: Pharmacodynamic modelling of drug-induced ventilatory depression and automatic drug dosing in conscious sedation. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2006: 5029-5032
Juul, R.V.; Foster, D.J.R.; Upton, R.N.; Andresen, T.; Graversen, C.; Drewes, Aørn.M.; Christrup, L.L.; Kreilgaard, M. 2014: Pharmacodynamic modelling of placebo and buprenorphine effects on event-related potentials in experimental pain. Basic and Clinical Pharmacology and Toxicology 115(4): 343-351
Ihmsen, H.; Viethen, V.; Forst, J.; Schwilden, H.; Schmitt, H.J.; Muenster, T. 2009: Pharmacodynamic modelling of rocuronium in adolescents with Duchenne muscular dystrophy. European Journal of Anaesthesiology 26(2): 105-110
Reeve, R.; Turner, J.Rick. 2013: Pharmacodynamic models: parameterizing the hill equation, Michaelis-Menten, the logistic curve, and relationships among these models. Journal of Biopharmaceutical Statistics 23(3): 648-661
Billing, H.; Breil, T.; Schmidt, J.; Tönshoff, B.; Schmitt, C.P.; Schmitt, C.; Giese, T.; Engelmann, G. 2012: Pharmacodynamic monitoring by residual NFAT-regulated gene expression in stable pediatric liver transplant recipients. Pediatric Transplantation 16(2): 187-194
Van Rossum, H.H.; de Fijter, J.W.; van Pelt, J. 2010: Pharmacodynamic monitoring of calcineurin inhibition therapy: principles, performance, and perspectives. Therapeutic Drug Monitoring 32(1): 3-10
Sommerer, C.; Giese, T.; Meuer, S.; Zeier, M. 2009: Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit?. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 24(1): 21-27
Yano, I. 2008: Pharmacodynamic monitoring of calcineurin phosphatase activity in transplant patients treated with calcineurin inhibitors. Drug Metabolism and Pharmacokinetics 23(3): 150-157
Archer, T.M.; Fellman, C.L.; Stokes, J.V.; Pinchuk, L.M.; Lunsford, K.V.; Pruett, S.B.; Langston, V.C.; Mackin, A.J. 2011: Pharmacodynamic monitoring of canine T-cell cytokine responses to oral cyclosporine. Journal of Veterinary Internal Medicine 25(6): 1391-1397
Sommerer, C.; Schnitzler, P.; Meuer, S.; Zeier, M.; Giese, T. 2011: Pharmacodynamic monitoring of cyclosporin a reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and older. Therapeutic Drug Monitoring 33(6): 694-698
Billing, H.; Giese, T.; Sommerer, C.; Zeier, M.; Feneberg, R.; Meuer, S.; Tönshoff, B. 2010: Pharmacodynamic monitoring of cyclosporine a by NFAT-regulated gene expression and the relationship with infectious complications in pediatric renal transplant recipients. Pediatric Transplantation 14(7): 844-851
Roos, K.; Gotthardt, D.; Giese, T.; Schnitzler, P.; Stremmel, W.; Czock, D.; Eisenbach, C. 2014: Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20(9): 1106-1117
Hoerning, A.é; Wilde, B.; Wang, J.; Tebbe, B.; Jing, L.; Wang, X.; Jian, F.; Zhu, J.; Dolff, S.; Kribben, A.; Hoyer, P.F.; Witzke, O. 2015: Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity. Transplantation 99(1): 210-219
Hedley, D.W.; Chow, S.; Goolsby, C.; Shankey, T.V. 2008: Pharmacodynamic monitoring of molecular-targeted agents in the peripheral blood of leukemia patients using flow cytometry. Toxicologic Pathology 36(1): 133-139
Steinebrunner, N.; Sandig, C.; Sommerer, C.; Hinz, U.; Giese, T.; Stremmel, W.; Zahn, A. 2014: Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study. Annals of Transplantation 19: 32-40
Nicolau, D.P. 2008: Pharmacodynamic optimization of beta-lactams in the patient care setting. Critical Care 12(Suppl 4): S2
Drozd, N.N.; Tolstenkov, A.S.; Makarov, V.A.; Kuznetsova, T.A.; Besednova, N.N.; Shevchenko, N.M.; Zvyagintseva, T.N. 2006: Pharmacodynamic parameters of anticoagulants based on sulfated polysaccharides from marine algae. Bulletin of Experimental Biology and Medicine 142(5): 591-593
Sugiyama, K.; Isogai, K.; Toyama, A.; Satoh, H.; Saito, K.; Nakagawa, Y.; Tasaki, M.; Takahashi, K.; Saito, N.; Hirano, T. 2008: Pharmacodynamic parameters of immunosuppressive drugs are not correlated with age, duration of dialysis, percentage of lymphocytes or lymphocyte stimulation index in renal transplant recipients. Biological and Pharmaceutical Bulletin 31(11): 2146-2149
Aguilar, L.; Granizo, J.José. 2011: Pharmacodynamic parameters to evaluate antibiotic cover as empirical treatment. Enfermedades Infecciosas y Microbiologia Clinica 29(3): 165-166
Kuti, J.L.; Dowzicky, M.; Nicolau, D.P. 2008: Pharmacodynamic performance of tigecycline versus common intravenous antibiotics for the empiric treatment of complicated skin and skin structure infections. Surgical Infections 9(1): 57-66
Russo, E.; Donato di Paola, E.; Gareri, P.; Siniscalchi, A.; Labate, A.; Gallelli, L.; Citraro, R.; De Sarro, G. 2013: Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacological Research 70(1): 1-12
Watanabe, M.; Ishizuka, K.; Ikemoto, T. 2007: Pharmacodynamic profile and clinical efficacy of moxifloxacin ophthalmic solution (Vegamox 0.5% ophthalmic solution. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 129(5): 375-385
Housman, S.T.; Sutherland, C.A.; Nicolau, D.P. 2014: Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitals. International Journal of Antimicrobial Agents 44(3): 235-241
Koomanachai, P.; Crandon, J.L.; Banevicius, M.A.; Peng, L.; Nicolau, D.P. 2009: Pharmacodynamic profile of tigecycline against methicillin-resistant Staphylococcus aureus in an experimental pneumonia model. Antimicrobial Agents and ChemoTherapy 53(12): 5060-5063
Goldberg, M.E.; Torjman, M.C.; Schwartzman, R.J.; Mager, D.E.; Wainer, I.W. 2010: Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome. Pain Physician 13(4): 379-387
Keel, R.A.; Zhanel, G.G.; Zelenitsky, S.; Nicolau, D.P. 2011: Pharmacodynamic profiling of antimicrobials against Gram-negative respiratory isolates from Canadian hospitals. Canadian Journal of Infectious Diseases and Medical Microbiology 22(4): 132-136
Kimko, H.; Xu, X.; Nandy, P.; Samtani, M.N.; Strauss, R.S.; Bagchi, P.; Noel, G.J. 2009: Pharmacodynamic profiling of ceftobiprole for treatment of complicated skin and skin structure infections. Antimicrobial Agents and ChemoTherapy 53(8): 3371-3374
Cuba, G.T.; Pignatari, A.C.C.; Patekoski, K.S.; Luchesi, L.J.; Kiffer, C.R.V. 2014: Pharmacodynamic profiling of commonly prescribed antimicrobial drugs against Escherichia coli isolates from urinary tract. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 18(5): 512-517
Roberts, J.A.; Kwa, A.; Montakantikul, P.; Gomersall, C.; Kuti, J.L.; Nicolau, D.P. 2011: Pharmacodynamic profiling of intravenous antibiotics against prevalent Gram-negative organisms across the globe: the PASSPORT Program-Asia-Pacific Region. International Journal of Antimicrobial Agents 37(3): 225-229
Maglio, D.; Sun, H.K.; Patel, T.; Banevicius, M.A.; Nightingale, C.H.; Arya, A.; Wang, G.; Chen, Z.; Phan, L.T.; Nicolau, D.P. 2014: Pharmacodynamic profiling of modithromycin: assessment in a pneumococcal murine pneumonia model. International Journal of Antimicrobial Agents 43(6): 540-546
Mulabegović, N.; Rakanović-Todić, M. 2008: Pharmacodynamic properties of a combination of met-enkephalin and alpha 1-13 adrenocorticotropic hormone. Medicinski Arhiv 62(1): 41-44
Kalantzi, K.I.; Tsoumani, M.E.; Goudevenos, I.A.; Tselepis, A.D. 2012: Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives. Expert Review of Clinical Pharmacology 5(3): 319-336
Ercoli, N.; Hueper, W.C. 1948: Pharmacodynamic properties of penicillin preparations with prolonged action. American Journal of the Medical Sciences 215(5): 498-505
Macht, D.I. 1946: Pharmacodynamic reactions of previously irradiated organisms. Federation Proceedings 5(1 Part 2): 69
Harrington, D.J.; Gorska, R.; Wheeler, R.; Davidson, S.; Murden, S.; Morse, C.; Shearer, M.J.; Mumford, A.D. 2008: Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions in VKORC1. Journal of Thrombosis and Haemostasis: Jth 6(10): 1663-1670
Staats, M.C.; Ernst, M.E. 2012: Pharmacodynamic response to warfarin after conversion of atrial fibrillation or flutter to sinus rhythm. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 69(13): 1158-1161
Sivanmalai, S.; Annamalai, S.; Kumar, S.; Prince, C.N.; Chandrakala; Thangaswamy, V. 2012: Pharmacodynamic responses of exogenous epinephrine during mandibular third molar surgery. Journal of Pharmacy and Bioallied Sciences 4(Suppl 2): S390-S393
Prickett, T.C.R.; Bothwell, J.C.; Yandle, T.G.; Richards, A.M.; Espiner, E.A. 2012: Pharmacodynamic responses of plasma and tissue C-type natriuretic peptide to GH: correlation with linear growth in GH-deficient rats. Journal of Endocrinology 212(2): 217-225
Fisher, J.E.; Scott, K.; Wei, N.; Zhao, J.Z.; Cusick, T.; Tijerina, M.; Karanam, B.; Duong, L.; Glantschnig, H. 2012: Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats. Bone 50(6): 1332-1342
Shen, Z-Bin.; Yin, Y-Qin.; Tang, C-Ping.; Yan, C-Yan.; Chen, C.; Guo, L-Bing. 2010: Pharmacodynamic screening and simulation study of anti-hypoxia active fraction of xiangdan injection. Journal of Ethnopharmacology 127(1): 103-107
Semrad, T.; Barzi, A.; Lenz, H.-J.; Hutchins, I.M.; Kim, E.J.; Gong, I.-Y.; Tanaka, M.; Beckett, L.; Holland, W.; Burich, R.A.; Snyder-Solis, L.; Mack, P.; Lara, P.N. 2015: Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results. International Journal of Clinical Oncology 20(3): 518-524
Yonkman, F.F.; Chess, D. 1946: Pharmacodynamic studies of a new antihistamine agent, N'-pyridyl-N benzyl-N-dimethylethylene diamine HCI, pyribenzamine HCI; effects on salivation, nictitating membrane, lachrymation, pupil and blood pressure. Journal of Pharmacology and Experimental Therapeutics 87: 256-264
Yonkman, F.F.; Oppenheimer, E. 1947: Pharmacodynamic studies of a new antihistaminic agent, pyribenzamine (N,N-dimethyl-N'-benzyl-N'-(alpha-pyridyl)-ethylene diamine hydrochloride). Journal of Pharmacology and Experimental Therapeutics 89(1): 31-41
Kingsley, B.; Kayarohanam, S.; Brindha, P.; Subramoniam, A. 2014: Pharmacodynamic studies on the isolated active fraction of Acacia farnesiana (L.) willd. Pharmacognosy Magazine 10(Suppl 2): S283-S287
Zhu, H.; Dang, X.; Yan, K.; Dai, P.; Luo, C.; Ma, J.; Li, Y.; Chang, T.M.S.; Chen, C. 2011: Pharmacodynamic study of polymerized porcine hemoglobin (pPolyHb) in a rat model of exchange transfusion. Artificial Cells Blood Substitutes and Immobilization Biotechnology 39(3): 119-126
Li, R.-J.; Qiu, J.; Zhang, X.-n.; Chen, J.; Li, G. 2012: Pharmacodynamic study of racemic TJ0711 on renal hypertensive rats after long-term administration. Yao Xue Xue Bao 47(8): 1001-1005
Vázquez, R.; Riveiro, Mía.Eugenia.; Mondillo, C.; Perazzo, J.Carlos.; Vermeulen, Mónica.; Baldi, A.; Davio, C.; Shayo, C. 2013: Pharmacodynamic study of the 7,8-dihydroxy-4-methylcoumarin-induced selective cytotoxicity toward U-937 leukemic cells versus mature monocytes: cytoplasmic p21(Cip1/WAF1) as resistance factor. Biochemical Pharmacology 86(2): 210-221
Cahen, R.; Chariot, J. 1960: Pharmacodynamic study of the sapwood of the lime tree. Coronary dilator effect. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 154: 2235-2238
Shamim, S.; Ahmad, S.I. 2012: Pharmacodynamic study on acute hypotensive activities of Carissa carandas extract in normal rats. Pakistan Journal of Pharmaceutical Sciences 25(3): 577-582
Liu, G.; Jeraj, R.; Vanderhoek, M.; Perlman, S.; Kolesar, J.; Harrison, M.; Simoncic, U.; Eickhoff, J.; Carmichael, L.; Chao, B.; Marnocha, R.; Ivy, P.; Wilding, G. 2011: Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(24): 7634-7644
Danielsson, M.; Rosenthal-Aizman, K.; Bergsson, G.; Undén, A. 2011: Pharmacodynamic synergy strictly dependent on the co-operative aggregation of enantiomers of cyclic peptides in the bacterial cell membrane. Bioorganic and Medicinal Chemistry Letters 21(18): 5262-5265
Loo, A.S.; Neely, M.; Anderson, E.J.; Ghossein, C.; McLaughlin, M.M.; Scheetz, M.H. 2013: Pharmacodynamic target attainment for various ceftazidime dosing schemes in high-flux hemodialysis. Antimicrobial Agents and ChemoTherapy 57(12): 5854-5859
Fallon, R.M.; Kuti, J.L.; Doern, G.V.; Girotto, J.E.; Nicolau, D.P. 2008: Pharmacodynamic target attainment of oral beta-lactams for the empiric treatment of acute otitis media in children. Paediatric Drugs 10(5): 329-335
Noreddin, A.M.; El-Khatib, W.F.; Aolie, J.; Salem, A.H.; Zhanel, G.G. 2009: Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 13(4): 483-487
DeGrado, J.R.; Cios, D.; Greenwood, B.C.; Kubiak, D.W.; Szumita, P.M. 2014: Pharmacodynamic target attainment with high-dose extended-interval tobramycin therapy in patients with cystic fibrosis. Journal of ChemoTherapy 26(2): 101-104
Meduna, L.J. 1947: Pharmacodynamic treatment of the psychoneuroses. Arquivos de Neuro-Psiquiatria 5(3): 244-248
Rojo, F.; Gracias, E.ía.; Villena, N.; Cruz, T.; Corominas, J.M.; Corradino, I.; Cedeño, M.; Campas, C.; Osorio, M.; Iznaga, N.; Bellosillo, B.; Rovira, A.; Marsoni, S.; Gascon, P.; Serrano, S.; Sessa, C.; Crombet, T.; Albanell, J. 2010: Pharmacodynamic trial of nimotuzumab in unresectable squamous cell carcinoma of the head and neck: a SENDO Foundation study. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16(8): 2474-2482
Mathis, H. 1951: Pharmacodynamic use of vitamins in stomatology. Deutsche Zahnarztliche Zeitschrift 14(9-10): 373-397
Fleischmann, R.; Kerr, B.; Yeh, L.-T.; Suster, M.; Shen, Z.; Polvent, E.; Hingorani, V.; Quart, B.; Manhard, K.; Miner, J.N.; Baumgartner, S. 2014: Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia. Rheumatology 53(12): 2167-2174
Nicasio, A.M.; Eagye, K.J.; Nicolau, D.P.; Shore, E.; Palter, M.; Pepe, J.; Kuti, J.L. 2010: Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia. Journal of Critical Care 25(1): 69-77
Jimeno, A.; Rudek, M.A.; Kulesza, P.; Ma, W.W.; Wheelhouse, J.; Howard, A.; Khan, Y.; Zhao, M.; Jacene, H.; Messersmith, W.A.; Laheru, D.; Donehower, R.C.; Garrett-Mayer, E.; Baker, S.D.; Hidalgo, M. 2008: Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(25): 4172-4179
Gabrielsson, J.; Fjellström, O.; Ulander, J.; Rowley, M.; Van Der Graaf, P.H. 2011: Pharmacodynamic-pharmacokinetic integration as a guide to medicinal chemistry. Current Topics in Medicinal Chemistry 11(4): 404-418
Yao, Z.; Hoffman, E.P.; Ghimbovschi, S.; DuBois, D.C.; Almon, R.R.; Jusko, W.J. 2008: Pharmacodynamic/pharmacogenomic modeling of insulin resistance genes in rat muscle after methylprednisolone treatment: exploring regulatory signaling cascades. Gene Regulation and Systems Biology 2: 141-161
Conly, J.; Shafran, S. 1995: Pharmacodynamics and alternative antimicrobial dosing regimens. Canadian Journal of Infectious Diseases 6(1): 9-11
Heerdt, P.M.; Malhotra, J.K.; Pan, B.Y.; Sunaga, H.; Savarese, J.J. 2010: Pharmacodynamics and cardiopulmonary side effects of CW002, a cysteine-reversible neuromuscular blocking drug in dogs. Anesthesiology 112(4): 910-916
Wiedersberg, S.; Naik, A.; Leopold, C.S.; Guy, R.H. 2009: Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability. British Journal of Dermatology 160(3): 676-686
Seyedmousavi, S.; Melchers, W.J.G.; Mouton, J.W.; Verweij, P.E. 2013: Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis. Antimicrobial Agents and ChemoTherapy 57(4): 1866-1871
Eisenbach, C.; Schönfeld, A.H.; Vogt, N.; Wente, M.N.; Encke, J.; Stremmel, W.; Martin, E.; Pfenninger, E.; Weigand, M.A. 2007: Pharmacodynamics and organ storage of hydroxyethyl starch in acute hemodilution in pigs: influence of molecular weight and degree of substitution. Intensive Care Medicine 33(9): 1637-1644
Kubitza, D.; Becka, M.; Mück, W.; Krätzschmar, J.öe. 2014: Pharmacodynamics and pharmacokinetics during the transition from warfarin to rivaroxaban: a randomized study in healthy subjects. British Journal of Clinical Pharmacology 78(2): 353-363
Loprete, L.; Leuratti, C.; Scarsi, C.; Radicioni, M. 2014: Pharmacodynamics and pharmacokinetics of a novel, low-dose, soft-gel capsule of acetylsalicylic acid in comparison with an oral solution after single-dose administration to healthy volunteers: a phase I, two-way crossover study. Clinical Drug Investigation 34(1): 19-25
Lortholary, O.; Lefort, A.ès.; Tod, M.; Chomat, A.-M.; Darras-Joly, C.ém.; Cordonnier, C.; Bourget, P.; Breilh, D.; Cohen, R.; Fantin, B.; Guetta, F.ço.; Hamon, X.; Herbrecht, R.; Leclerq, B.; Lenormand, Y.; Leverger, G.; Loze, S.; Nitenberg, G.ér.; Petitjean, O.; Pivot, C.; Potel, G.; Rozenbaum, M.; Schlemmer, B.; Sculier, J.-P. 2008: Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia. LANCET. Infectious Diseases 8(10): 612-620
Zheng, Z.-H.; Zhu, X.-X.; Gan, H.; Gu, R.-L.; Wu, Z.-N.; Meng, Z.-Y.; Dou, G.-F. 2013: Pharmacodynamics and pharmacokinetics of batroxobin in Beagle dog. Yao Xue Xue Bao 48(8): 1307-1311
Catalán-González, M.; Carlos Montejo-González, J. 2009: Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate. Revista Iberoamericana de Micologia 26(1): 23-34
Kato, M.; Satoh, D.; Okada, Y.; Sugiyama, K.; Toda, N.; Kurosawa, S. 2007: Pharmacodynamics and pharmacokinetics of remifentanil: overview and comparison with other opioids. Masui. Japanese Journal of Anesthesiology 56(11): 1281-1286
Small, D.S.; Payne, C.D.; Kothare, P.; Yuen, E.; Natanegara, F.; Teng Loh, M.; Jakubowski, J.A.; Richard Lachno, D.; Li, Y.G.; Winters, K.J.; Farid, N.A.; Ni, L.; Salazar, D.E.; Tomlin, M.; Kelly, R. 2010: Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trial. Clinical Therapeutics 32(2): 365-379
Lanz, T.A.; Wood, K.M.; Richter, K.E.G.; Nolan, C.E.; Becker, S.L.; Pozdnyakov, N.; Martin, B.-A.; Du, P.; Oborski, C.E.; Wood, D.E.; Brown, T.M.; Finley, J.E.; Sokolowski, S.A.; Hicks, C.D.; Coffman, K.J.; Geoghegan, K.F.; Brodney, M.A.; Liston, D.; Tate, B. 2010: Pharmacodynamics and pharmacokinetics of the gamma-secretase inhibitor PF-3084014. Journal of Pharmacology and Experimental Therapeutics 334(1): 269-277
Kosoglou, T.; Reyderman, L.; Tiessen, R.G.; van Vliet, A.é A.; Fales, R.R.; Keller, R.; Yang, B.; Cutler, D.L. 2012: Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects. European Journal of Clinical Pharmacology 68(3): 249-258
Liem-Moolenaar, M.; Cerneus, D.; Molloy, C.J.; End, D.; Brown, K.H.; de Kam, M.L.; Cohen, A.F.; van Hensbergen, Y.; Burggraaf, J. 2008: Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans. Clinical pharmacology and therapeutics 84(4): 481-487
Kierkus, J.; Furmaga-Jablonska, W.; Sullivan, J.E.; David, E.S.; Stewart, D.L.; Rath, N.; Fu, C.; Wang, W.; Maguire, M.K.; Comer, G.M. 2011: Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11 months with a clinical diagnosis of gastroesophageal reflux disease. Digestive Diseases and Sciences 56(2): 425-434
El-Khatib, F.H.; Jiang, J.; Gerrity, R.G.; Damiano, E.R. 2007: Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic Swine model in vivo. Diabetes Technology and Therapeutics 9(2): 135-144
Omari, T.; Lundborg, P.; Sandström, M.; Bondarov, P.; Fjellman, M.; Haslam, R.; Davidson, G. 2009: Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease. Journal of Pediatrics 155(2): 222-228
Cui, X.; Cao, D.-Y.; Wang, Z.-M.; Zheng, A.-P. 2013: Pharmacodynamics and toxicity of vasoactive intestinal peptide for intranasal administration. Die Pharmazie 68(1): 69-74
Rico, S.; Antonijoan, R.-M.ía.; Ballester, M.R.; Gutierro, I.; Ayani, I.; Martinez-Gonzalez, J.; Borrell, M.; Fontcuberta, J.; Gich, I. 2014: Pharmacodynamics assessment of Bemiparin after multiple prophylactic and single therapeutic doses in adult and elderly healthy volunteers and in subjects with varying degrees of renal impairment. Thrombosis Research 133(6): 1029-1038
Bowie, M.W.; Slattum, P.W. 2007: Pharmacodynamics in older adults: a review. American Journal of Geriatric PharmacoTherapy 5(3): 263-303
Wong, H.; Belvin, M.; Herter, S.; Hoeflich, K.P.; Murray, L.J.; Wong, L.; Choo, E.F. 2009: Pharmacodynamics of 2-[4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl]ethan-1-ol (GDC-0879), a potent and selective B-Raf kinase inhibitor: understanding relationships between systemic concentrations, phosphorylated mitogen-activated protein kinase kinase 1 inhibition, and efficacy. Journal of Pharmacology and Experimental Therapeutics 329(1): 360-367